Document:

EX-4.2

 Exhibit 4.2 

Execution Version 

FIRST SUPPLEMENTAL INDENTURE 

DATED AS OF AUGUST 11, 2017 

TO 
 INDENTURE 

DATED AS OF AUGUST 11, 2017 

BETWEEN 
 BIOMARIN
PHARMACEUTICAL INC. 
 AND 

WILMINGTON TRUST, NATIONAL ASSOCIATION, 

AS TRUSTEE 

 TABLE OF CONTENTS 

 

							
	 	 	 	  	Page	 
	ARTICLE 1	 
	DEFINITIONS AND INCORPORATION BY REFERENCE	 
			
	 Section 1.01
	 	 Scope of Supplemental Indenture
	  	 	2	 
	 Section 1.02
	 	 Definitions
	  	 	2	 
	 Section 1.03
	 	 Other Definitions
	  	 	9	 
	 Section 1.04
	 	 Rules of Construction
	  	 	10	 
	 Section 1.05
	 	 Acts of Holders
	  	 	11	 
	
	ARTICLE 2	 
	THE NOTES	 
			
	 Section 2.01
	 	 Designation, Form and Dating
	  	 	12	 
	 Section 2.02
	 	 Interest
	  	 	13	 
	 Section 2.03
	 	 Amount of Series Unlimited
	  	 	13	 
	 Section 2.04
	 	 Registrar, Paying Agent, Notice Agent, Conversion Agent and Trustee
	  	 	13	 
	 Section 2.05
	 	 Conversion Agent to Hold Shares in Trust
	  	 	16	 
	 Section 2.06
	 	 CUSIPs and ISINs
	  	 	16	 
	 Section 2.07
	 	 Defaulted Interest
	  	 	16	 
	 Section 2.08
	 	 No Sinking Fund
	  	 	16	 
	 Section 2.09
	 	 Surrender for Cancellation
	  	 	16	 
	
	ARTICLE 3	 
	REPURCHASE OF NOTES	 
			
	 Section 3.01
	 	 Repurchase of Notes at Option of the Holder upon a Fundamental Change
	  	 	17	 
	 Section 3.02
	 	 Effect of Fundamental Change Repurchase Notice
	  	 	20	 
	 Section 3.03
	 	 Deposit of Fundamental Change Repurchase Price
	  	 	20	 
	 Section 3.04
	 	 Repayment to the Company
	  	 	20	 
	 Section 3.05
	 	 Notes Purchased in Part
	  	 	20	 
	 Section 3.06
	 	 Compliance with Securities Laws upon Purchase of Notes
	  	 	21	 
	 Section 3.07
	 	 No Company Redemption Rights
	  	 	21	 
	 Section 3.08
	 	 Repurchase by Third Party
	  	 	21	 
	 Section 3.09
	 	 Exempted Fundamental Change
	  	 	21	 
	
	ARTICLE 4	 
	CONVERSION	 
			
	 Section 4.01
	 	 Conversion Privilege and Conversion Rate
	  	 	22	 
	 Section 4.02
	 	 Settlement Upon Conversion; Conversion Procedure
	  	 	24	 
	 Section 4.03
	 	 Fractional Shares
	  	 	26	 
	 Section 4.04
	 	 Taxes on Conversion
	  	 	26	 
	 Section 4.05
	 	 Company to Provide Common Stock
	  	 	26	 
	 Section 4.06
	 	 Adjustment of Conversion Rate
	  	 	26	 
	 Section 4.07
	 	 No Adjustment
	  	 	34	 

  
 i 

							
	 Section 4.08
	 	 Notice of Adjustment
	  	 	35	 
	 Section 4.09
	 	 [Reserved]
	  	 	35	 
	 Section 4.10
	 	 Effect of Reclassification, Consolidation, Merger or Sale on Conversion Privilege
	  	 	35	 
	 Section 4.11
	 	 Trustee’s Disclaimer
	  	 	37	 
	 Section 4.12
	 	 Voluntary Increase
	  	 	38	 
	 Section 4.13
	 	 Other Adjustments
	  	 	38	 
	 Section 4.14
	 	 Exchange in Lieu of Conversion
	  	 	38	 
	
	ARTICLE 5	 
	SUBORDINATION	 
			
	 Section 5.01
	 	 Notes Subordinated to Senior Debt
	  	 	39	 
	 Section 5.02
	 	 Subrogation
	  	 	40	 
	 Section 5.03
	 	 Obligation of the Company is Absolute and Unconditional
	  	 	41	 
	 Section 5.04
	 	 Maturity of or Default on Senior Debt
	  	 	41	 
	 Section 5.05
	 	 Payments on Notes Permitted
	  	 	41	 
	 Section 5.06
	 	 Effectuation of Subordination by Trustee
	  	 	41	 
	 Section 5.07
	 	 Knowledge of Trustee
	  	 	42	 
	 Section 5.08
	 	 Trustee’s Relation to Senior Debt
	  	 	42	 
	 Section 5.09
	 	 Rights of Holders of Senior Debt Not Impaired
	  	 	42	 
	 Section 5.10
	 	 Modification of Terms of Senior Debt
	  	 	42	 
	 Section 5.11
	 	 Certain Conversions Not Deemed Payment
	  	 	43	 
	 Section 5.12
	 	 Relation to other Indebtedness
	  	 	43	 
	
	ARTICLE 6	 
	COVENANTS	 
			
	 Section 6.01
	 	 Payment of Notes
	  	 	44	 
	 Section 6.02
	 	 SEC Reports
	  	 	45	 
	 Section 6.03
	 	 Stay, Extension and Usury Laws
	  	 	46	 
	
	ARTICLE 7	 
	CONSOLIDATION; MERGER; CONVEYANCE; TRANSFER OR LEASE	 
			
	 Section 7.01
	 	 Company May Consolidate, Etc., Only on Certain Terms
	  	 	46	 
	 Section 7.02
	 	 Successor Substituted
	  	 	46	 
	
	ARTICLE 8	 
	DEFAULTS AND REMEDIES	 
			
	 Section 8.01
	 	 Events of Default
	  	 	47	 
	 Section 8.02
	 	 Acceleration of Maturity; Rescission and Annulment
	  	 	48	 
	 Section 8.03
	 	 Other Remedies
	  	 	50	 
	 Section 8.04
	 	 Waiver of Past Defaults
	  	 	50	 
	 Section 8.05
	 	 Control by Majority
	  	 	51	 
	 Section 8.06
	 	 Limitation on Suit
	  	 	51	 
	 Section 8.07
	 	 Unconditional Rights of Holders to Receive Payment and to Convert
	  	 	51	 
	 Section 8.08
	 	 Collection of Indebtedness and Suits for Enforcement by the Trustee
	  	 	52	 

  
 ii 

							
	 Section 8.09
	 	 Trustee May File Proofs of Claim
	  	 	52	 
	 Section 8.10
	 	 Trustee May Enforce Claims Without Possession of Notes
	  	 	53	 
	 Section 8.11
	 	 Restoration of Rights and Remedies
	  	 	53	 
	 Section 8.12
	 	 Rights and Remedies Cumulative
	  	 	53	 
	 Section 8.13
	 	 Delay or Omission Not Waiver
	  	 	54	 
	 Section 8.14
	 	 Application of Money Collected
	  	 	54	 
	 Section 8.15
	 	 Undertaking for Costs
	  	 	54	 
	 Section 8.16
	 	 Waiver of Stay or Extension Laws
	  	 	55	 
	 Section 8.17
	 	 Notice of Defaults
	  	 	55	 
	
	ARTICLE 9	 
	AMENDMENTS AND WAIVERS	 
			
	 Section 9.01
	 	 Without Consent of Holders
	  	 	55	 
	 Section 9.02
	 	 With Consent of Holders
	  	 	56	 
	 Section 9.03
	 	 Revocation and Effect of Consents
	  	 	57	 
	 Section 9.04
	 	 Notation on or Exchange of Notes
	  	 	58	 
	 Section 9.05
	 	 Trustee Protected
	  	 	58	 
	
	ARTICLE 10	 
	SATISFACTION AND DISCHARGE	 
			
	 Section 10.01
	 	 Satisfaction and Discharge of Indenture
	  	 	58	 
	 Section 10.02
	 	 Return of Unclaimed Money
	  	 	59	 
	 Section 10.03
	 	 Application of Trust Funds; Indemnification
	  	 	59	 
	
	ARTICLE 11	 
	MEETING OF HOLDERS OF NOTES	 
			
	 Section 11.01
	 	 Purposes for Which Meetings May Be Called
	  	 	60	 
	 Section 11.02
	 	 Call Notice and Place of Meetings
	  	 	60	 
	 Section 11.03
	 	 Persons Entitled to Vote at Meetings
	  	 	61	 
	 Section 11.04
	 	 Quorum; Action
	  	 	61	 
	 Section 11.05
	 	 Determination of Voting Rights; Conduct and Adjournment of Meetings
	  	 	61	 
	 Section 11.06
	 	 Counting Votes and Recording Action of Meetings
	  	 	62	 
	
	ARTICLE 12	 
	MISCELLANEOUS	 
			
	 Section 12.01
	 	 Calculations in Respect of Notes
	  	 	62	 
	 Section 12.02
	 	 Notices
	  	 	63	 

  
 iii 

 THIS FIRST SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated
as of August 11, 2017, is between BioMarin Pharmaceutical Inc., a corporation duly organized under the laws of the State of Delaware (the “Company”), and Wilmington Trust, National Association, a national banking association,
as Trustee (the “Trustee”), and supplements the indenture, dated as of August 11, 2017, between the Company and the Trustee (the “Base Indenture” and, as amended and supplemented by this Supplemental Indenture,
and as it may be further amended or supplemented from time to time with respect to the Notes (as defined below), the “Indenture”). 

RECITALS 
 WHEREAS, the
Company executed and delivered the Base Indenture to the Trustee to provide, among other things, for the issuance, from time to time, of the Company’s Securities, in an unlimited aggregate principal amount, in one or more series to be
established by the Company under, and authenticated and delivered as provided in, the Base Indenture; 
 WHEREAS, Section 2.01 of the
Base Indenture provides that the Company may issue such Securities in the form and on the terms set forth in one or more supplemental indentures; 

WHEREAS, the issuance and sale of up to $495,000,000 aggregate principal amount of the Company’s 0.599% Senior Subordinated Convertible
Notes due 2024 (the “Notes” and each of them a “Note”) has been authorized by resolutions adopted by the Board of Directors and the Pricing Committee of the Board of Directors; 

WHEREAS, the form of Note and the certificate of authentication to be borne by each Note, are to be substantially in the form hereinafter
provided; 
 WHEREAS, the conditions set forth in the Base Indenture for the execution and delivery of this Supplemental Indenture have been
complied with; and 
 WHEREAS, all acts and things necessary to make the Base Indenture, the Supplemental Indenture and the Notes, when
executed by the Company and authenticated and delivered by the Trustee or a duly authorized authenticating agent, as provided in this Supplemental Indenture, the valid, binding and legal obligations of the Company, enforceable according to their
terms, have been done and performed, and the execution of this Supplemental Indenture and the issuance hereunder of the Notes have in all respects been duly authorized. 

NOW, THEREFORE, THIS SUPPLEMENTAL INDENTURE WITNESSETH: 

That in order to declare the terms and conditions upon which the Notes are, and are to be, authenticated, issued and delivered, and in
consideration of the premises and of the purchase and acceptance of the Notes by the Holders thereof, the Company covenants and agrees with the Trustee for the equal and proportionate benefit of the respective Holders from time to time of the Notes
(except as otherwise provided below), as follows: 

  
 1 

 ARTICLE 1 

DEFINITIONS AND INCORPORATION BY REFERENCE 

Section 1.01    Scope of Supplemental Indenture. This Supplemental Indenture supplements the provisions of the
Base Indenture, to which provisions reference is hereby made. The changes, modifications and supplements to the Base Indenture effected by this Supplemental Indenture shall be applicable only with respect to, and shall only govern the terms of, the
Notes, which may be issued from time to time, and shall not apply to any other Securities that may be issued under the Base Indenture unless a supplemental indenture with respect to such other securities specifically incorporates such changes,
modifications and supplements. For all purposes under the Base Indenture, the Notes shall constitute a single series of Notes, and with regard to any matter requiring the consent under the Base Indenture of Holders of multiple Series of Notes voting
together as a single class, the consent of Holders of the Notes voting as a separate class shall also be required and the same threshold shall apply. The provisions of this Supplemental Indenture shall supersede any conflicting provisions in the
Base Indenture. 
 Section 1.02    Definitions. The terms defined in this Section 1.02 (except as
herein otherwise expressly provided or unless the context otherwise requires) for all purposes of the Indenture shall have the respective meanings specified in this Section 1.02, and to the extent applicable, supersede any definition thereof in
the Base Indenture. All words, terms and phrases defined in the Base Indenture (but not otherwise defined herein) shall have the same meanings as in the Base Indenture. The words “herein,” “hereof,” “hereunder,” and
words of similar import refer to the Indenture as a whole and not to any particular Article, Section or other subdivision. 
 “2018
Notes” means the Company’s 0.75% Senior Subordinated Convertible Notes due 2018 issued pursuant to that certain First Supplemental Indenture, dated October 15, 2013, by and between the Company and the Trustee, as amended,
restated, supplemented or otherwise modified from time to time. 
 “2020 Notes” means the Company’s 1.50% Senior
Subordinated Convertible Notes due 2020 issued pursuant to that certain Second Supplemental Indenture, dated October 15, 2013, by and between the Company and the Trustee, as amended, restated, supplemented or otherwise modified from time to
time. 
 “Agent” means any Registrar, Paying Agent, Notice Agent or Conversion Agent. 

“Applicable Procedures” means, with respect to any conversion, transfer or exchange of beneficial ownership interests in a
Global Note, the rules and procedures of the Depositary, to the extent applicable to such conversion, transfer or exchange. 

“Business Day” means any day except a Saturday, Sunday or a legal holiday in the City of New York on which banking
institutions are authorized or required by law, regulation or executive order to close; provided, however, that solely for purposes of determining the dates on which payments are due on the Notes, a day on which banking institutions in
the applicable place of payment are authorized or required by law, regulation or executive order to close will be deemed not to be a “Business Day.” 

  
 2 

 “Capital Stock” of any Person means any and all shares, interests, rights to
purchase, warrants, options, participations or other equivalents of or interests in (however designated) equity of such Person, but excluding any debt securities convertible into or exchangeable for such equity. 

“Cash” means such coin or currency of the United States as at any time of payment is legal tender for the payment of public
and private debts. 
 “Certificated Note” means a Note that is in substantially the form attached as Exhibit A but that
does not include the Global Notes Legend or the attached schedule of exchanges. 
 “Change of Control” means the occurrence
of any of the following events from and after the Issue Date: 
 (i)    the acquisition by any person, including any
syndicate or group deemed to be a “person” (as such terms are used in Section 13(d)(3) of the Exchange Act, or any successor provision to the foregoing), of beneficial ownership (as defined in Rule
13d-3 under the Exchange Act), directly or indirectly, through a purchase, merger or other acquisition transaction or series of transactions of shares of the Company’s Capital Stock entitling that person
to exercise 50% or more of the total voting power of all shares of the Company’s Capital Stock entitled to vote generally in elections of directors, other than any acquisition by the Company, any of the Company’s subsidiaries or any of the
Company’s employee benefit plans; 
 (ii)    the consummation of (A) any recapitalization, reclassification or
change of Common Stock (other than changes resulting from a subdivision, combination or change in par value) as a result of which all of the Common Stock would be converted into, or exchanged solely for, stock, other securities, or other property or
assets; (B) any share exchange, consolidation or merger of the Company pursuant to which the Common Stock will be converted into Cash, securities or other property; or (C) any sale, lease or other transfer in one transaction or a series of
transactions of all or substantially all of the consolidated assets of the Company and its Subsidiaries, taken as a whole, to any Person other than one or more Wholly Owned Subsidiaries of the Company; provided, however, that a
transaction described in clause (A) or (B) of this clause (ii) in which the holders of all classes of the Company’s common equity immediately prior to such transaction own, directly or indirectly, more than 50% of all classes of
common equity of the continuing, acquiring or surviving corporation or transferee or the parent thereof immediately after such transaction in substantially the same proportions (relative to each other) as such ownership immediately prior to such
transaction shall not be a Change of Control pursuant to this clause (ii); or 
 (iii)    the Company’s
stockholders pass a resolution approving a plan of liquidation or dissolution. 
 Notwithstanding anything to the contrary set forth herein,
a Change of Control will not be deemed to have occurred if, in the case of a merger or consolidation, at least 90% of the consideration (excluding Cash payments for fractional shares and Cash payments pursuant to dissenters’ appraisal rights)
in the merger or consolidation constituting the Change of Control consists of shares of common stock listed for trading on The New York Stock Exchange, the 

  
 3 

 
NASDAQ Global Market or the NASDAQ Global Select Market (or any of their respective successors), or which will be so listed when issued or exchanged in connection with such Change of Control, and
such transaction constitutes a Common Stock Change Event whose Reference Property consists of such consideration (subject to Section 4.02). 

“Close of Business” means 5:00 p.m., New York City time. 

“Common Stock” means the common stock of the Company, par value $0.001 per share, as it exists on the date of this Indenture
and any shares of any class or classes of Capital Stock of the Company resulting from any reclassification or reclassifications thereof, or, in the event of a merger, consolidation or other similar transaction involving the Company that is otherwise
permitted hereunder in which the Company is not the surviving corporation the common stock, common equity interests, ordinary shares or depositary shares or other certificates representing common equity interests of such surviving corporation or its
direct or indirect parent corporation, and which have no preference in respect of dividends or of amounts payable in the event of any voluntary or involuntary liquidation, dissolution or winding-up of the
Company and which are not subject to redemption by the Company; provided, however, that if at any time there shall be more than one such resulting class, the shares of each such class then so issuable on conversion of Notes shall be
substantially in the proportion which the total number of shares of such class resulting from all such reclassifications bears to the total number of shares of all such classes resulting from all such reclassifications. 

“Company Order” means a written order of the Company, signed by one of its Officers and delivered to the Trustee. 

“Conversion Price” per share of Common Stock as of any day means the result obtained by dividing (i) $1,000 by (ii) the
then applicable Conversion Rate. 
 “Conversion Rate” means the rate at which shares of Common Stock shall be delivered
upon conversion, which rate shall be initially 8.0212 shares of Common Stock for each $1,000 principal amount of the Notes, as adjusted from time to time pursuant to the provisions of this Indenture. 

“Effective Date” means, for purposes of Section 4.06, the first date on which the shares of Common Stock trade on the
applicable exchange or in the applicable market, regular way, reflecting the relevant share split or share combination, as applicable. 

“Ex-Dividend Date” means the first date on which the shares of Common Stock trade on
the applicable exchange or in the applicable market, regular way, without the right to receive the issuance, dividend or distribution in question, from the Company or, if applicable, from the seller of Common Stock on such exchange or market (in the
form of due bills or otherwise) as determined by such exchange or market. Any alternative trading convention on the applicable exchange or market in respect of the Common Stock under a separate ticker symbol or CUSIP number will not be considered
“regular way.” 
 “Final Maturity Date” means August 1, 2024. 

  
 4 

 “Fundamental Change” means the occurrence of either a Change of Control or a
Termination of Trading. 
 “Fundamental Change Effective Date” means the date on which any Fundamental Change becomes
effective. 
 “Fundamental Change Repurchase Price” of any Note means 100% of the principal amount of the Note to be
repurchased plus interest accrued and unpaid to, but excluding, the Fundamental Change Repurchase Date, subject to Section 3.01(a). 

“GAAP” means generally accepted accounting principles in the United States of America set forth in the opinions and
pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and the statements and pronouncements of the Financial Accounting Standards Board or in such other statements by such other entity as
approved by a significant segment of the accounting profession, which are in effect from time to time. 
 “Global Note” or
“Global Notes” means a Note or Notes, as the case may be, in global form that is in substantially the form attached as Exhibit A and that includes the Global Notes Legend and the schedule of exchanges and which is deposited
with the Depositary or its custodian and registered in the name of the Depositary or its nominee. 
 “Global Notes Legend”
means the legend set forth as such in Exhibit A hereto. 
 “Holder” or “Holder of a Note” means the Person
in whose name a Note is registered on the Registrar’s books. 
 “Indebtedness,” when used with respect to any Person,
and without duplication, means: 
 (i)    all indebtedness, obligations and other liabilities (contingent or otherwise)
of such Person (a) for borrowed money (including obligations of such Person in respect of overdrafts, foreign exchange contracts, currency exchange agreements, Interest Rate Protection Agreements, and any loans or advances from banks, whether
or not evidenced by notes or similar instruments); (b) evidenced by bonds, notes or other instruments for the payment of money or (c) incurred in connection with the acquisition of any property, services or assets (whether or not the recourse
of the lender is to the whole of the assets of such Person or to only a portion thereof), other than any account payable or other accrued current liability or obligation to trade creditors incurred in the ordinary course of business in connection
with the obtaining of materials or services; 
 (ii)    all reimbursement obligations and other liabilities (contingent
or otherwise) of such Person with respect to letters of credit, bank guarantees, bankers’ acceptances, surety bonds, performance bonds or any other guaranty of contractual performance; 

(iii)    all obligations and liabilities (contingent or otherwise) in respect of (a) leases of such Person required,
in conformity with GAAP, to be accounted for as capitalized lease obligations on the balance sheet of such Person or (b) any lease or related documents, including a purchase agreement, in connection with the lease of real property which
provides that 

  
 5 

 
such Person is contractually obligated to purchase or cause a third party to purchase the leased property and thereby guarantee a minimum residual value of the leased property to the landlord,
and the obligations of such Person under such lease or related document to purchase or to cause a third party to purchase the leased property; 

(iv)    all obligations of such Person (contingent or otherwise) with respect to an interest rate or other swap, cap or
collar agreement or other similar instrument or agreement or foreign currency hedge, exchange, purchase or similar instrument or agreement; 

(v)    all direct or indirect guaranties or similar agreements by such Person in respect of, and obligations or
liabilities (contingent or otherwise) of such Person to purchase or otherwise acquire or otherwise assure a creditor against loss in respect of, indebtedness, obligations or liabilities of another Person of the kind described in clauses
(i) through (iv) of this definition, inclusive; 
 (vi)    any indebtedness or other obligations described in
clauses (i) through (v) of this definition, inclusive, secured by any mortgage, pledge, lien or other encumbrance existing on property that is owned or held by such Person, regardless of whether the indebtedness or other obligation secured
thereby shall have been assumed by such Person; and 
 (vii)    any and all deferrals, renewals, extensions,
refinancings, replacements, restatements and refundings of, or amendments, modifications or supplements to, any indebtedness, obligation or liability of the kind described in clauses (i) through (vi) of this definition, inclusive. 

The 2018 Notes and the 2020 Notes shall not be “Senior Debt” for purposes of this Indenture but shall rank equally in right of
payment with the Notes. 
 “Interest Payment Date” means February 1 and August 1 of each year, commencing on
February 1, 2018 (or such other date as may be set forth in the certificate representing the applicable Note). 
 “Interest
Rate” means 0.599%. 
 “Interest Rate Protection Agreements” means, with respect to any Person, any interest rate
swap agreement, interest rate cap or collar agreement or other financial agreement or arrangement designed to protect such Person against fluctuations in interest rates, as in effect from time to time. 

“Issue Date” of any Note means the date on which the Note was originally issued or deemed issued as set forth on the face of
the Note. 
 “Last Reported Sale Price” of the Common Stock on any date means the closing sale price (or if no closing sale
price is reported, the average of the bid and ask prices or, if more than one in either case, the average of the average bid and the average ask prices) per share on that date as reported in composite transactions for the principal U.S. national or
regional securities exchange on which the Common Stock is traded. If the Common Stock is not listed for trading on a U.S. national or regional securities exchange on the relevant date, the “Last Reported Sale

  
 6 

 
Price” will be the last quoted bid price per share for the Common Stock in the over-the-counter market on the
relevant date as reported by the OTC Markets Group Inc. or a similar organization. If the Common Stock is not so quoted, the “Last Reported Sale Price” will be the average of the mid-point of the
last bid and ask prices per share for the Common Stock on the relevant date from each of at least three nationally recognized independent investment banking firms, selected by the Company for this purpose. Any such determination will be conclusive
absent manifest error. 
 “Make-Whole Fundamental Change” means a Fundamental Change, but without giving effect to the
proviso to clause (ii) of the definition of a Change of Control. 
 “Notes Custodian” means the Trustee, as custodian
with respect to the Notes in global form, or any successor thereto. 
 “Open of Business” means 9:00 a.m., New York City
time. 
 “Prospectus Supplement” means the preliminary prospectus supplement for the offering and sale of the Notes, dated
August 7, 2017, as supplemented by the related pricing term sheet filed with the SEC as a free writing prospectus. 

“Receiver” means any receiver, trustee, assignee, liquidator or similar official under any Bankruptcy Law. 

“Record Date” means, with respect to any dividend, distribution or other transaction or event in which the holders of Common
Stock (or other applicable security) have the right to receive any cash, securities or other property or in which the Common Stock (or such other security) is exchanged for or converted into any combination of cash, securities or other property, the
date fixed for determination of holders of the Common Stock (or such other security) entitled to receive such cash, securities or other property (whether such date is fixed by the Board of Directors, by statute, by contract or otherwise). 

“Regular Record Date” means, with respect to each Interest Payment Date, January 15 or July 15 (whether or not such
day is a Business Day), as the case may be, immediately preceding such Interest Payment Date. 
 “Relevant Exchange” means
The NASDAQ Global Select Market or, if the Common Stock is not then listed on The NASDAQ Global Select Market, the principal U.S. national or regional securities exchange on which the Common Stock is listed for trading. 

“Rights” means any common stock or preferred stock purchase right or warrant, as the case may be, that all or substantially
all shares of Common Stock are entitled to receive under a Rights Plan. 
 “Rights Plan” means any preferred shares rights
plan or any similar plan adopted by the Company after the date hereof. 
 “Scheduled Trading Day” means a day that is
scheduled to be a Trading Day on the principal U.S. national or regional securities exchange or market on which the Common Stock 

  
 7 

 
(or other security for which a closing sale price must be determined) is listed or admitted for trading. If the Common Stock (or such other security) is not so listed or admitted for trading,
“Scheduled Trading Day” means a “Business Day.” 
 “Securities Act” means the Securities Act of 1933,
as amended, and the rules and regulations promulgated thereunder, as in effect from time to time. 
 “Senior Debt” means
all the (i) principal of, (ii) premium, if any, on (iii) interest (including all interest accruing subsequent to the commencement of any bankruptcy or similar proceeding, whether or not a claim for post-petition interest is allowable
as a claim in any such proceeding), on, (iv) termination payments with respect to or in connection with and (v) all fees, costs, expenses and other amounts accrued or due on or in connection with, Indebtedness of the Company, whether
outstanding on the date of this Indenture or thereafter created, incurred, assumed, guaranteed or in effect guaranteed by the Company (including all deferrals, renewals, extensions or refundings of, or amendments, modifications or supplements to,
the foregoing), in each case except for: 
 (i)    Indebtedness that by its terms expressly provides that it shall not
be senior in right of payment to the Notes or expressly provides that such Indebtedness is equal with or junior to the Notes; 

(ii)    Indebtedness between or among the Company or any of the Subsidiaries or other affiliates of the Company; 

(iii)    any Indebtedness incurred for the purchase of goods or materials or for services obtained in the ordinary course
of business (other than with the proceeds of revolving credit borrowings); and 
 (iv)    any Indebtedness that is
classified as non-recourse in accordance with GAAP or any unsecured claim arising in respect thereof pursuant to Section 1111(b)(1) of Title 11 of the United States Code. 

“Significant Subsidiary” of any Person means any subsidiary of that Person that constitutes, or any group of subsidiaries of
that person that, in the aggregate, would constitute, a “significant subsidiary” (as defined in Rule 1-02(w) of Regulation S-X under the Exchange Act) of that
Person; provided, however, that, if a subsidiary meets the criteria of clause (3) of the definition of “significant subsidiary” in Rule 1-02(w) but not clause (1) or (2) thereof, then such
subsidiary will be deemed not to be a Significant Subsidiary of that Person unless such subsidiary’s or group’s income from continuing operations before income taxes, extraordinary items and cumulative effect of a change in accounting
principle, exclusive of amounts attributable to any non-controlling interests, for the last completed fiscal year before the date of determination exceeds $50.0 million. 

“Special Interest” means additional interest payable on the Securities in the circumstances provided in Section 8.02.
References to interest in this Indenture include Special Interest then payable. 

  
 8 

 “Stock Price” means the price paid, or deemed to be paid, per share of the
Common Stock in connection with a Make-Whole Fundamental Change as determined pursuant to Section 4.01(d). 
 “T+2 Effective
Date” means the date, if at all, the Relevant Exchange has adopted a normal settlement cycle of two Business Days for trading in the Common Stock, and the T+2 Effective Date will be the first date for which trades executed on that date are
subject to such new cycle. 
 “Termination of Trading” means an event that will be deemed to have occurred if the
Common Stock is not listed for trading on any of The New York Stock Exchange, the NASDAQ Global Market and the NASDAQ Global Select Market (or any of their respective successors). 

“Trading Day” means, a day on which (i) trading in the Common Stock (or other security for which a Last Reported Sale
Price must be determined) generally occurs on the NASDAQ Global Select Market or, if the Common Stock (or such other security) is not then listed on the NASDAQ Global Select Market, on the principal other U.S. national or regional securities
exchange on which the Common Stock (or such other security) is then listed or, if the Common Stock (or such other security) is not then listed on a U.S. national or regional securities exchange, on the principal other market on which the Common
Stock (or such other security) is then traded and (ii) a Last Reported Sale Price for the Common Stock (or closing sale price for such other security) is available on such securities exchange or market. If the Common Stock (or such other
security) is not so listed or traded, “Trading Day” means a “Business Day.” 
 “Underwriters” means
Merrill Lynch, Pierce, Fenner & Smith Incorporated, Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC. 

“Wholly Owned Subsidiary” of a Person means any Subsidiary of such Person all of the outstanding Capital Stock or other
ownership interests of which (other than directors’ qualifying shares) are owned by such Person or one or more Wholly Owned Subsidiaries of such Person, the calculation of which shall exclude nominal amounts of the voting power of shares of
Capital Stock or other interests in the relevant subsidiary as may be required to satisfy local minority interest requirements outside of the United States. 

Section 1.03    Other Definitions. In addition to the definitions listed in Section 1.02 hereof and
Section 1.01 of the Base Indenture (to the extent not superseded by definitions contained herein), the following defined terms are also used herein: 
  

			
	 Term
	  	Defined
in Section
	 “Act”
	  	1.05
	 “Additional Notes”
	  	2.03
	 “Averaging Period”
	  	4.06(a)(5)
	 “Bankruptcy Law”

“Base Indenture”
	  	8.01(h)
 Preamble

	 “Common Stock Change Event”
	  	4.10
	 “Conversion Agent”
	  	2.04

  
 9 

			
	 Term
	  	Defined
in Section
	 “Conversion Date”
	  	4.02(b)
	 “Conversion Notice”
	  	4.02(b)
	 “Conversion Obligation”
	  	4.01(a)
	 “Corporate Trust Administration Office”

“Custodian”
	  	2.04
 8.01(h)

	 “Defaulted Interest”
	  	2.07
	 “Deferral Exception”
	  	4.07(b)
	 “Event of Default”
	  	8.01
	 “Exchange Election”
	  	4.14(a)
	 “Exempted Fundamental Change”
	  	3.09
	 “Expiration Date”
	  	4.06(a)(5)
	 “Expiration Time”
	  	4.06(a)(5)
	 “Fundamental Change Company Notice”
	  	3.01(b)
	 “Fundamental Change Repurchase Date”
	  	3.01(a)
	 “Fundamental Change Repurchase Notice”
	  	3.01(c)
	 “Indenture”
	  	Preamble
	 “Junior Securities”
	  	5.11(b)
	 “Make-Whole Fundamental Change Effective Date”
	  	4.01(d)
	 “Make-Whole Premium”
	  	4.01(d)
	 “Note”
	  	Recitals
	 “Notice Agent”
	  	2.04
	 “Paying Agent”
	  	2.04
	 “Reference Property”

“Reference Property Unit”
	  	4.10
 4.10

	 “Registrar”
	  	2.04
	 “Reorganization Event”
	  	7.01(a)
	 “Reorganization Successor Corporation”
	  	7.01(a)
	 “Spin-off”
	  	4.06(a)(3)
	 “Successor Person”
	  	4.10
	 “Supplemental Indenture”
	  	Preamble
	 “Underwriting Agreement”
	  	2.01
	 “Valuation Period”
	  	4.06(a)(3)

 Section 1.04    Rules of Construction. Unless the context otherwise requires:

 (a)    a term has the meaning assigned to it; 

(b)    an accounting term not otherwise defined has the meaning assigned to it in accordance with GAAP; 

(c)    references to GAAP shall mean generally accepted accounting principles in effect as of the time when and for the
period as to which such accounting principles are to be applied; 

  
 10 

 (d)    “or” is not exclusive; 

(e)    words in the singular include the plural, and in the plural include the singular; and 

(f)    provisions apply to successive events and transactions; and 

(g)    unless the context requires otherwise, all references to interest on the Notes will include any Special Interest
payable pursuant to Section 8.02 hereof but, for the avoidance of doubt, will not include any Defaulted Interest payable pursuant to the terms of Section 2.07. 

Section 1.05    Acts of Holders. Any request, demand, authorization, direction, notice, consent, waiver or
other action provided by the Indenture to be given or taken by Holders may be embodied in and evidenced by one or more instruments of substantially similar tenor signed by such Holders in person or by an agent duly appointed in writing; and, except
as herein otherwise expressly provided, such action will become effective when such instrument or instruments are delivered to the Trustee and to the Company. Such instrument or instruments (and the action embodied therein and evidenced thereby) are
herein sometimes referred to as the “Act” of Holders signing such instrument or instruments. Proof of execution of any such instrument or of a writing appointing any such agent in accordance with the requirements of the Indenture
will be sufficient for any purpose of this Supplemental Indenture and conclusive in favor of the Trustee and the Company, if made in the manner provided in this Section 1.05. 

Subject to any additional requirements contained in the Indenture, the fact and date of the execution by any Person of any such instrument or
writing may be proved by the affidavit of a witness of such execution or by a certificate of a notary public or other officer authorized by law to take acknowledgments of deeds, certifying that the individual signing such instrument or writing
acknowledged to such officer the execution thereof. Where such execution is by a signer acting in a capacity other than such signer’s individual capacity, such certificate or affidavit will also constitute sufficient proof of such signer’s
authority, subject to any additional requirements in the Indenture. The fact and date of the execution of any such instrument or writing, or the authority of the Person executing the same, may also be proved in any other manner that the Trustee
deems sufficient. 
 The ownership of the Notes shall be proved by the Registrar. Notwithstanding anything herein to the contrary, the
Trustee may require additional proof of the execution of any instrument by a Holder or his or her agent or proxy and proof of the holding by any Person of any of the Notes as provided in Section 8.02 of the Base Indenture. 

Any request, demand, authorization, direction, notice, consent, waiver or other Act of the Holder of any Note will bind every future Holder of
the same Note and the Holder of every Note issued upon the registration of transfer thereof or in exchange therefor or in lieu thereof in respect of anything done, omitted or suffered to be done by the Trustee, the Company, the Paying Agent, the
Conversion Agent or the Registrar in reliance thereon, whether or not notation of such action is made upon such Note. 
 If the Company
solicits from the Holders any request, demand, authorization, direction, notice, consent, waiver or other Act, the Company may, at its option, by or pursuant to a Board Resolution, fix in advance a record date for the determination of Holders
entitled to give such 

  
 11 

 
request, demand, authorization, direction, notice, consent, waiver or other Act, but the Company will have no obligation to do so. If such a record date is fixed, such request, demand,
authorization, direction, notice, consent, waiver or other Act may be given before or after such record date, but only the Holders of record at the Close of Business on such record date will be deemed to be Holders for the purposes of determining
whether Holders of the requisite proportion of outstanding Notes have authorized or agreed or consented to such request, demand, authorization, direction, notice, consent, waiver or other Act, and for that purpose the outstanding Notes will be
computed as of such record date; provided that no such authorization, agreement or consent by the Holders on such record date will be deemed effective unless it will become effective pursuant to the provisions of this Supplemental Indenture
not later than six months after the record date. 
 ARTICLE 2 

THE NOTES 

Section 2.01    Designation, Form and Dating. There is hereby authorized a series of senior subordinated
unsecured notes of the Company designated as “0.599% Senior Subordinated Convertible Notes due 2024.” The Notes are initially being sold pursuant to an Underwriting Agreement, dated August 7, 2017 (the “Underwriting
Agreement”), between the Company and the Underwriters. The Notes shall originally be issued only in fully registered form without coupons and only in minimum denominations of $1,000 in principal amount and any integral multiple of $1,000 in
excess thereof. 
 The Notes and the Trustee’s certificate of authentication to be borne by such Notes will be substantially in the
form set forth in Exhibit A. The terms and provisions contained in the form of Notes attached as Exhibit A hereto shall constitute, and are hereby expressly made, a part of this Indenture and, to the extent applicable, the Company and the Trustee,
by their execution and delivery of this Supplemental Indenture, expressly agree to such terms and provisions and to be bound thereby. However, to the extent any provision of any Note conflicts with the express provisions of the Indenture, the
provisions of the Indenture shall govern and be controlling. 
 Any of the Notes may have such letters, numbers or other marks of
identification and such notations, legends, endorsements or changes as the Officers executing the same may approve (execution thereof to be conclusive evidence of such approval) and as are approved by the Trustee and not inconsistent with the
provisions of this Indenture, or as may be required by the Trustee, the Depositary, or as may be required to comply with any applicable law or with any rule or regulation made pursuant thereto or with any rule or regulation of any securities
exchange or automated quotation system on which the Notes may be listed, or to conform to usage, or to indicate any special limitations or restrictions to which any particular Notes are subject. 

Subject to Section 2.11 of the Base Indenture, so long as the Notes are eligible for book-entry settlement with the Depositary, or unless
otherwise required by law, all of the Notes will be represented by one or more Global Notes. The Company has designated the Depository Trust Company as the initial Depositary of the Notes represented by one or more Global Notes. The transfer and
exchange of beneficial interests in any such Global Note shall be effected through the Depositary in accordance with this Indenture and the Applicable Procedures. None of the 

  
 12 

 
Company, any of the Underwriters, the Trustee, the Registrar, the Conversion Agent or any Paying Agent will have any responsibility or liability for the performance by the Depositary or the
participants or indirect participants of their respective obligations under the rules and procedures governing their respective operations. 

Each Global Note will represent such of the outstanding Notes as are specified therein and each will provide that it shall represent the
aggregate principal amount of outstanding Notes from time to time endorsed thereon and that the aggregate principal amount of outstanding Notes represented thereby may from time to time be reduced or increased, as appropriate, to reflect exchanges,
purchases or conversions of such Notes. 
 Section 2.02    Interest. The rate or rates at which the Notes
shall bear interest, the date or dates from which such interest shall accrue, the Interest Payment Dates on which such interest shall be payable and the Regular Record Date for any interest payable on any Interest Payment Date, in each case, shall
be as set forth in the form of Note set forth as Exhibit A hereto. Interest will be computed on the basis of a 360-day year composed of twelve 30-day months. 

Section 2.03    Amount of Series Unlimited. 

The Company may, without the consent of the Holders, issue additional Notes with the same terms and the same CUSIP number as the initial Notes
(“Additional Notes”) (other than differences in the issue date, the issue price, the first Interest Payment Date, and interest accrued prior to the issue date of such Additional Notes and, if applicable, restrictions on transfer in
respect of such Additional Notes) under this Indenture in an unlimited aggregate principal amount; provided, however, that if such Additional Notes are not part of the same issue as the initial Notes issued for federal income tax
purposes or securities law purposes, then they will be identified by a separate CUSIP number or no CUSIP number. The initial Notes and any such Additional Notes will be treated as a single class for all purposes under this Indenture and all
references to “Notes” in this Indenture include such Additional Notes. 
 At any time after the execution and delivery of this
Supplemental Indenture, the Company may deliver Notes (including Additional Notes) executed by the Company to the Trustee for authentication, together with a Company Order for the authentication and delivery of such Notes, and the Trustee, in
accordance with such Company Order, shall authenticate and make available for delivery such Notes. 

Section 2.04    Registrar, Paying Agent, Notice Agent, Conversion Agent and Trustee. Sections 2.05 and 4.03 of
the Base Indenture are hereby amended and restated in full solely with respect to the Notes as follows: The Company will maintain an office or agency where Notes may be surrendered for registration of transfer or exchange (the
“Registrar”), where Notes may be presented or surrendered for payment (the “Paying Agent”), where notices and demands to or upon the Company in respect of the Notes and this Indenture may be delivered; provided
that, such office or agency shall not be an office or agency of the Company for service of legal process against the Company (the “Notice Agent”) and where Notes may be presented for conversion (the “Conversion
Agent”). 

  
 13 

 The Registrar will keep a register with respect to the Notes and to their transfer and exchange.
The Company will give prompt written notice to the Trustee of the name and address, and any change in the name or address, of each Registrar, Paying Agent, Notice Agent or Conversion Agent. If at any time the Company shall fail to maintain any such
required Registrar, Paying Agent, Notice Agent or Conversion Agent or shall fail to furnish the Trustee with the name and address thereof, such presentations, surrenders, notices and demands may be made or served at the Corporate Trust
Administration Office of the Trustee, and the Company hereby appoints the Trustee as its agent to receive all such presentations, surrenders, notices and demands; provided that, such office or agency shall not be an office or agency of the
Company for service of legal process against the Company. 
 The Company may also from time to time designate one or more co-registrars, additional paying agents, additional notice agents or additional conversion agents and may from time to time rescind such designations; provided, however, that no such designation or rescission shall
in any manner relieve the Company of its obligations to maintain a Registrar, Paying Agent, Notice Agent and Conversion Agent in each place so specified for such purposes. The Company will give prompt written notice to the Trustee of any such
designation or rescission and of any change in the name or address of any such co-registrar, additional paying agent, additional notice agent or conversion agent. The term Registrar includes any additional
registrars named pursuant to this Supplemental Indenture. The term Paying Agent includes any additional paying agent named pursuant to this Supplemental Indenture. The term Notice Agent includes any additional notice agent named pursuant to this
Supplemental Indenture. The term Conversion Agent includes any additional conversion agent named pursuant to this Supplemental Indenture. 

The Company hereby initially designates the Trustee as the initial Registrar, Paying Agent, Notice Agent and Conversion Agent. The Company
further designates the office of the Trustee (Wilmington Trust, National Association, 1100 North Market Street, Wilmington, Delaware 19890-0001, Attention: BioMarin Pharmaceutical Inc. Administrator) (the “Corporate Trust Administration
Office”) as its office where Notes may be: 
 (1)    presented or surrendered for payment; 

(2)    surrendered for registration of transfer or exchange; or 

(3)    surrendered for conversion. 

The Company may at any time and from time to time vary or terminate the appointment of any such office or appoint any additional offices for
any or all of such purposes; provided, however, that until all of the Notes have been delivered to the Trustee for cancellation, or money sufficient to pay the principal of and premium, if any, and interest on the Notes have been made
available for payment and either paid or returned to the Company pursuant to the provisions of Section 10.03 hereof, the Company will maintain an office or agency where Notes may be presented or surrendered for payment, where Notes may be
surrendered for registration of transfer or exchange and where Notes may be surrendered for conversion. The Company will give prompt written notice to the Trustee, and notice to the Holders, of the appointment or termination of any such agents and
of the location and any change in the location of any such office or agency. 

  
 14 

 If the Company shall appoint one or more paying agents for the Notes, other than the Trustee, the
Company will cause each such paying agent to execute and deliver to the Trustee an instrument in which such agent shall agree with the Trustee, subject to the provisions of this Section 2.04: 

(1) that it will hold all sums held by it as such agent for the payment of the principal (including the Fundamental Change Repurchase Price,
if applicable) of (and premium, if any) or interest on the Notes in trust for the benefit of the Trustee and the Holders; 
 (2) that it
will give the Trustee prompt notice of any failure by the Company to make any payment of the principal (including the Fundamental Change Repurchase Price, if applicable) of (and premium, if any) or interest on the Notes when the same shall be due
and payable; and 
 (3) that it will, at any time during the continuance of any failure referred to in the preceding paragraph
(2) above, or otherwise of any Event of Default, upon the written request of the Trustee, forthwith pay to the Trustee all sums so held in trust by such paying agent; and 

(4) that it will perform all other duties of paying agent as set forth in the Indenture. 

If the Company shall act as its own paying agent with respect to the Notes, it will on or before each due date of the principal (including the
Fundamental Change Repurchase Price, if applicable) of or interest on the Notes, set aside, segregate and hold in trust for the benefit of the Persons entitled thereto a sum sufficient to pay such principal (including the Fundamental Change
Repurchase Price, if applicable) or interest so becoming due on the Notes until such sums shall be paid to such Persons or otherwise disposed of as herein provided and will promptly notify the Trustee of such action, or any failure by it to take
such action. 
 If at any time the Company shall fail to maintain any such required office or agency, or shall fail to furnish the Trustee
with the address thereof, presentations and surrenders may be made at the Corporate Trust Administration Office; provided that, such office or agency shall not be an office or agency of the Company for service of legal process against the
Company. 
 The Company may also from time to time designate one or more Conversion Agents and from time to time rescind such designations.
The Company will give prompt written notice to the Trustee of any such designation or rescission and of any change in the name or address of such Conversion Agent. 

The rights, privileges, protections, immunities and benefits given to the Trustee under Article 7 of the Base Indenture including, without
limitation, its right to be indemnified, are extended to, and shall be enforceable by, the Trustee in each of its capacities hereunder, and each Conversion Agent or other Agent acting hereunder. 

Without prejudice to any other rights of the Trustee under Article 7 of the Base Indenture, upon any application by the Company to the Trustee
to take or refrain from taking any action, the Company shall furnish to the Trustee an Officer’s Certificate and Opinion of Counsel in accordance with the Indenture in form satisfactory to the Trustee. 

  
 15 

 Section 2.05    Conversion Agent to Hold Shares in Trust. The
Company shall require each Conversion Agent other than the Trustee to agree in writing that the Conversion Agent will hold in trust for the benefit of Holders or the Trustee all shares of Common Stock held by the Conversion Agent for the delivery of
Common Stock when due upon conversion, and will notify the Trustee in writing of any default by the Company in making any such delivery. While any such default continues, the Trustee may require a Conversion Agent to deliver all shares of Common
Stock held by it to the Trustee. The Company at any time may require a Conversion Agent to pay all money held by it to the Trustee. Upon such acknowledgement by the Trustee of its receipt of any such payment, the Conversion Agent (if other than the
Company or a Subsidiary) shall have no further liability for such money. If the Company or a Subsidiary acts as Conversion Agent, it shall segregate and hold in a separate trust fund for the benefit of the Holders all shares held by it as Conversion
Agent. Upon any bankruptcy or reorganization proceedings relating to the Company, the Trustee shall serve as Conversion Agent for the Notes. 

Section 2.06    CUSIPs and ISINs. 

(a)    Whenever “CUSIP” and “ISIN” numbers are generally in use, the Company will use CUSIP and ISIN
numbers with respect to the Notes. Whenever the Company uses CUSIP and ISIN numbers, the Trustee may also use CUSIP and ISIN numbers in each notice it delivers to the Holders; provided, that neither the Company nor the Trustee will be
responsible for any defect in any CUSIP or ISIN number that appears on any Note, check, advice of payment or notice. The Company will promptly notify the Trustee in writing in the event of any change in the CUSIP or ISIN numbers. 

(b)    In addition, if, when any shares of Common Stock are issued upon conversion of a Note, CUSIP and ISIN numbers are
generally in use, the Company will use CUSIP and ISIN numbers with respect to such shares of Common Stock. 

(c)    Whenever any of the CUSIP or ISIN numbers with respect to the Notes or the shares of Common Stock issuable upon
conversion, if any, of the Notes changes, ceases to be used, or begins to be used, the Company will deliver prompt written notice of such change, cessation, or beginning to each of the Trustee and the Holders. 

Section 2.07    Defaulted Interest. If the Company defaults in a payment of interest on Notes, it will pay the
defaulted interest, plus, to the extent permitted by law, any interest payable on the defaulted interest (the “Defaulted Interest”), to the Persons who are Holders on a subsequent special record date. The Company will fix the record
date and payment date. At least 30 days before the record date, the Company will send to the Trustee and to each Holder a notice that states the record date, the payment date and the amount of interest to be paid. The Company may pay defaulted
interest in any other lawful manner. 
 Section 2.08    No Sinking Fund. No sinking fund is provided for the
Notes. 
 Section 2.09    Surrender for Cancellation. The Company will surrender any Note repurchased by the
Company, including pursuant to Article 3, to the Trustee for cancellation. Any Notes surrendered to the Trustee for cancellation may not be reissued or resold by the Company and will be canceled promptly. 

  
 16 

 The Trustee will cancel all Notes surrendered for transfer, exchange, payment, replacement or
cancellation and will destroy such canceled Notes (subject to the record retention requirements of the Exchange Act and the Trustee) and deliver a certificate of such cancellation to the Company, upon receipt of a Company Order. 

ARTICLE 3 

REPURCHASE OF NOTES 

Section 3.01    Repurchase of Notes at Option of the Holder upon a Fundamental Change. 

(a)    If a Fundamental Change occurs, each Holder of a Note will have the right, at the option of the Holder, to require
the Company to repurchase for Cash all or any portion of the Notes of such Holder equal to $1,000 principal amount (or an integral multiple of $1,000 in excess thereof) at the Fundamental Change Repurchase Price, on a Business Day specified by the
Company that is no more than 35, nor less than 20, Business Days after the date of the Fundamental Change Company Notice pursuant to Section 3.01(b) (the “Fundamental Change Repurchase Date”). However, if the Fundamental Change
Repurchase Date is after a Regular Record Date and on or before the next Interest Payment Date, then (i) the Holder of such Note at the Close of Business on such Regular Record Date will be entitled, notwithstanding such repurchase, to receive,
on or before such Interest Payment Date, the unpaid interest that would have accrued on such Note to, but not including, such Interest Payment Date; and (ii) the Fundamental Change Repurchase Price will not include accrued and unpaid interest
on such Note to, but excluding, the Fundamental Change Repurchase Date. 
 (b)    On or before the 20th calendar day
after the effective date of a Fundamental Change, the Company will deliver a written notice of the Fundamental Change and of the resulting repurchase right to the Trustee, the Paying Agent (if other than the Trustee) and to all Holders (the
“Fundamental Change Company Notice”). The Fundamental Change Company Notice shall state: 

(i)    the events causing such Fundamental Change; 

(ii)    the date of such Fundamental Change; 

(iii)    the last date by which a Holder may exercise the repurchase right pursuant to this
Section 3.01; 
 (iv)    the Fundamental Change Repurchase Date; 

(v)    the Fundamental Change Repurchase Price; 

(vi)    the Holder’s right to require the Company to purchase the Notes; 

(vii)    the name and address of each Paying Agent and Conversion Agent; 

(viii)    the then effective Conversion Rate and any adjustments to the Conversion Rate resulting from such
Fundamental Change (and the timing of any such adjustments); 

  
 17 

 (ix)    whether a Make-Whole Premium shall be payable by the
Company upon conversion; 
 (x)    the procedures that the Holder must follow to exercise rights under
this Section 3.01, including that the Notes with respect to which a Fundamental Change Repurchase Notice has been delivered by a Holder may be converted only if the Holder withdraws such notice in accordance with the terms of this Indenture;

 (xi)    that, unless the Company fails to pay such Fundamental Change Repurchase Price, Notes covered
by any Fundamental Change Repurchase Notice will cease to be outstanding and, subject to Section 3.01(a)(i), interest will cease to accrue on and after the Fundamental Change Repurchase Date; and 

(xii)    the CUSIP number of the Notes and that no representation is made as to the correctness or accuracy
of the CUSIP numbers listed in the notice or printed on the Notes to be repurchased. 
 At the Company’s written request, the Trustee
shall give such Fundamental Change Company Notice to the Holders in the Company’s name and at the Company’s expense; provided that, in all cases, the Company makes such request at least three (3) Business Days prior to the date
by which such Fundamental Change Company Notice must be given to the Holders in accordance with this Section 3.01; provided, further, that the text of such Fundamental Change Company Notice shall be prepared by the Company and that the
Trustee shall not be responsible for determining if a Fundamental Change has occurred. or for determining the occurrence or correctness of any of the events or information in such Fundamental Change Company Notice. If any of the Notes is in the form
of a Global Note, then the Company will modify such notice to the extent necessary to accord with the Applicable Procedures relating to the purchase of Global Notes. 

No failure of the Company to give the foregoing notices or defect therein shall limit any Holder’s right to exercise its right to cause
the Company to repurchase such Holder’s Notes pursuant to this Section 3.01. 
 (c)    To exercise its rights
specified in Section 3.01(a), a Holder must, in the case of Certificated Notes, deliver a written notice (which shall be in substantially the form attached as Exhibit A under the heading “Fundamental Change Repurchase Notice”) or, in
the case of Global Notes, deliver a notice in accordance with the Applicable Procedures of the exercise of such rights (a “Fundamental Change Repurchase Notice”) to the Paying Agent and the Trustee at any time prior to the Close of
Business on the Business Day immediately before the related Fundamental Change Repurchase Date (or such later time as may be required by applicable law). 

(1)    The Fundamental Change Repurchase Notice shall state: (A) the certificate number (in the case
of Certificated Notes) of the Note which the Holder will deliver to be repurchased (or, in the case of Global Notes, any other items required to comply with the Applicable Procedures), (B) the portion of the principal amount of the Note which the
Holder will deliver to be repurchased and (C) that such Note shall be 

  
 18 

 
repurchased as of the Fundamental Change Repurchase Date pursuant to the terms and conditions specified in the Notes and in this Indenture. The Trustee and Paying Agent shall have no duty to
verify the accuracy of any information contained in a Fundamental Change Repurchase Notice. 

(2)    Notes to be repurchased must be delivered to the Paying Agent (together with all necessary
endorsements) at the office of such Paying Agent (in the case of Certificated Notes) or in compliance with the Applicable Procedures (in the case of Global Notes) for the Holder of those Notes to be entitled to receive the Fundamental Change
Repurchase Price. 
 (3)    The Company shall only be obliged to repurchase, pursuant to this
Section 3.01, a portion of a Note if the principal amount of such portion is $1,000 or an integral multiple of $1,000 in excess thereof (provisions of this Indenture that apply to the repurchase of all of a Note also apply to the repurchase of
such portion of such Note). 
 (4)    A Paying Agent shall promptly notify the Company of the receipt by
it of any Fundamental Change Repurchase Notice. 
 (d)    A Holder that has delivered a Fundamental Change Repurchase
Notice with respect to a Note may withdraw such notice by delivering a withdrawal notice to the Paying Agent and the Trustee (in the case of Certificated Notes) or in accordance with the Applicable Procedures (in the case of Global Notes) at any
time before the Close of Business on the Business Day immediately before the Fundamental Change Repurchase Date. The withdrawal notice must specify the (i) the principal amount of the Notes with respect to which such notice of withdrawal is
being submitted, (ii) if Certificated Notes have been issued, the certificate number of the Note in respect of which such notice of withdrawal is being submitted, and (iii) the principal amount, if any, of such Note that remains subject to
the original Fundamental Change Repurchase Notice, which portion must be in principal amounts of $1,000 or an integral multiple of $1,000; provided, however, that if the Notes are Global Notes, the notice must comply with
Applicable Procedures. 
 (e)    The Company shall deposit Cash at the time and in the manner as provided in
Section 3.03, sufficient to pay the aggregate Fundamental Change Repurchase Price of all Notes to be purchased pursuant to this Section 3.01. 

(f)    If a Holder has validly delivered a Fundamental Change Repurchase Notice with respect to a Note, then such Note may
not be converted, except to the extent (i) such notice is withdrawn in accordance with the procedures described in this Section 3.01; or (ii) the Company fails to pay the related Fundamental Change Repurchase Price for such Note. 

(g)    Notwithstanding anything to the contrary above, the Company may not repurchase any of the Notes in connection with
a Fundamental Change if the principal amount of the Notes has been accelerated (other than as a result of a default in the payment of the related Fundamental Change Repurchase Price and any related interest) and such acceleration has not been
rescinded on or before the Fundamental Change Repurchase Date. 

  
 19 

 Section 3.02    Effect of Fundamental Change Repurchase Notice.
Upon receipt by any Paying Agent of a properly completed Fundamental Change Repurchase Notice from a Holder, the Holder of the Note in respect of which such Fundamental Change Repurchase Notice was given shall thereafter be entitled to receive the
Fundamental Change Repurchase Price with respect to such Note, subject to the occurrence of the Fundamental Change Effective Date. Such Fundamental Change Repurchase Price shall be paid to such Holder promptly, but no later than two Business Days,
following the later of (1) the Fundamental Change Repurchase Date (provided that the conditions in Section 3.01 have been satisfied) and (2) the time of delivery of such Note to a Paying Agent by the Holder thereof in the
manner required by Section 3.01(c), in each case subject to receipt of funds by the Paying Agent in accordance with Section 3.03. 

Section 3.03    Deposit of Fundamental Change Repurchase Price. 

(a)    On or before 10:00 a.m. New York City time on the applicable Fundamental Change Repurchase Date, the Company will
deposit with the Paying Agent (or if the Company or an Affiliate of the Company is acting as the Paying Agent, shall segregate and hold in trust) an amount of money (in immediately available funds if deposited such Business Day), sufficient to pay
the aggregate Fundamental Change Repurchase Price of all the Notes or portions thereof that are to be purchased as of the Fundamental Change Repurchase Date. 

(b)    If a Paying Agent holds on the Fundamental Change Repurchase Date, in accordance with the terms hereof, money
sufficient to pay the Fundamental Change Repurchase Price of any Note for which a Fundamental Change Repurchase Notice has been tendered and not withdrawn in accordance with this Indenture then, on and after the applicable Fundamental Change
Repurchase Date, whether or not the Note is delivered to the Paying Agent, each such Note will cease to be outstanding, interest shall cease to accrue, and the rights of the Holder in respect of the Note shall terminate (other than the right to
receive the Fundamental Change Repurchase Price upon delivery of the Note as aforesaid). 
 (c)    If Notes are
repurchased on a date that is after a Regular Record Date for an Interest Payment Date and prior to the corresponding Interest Payment Date, the Company will not pay accrued interest to the Holder of Notes being repurchased, and will instead pay the
full amount of the relevant interest payment on such Interest Payment Date to the Holder of record on such Regular Record Date. 

Section 3.04    Repayment to the Company. To the extent that the aggregate amount of Cash deposited by the
Company pursuant to Section 3.03 exceeds the aggregate Fundamental Change Repurchase Price of the Notes or portions thereof that the Company is obligated to purchase, then promptly after the Fundamental Change Repurchase Date and upon receipt
of a Company Order, the Paying Agent shall return any such excess Cash to the Company. 
 Section 3.05    Notes
Purchased in Part. Any Certificated Note that is to be purchased only in part shall be surrendered at the office of a Paying Agent, and promptly after the Fundamental Change Repurchase Date, the Company shall execute and the Trustee, upon
receipt of a Company Order, shall authenticate and make available for delivery to the Holder of such Certificated Note, without service charge, a new Certificated Note or Certificated Notes, of such authorized denomination or denominations as may be
requested by such Holder (which 

  
 20 

 
must be equal to $1,000 principal amount or any integral multiple of $1,000 in excess thereof), in aggregate principal amount equal to, and in exchange for, the portion of the principal amount of
the Note so surrendered that is not purchased. 
 Section 3.06    Compliance with Securities Laws upon Purchase
of Notes. In connection with any offer to repurchase Notes under Section 3.01, the Company shall (a) comply with Rule 13e-4 and Rule 14e-1 (or any
successor to either such Rule), and any other tender offer rules, if applicable, under the Exchange Act, (b) file the related Schedule TO (or any successor or similar schedule, form or report) if required under the Exchange Act, and
(c) otherwise comply with all federal and state securities laws in connection with such offer to purchase Notes, all so as to permit the rights of the Holders and obligations of the Company under Sections 3.01 through 3.04 to be exercised in
the time and in the manner specified therein. To the extent that compliance with any such laws, rules and regulations would result in a conflict with any of the terms hereof, this Indenture is hereby modified to the extent required for the Company
to comply with such laws, rules and regulations. 
 Section 3.07    No Company Redemption Rights. Article 3
of the Base Indenture shall not apply to the Notes. The Company may not redeem the Notes prior to the Final Maturity Date. The Notes are not subject to redemption through the operation of any sinking fund or otherwise. 

Section 3.08    Repurchase by Third Party. Notwithstanding anything to the contrary in this Article 3, the
Company will be deemed to satisfy its obligations to repurchase Notes pursuant to this Article 3 if (i) one or more third parties conduct the repurchase offer and repurchase tendered Notes in a manner that would have satisfied the
Company’s obligations to do the same if conducted directly by the Company; and (ii) an owner of a beneficial interest in the Notes would not receive a lesser amount (as a result of taxes, additional expenses or for any other reason) than
such owner would have received had the Company repurchased the Notes. 
 Section 3.09    Exempted Fundamental
Change. 
 (a)    Notwithstanding anything to the contrary, the Company will not be required to send a Fundamental
Change Company Notice, or offer to repurchase any Notes as set forth in this Article 3, in connection with a Fundamental Change occurring pursuant to clause (ii)(A) or clause (ii)(B) (or pursuant to clause (i) that also constitutes a
Fundamental Change occurring pursuant to either clause (i)(A) or clause (ii)(B)) of the definition of Change of Control, if: 

(i)    such Fundamental Change constitutes a Common Stock Change Event for which all or part of the
reference property consists of Cash in U.S. dollars; and 
 (ii)    immediately after such Fundamental
Change, the Notes become convertible (pursuant to Section 4.10 and, if applicable, Section 4.01(d)) into such Cash in an amount per $1,000 principal amount of Notes that equals or exceeds the Fundamental Change Repurchase Price per $1,000
principal amount of Notes (calculated assuming that the same includes accrued interest to, but excluding, the latest possible Fundamental Change Repurchase Date for such Fundamental Change) (any such

  
 21 

 
Fundamental Change described in this Section 3.09, an “Exempted Fundamental Change”). 

(b)    The Company will send notice to the Holders and the Trustee of such Exempted Fundamental Change no later than two
Business Days after the effective date of such Fundamental Change, stating that such Fundamental Change is an Exempted Fundamental Change for which the Company is not required to make an offer to repurchase the Notes. 

ARTICLE 4 

CONVERSION 

Section 4.01    Conversion Privilege and Conversion Rate. 

(a)    Subject to and upon compliance with the provisions of this Article 4, each Holder of a Note will have the right, at
such Holder’s option, to convert all or any portion (if the portion to be converted is $1,000 principal amount or a multiple thereof) of such Note into shares of Common Stock (together with Cash in lieu of any fractional share, if applicable)
at any time prior to the Close of Business on the second Scheduled Trading Day immediately preceding the Final Maturity Date, in each case, at the Conversion Rate (subject to the settlement provisions of Section 4.02, the “Conversion
Obligation”). Whenever in this Indenture there is a reference to the Conversion Rate or Conversion Price as of a particular date without reference to a specific time, such reference will be deemed to be the Close of Business on such date.

 (b)    Provisions of this Indenture that apply to conversion of all of a Note also apply to conversion of a portion
of a Note. 
 (c)    The Conversion Rate shall be adjusted in certain instances as provided in Section 4.01(d) and
Section 4.06. 
 (d)    If there shall have occurred a Make-Whole Fundamental Change, the Company will, except as
otherwise provided below, pay a “Make-Whole Premium” to the Holders of the Notes who convert their Notes in connection with such Make-Whole Fundamental Change by increasing the Conversion Rate for such Notes. The Make-Whole Premium
will be in addition to, and not in substitution for, any cash, securities or other assets otherwise due to Holders upon conversion. The number of additional shares of Common Stock per $1,000 principal amount of the Notes constituting the Make-Whole
Premium shall be determined by reference to the table below, based on the date on which the Make-Whole Fundamental Change becomes effective (the “Make-Whole Fundamental Change Effective Date”) and the Stock Price; provided
that: 
 (i) if the actual Stock Price on the Make-Whole Fundamental Change Effective Date is between two Stock Prices on the table or the
actual Make-Whole Fundamental Change Effective Date is between two Make-Whole Fundamental Change Effective Dates on the table, the Make-Whole Premium will be determined by a straight-line interpolation between the Make-Whole Premiums set forth for
the two Stock Prices and the two Make-Whole Fundamental Change Effective Dates on the table based on a 365- or 366-day year, as applicable; 

  
 22 

 (ii) if the Stock Price exceeds $500.00 per share, subject to adjustment as set forth herein, no
Make-Whole Premium will be paid; 
 (iii) if the Stock Price is less than $89.05 per share, subject to adjustment as set forth herein, no
Make-Whole Premium will be paid. 
 If holders of the Common Stock receive only Cash in the Make-Whole Fundamental Change, the Stock Price
shall be the Cash amount paid per share of the Common Stock in such Make-Whole Fundamental Change. Otherwise, the Stock Price shall be equal to the average of the Last Reported Sale Prices of the Common Stock for the 15 Trading Days immediately
prior to, but not including, the Make-Whole Fundamental Change Effective Date. 
 The following table sets forth what the Make-Whole Premium would be for
each Stock Price and Make-Whole Fundamental Change Effective Date set forth below (expressed as additional shares of Common Stock per $1,000 principal amount of Notes): 
  

																																																	
	 Make-Whole

Fundamental
 Change Effective
	 	Stock Price	 
	
Date                
      
	 	$89.05	 	 	$100.00	 	 	$110.00	 	 	$124.67	 	 	$140.00	 	 	$160.00	 	 	$200.00	 	 	$250.00	 	 	$300.00	 	 	$350.00	 	 	$400.00	 	 	$500.00	 
	 August 11, 2017
	 	 	3.2084	 	 	 	2.5922	 	 	 	2.1244	 	 	 	1.6392	 	 	 	1.2761	 	 	 	0.9428	 	 	 	0.5470	 	 	 	0.2994	 	 	 	0.1720	 	 	 	0.1009	 	 	 	0.0589	 	 	 	0.0169	 
	 August 1, 2018
	 	 	3.2084	 	 	 	2.5877	 	 	 	2.1242	 	 	 	1.6201	 	 	 	1.2457	 	 	 	0.9055	 	 	 	0.5095	 	 	 	0.2683	 	 	 	0.1483	 	 	 	0.0834	 	 	 	0.0459	 	 	 	0.0111	 
	 August 1, 2019
	 	 	3.2084	 	 	 	2.5688	 	 	 	2.1064	 	 	 	1.5825	 	 	 	1.1972	 	 	 	0.8523	 	 	 	0.4600	 	 	 	0.2302	 	 	 	0.1207	 	 	 	0.0638	 	 	 	0.0323	 	 	 	0.0061	 
	 August 1, 2020
	 	 	3.2084	 	 	 	2.5681	 	 	 	2.0591	 	 	 	1.5150	 	 	 	1.1206	 	 	 	0.7745	 	 	 	0.3938	 	 	 	0.1829	 	 	 	0.0887	 	 	 	0.0424	 	 	 	0.0185	 	 	 	0.0020	 
	 August 1, 2021
	 	 	3.2084	 	 	 	2.5094	 	 	 	1.9722	 	 	 	1.4071	 	 	 	1.0062	 	 	 	0.6643	 	 	 	0.3077	 	 	 	0.1269	 	 	 	0.0535	 	 	 	0.0213	 	 	 	0.0077	 	 	 	—  	 
	 August 1, 2022
	 	 	3.2084	 	 	 	2.3964	 	 	 	1.8245	 	 	 	1.2360	 	 	 	0.8335	 	 	 	0.5074	 	 	 	0.1984	 	 	 	0.0653	 	 	 	0.0209	 	 	 	0.0061	 	 	 	0.0007	 	 	 	—  	 
	 August 1, 2023
	 	 	3.2084	 	 	 	2.1807	 	 	 	1.5541	 	 	 	0.9378	 	 	 	0.5497	 	 	 	0.2731	 	 	 	0.0689	 	 	 	0.0131	 	 	 	0.0022	 	 	 	—  	 	 	 	—  	 	 	 	—  	 
	 August 1, 2024
	 	 	3.2084	 	 	 	1.9788	 	 	 	1.0697	 	 	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	—  	 

 Notwithstanding the foregoing paragraph, in no event will the Conversion Rate exceed 11.2296 shares per $1,000
principal amount of the Notes, subject to adjustment in the same manner as the Conversion Rate as set forth in clauses (1) through (5), inclusive, of Section 4.06(a). 

Each Stock Price set forth in the first column of the table above will be adjusted as of any date on which the Conversion Rate of the Notes is
adjusted. Each adjusted Stock Price will equal the Stock Price applicable immediately prior to such adjustment multiplied by a fraction, the numerator of which is the Conversion Rate immediately prior to the adjustment giving rise to the Stock Price
adjustment and the denominator of which is the Conversion Rate as so adjusted. The number of additional shares set forth in the table above will be adjusted in the same manner as the Conversion Rate as set forth in Section 4.06(a) hereof, other
than as a result of an adjustment to the Conversion Rate by adding the Make-Whole Premium as described above. 
 A conversion of Notes by a
Holder shall be deemed for these purposes to be “in connection with” a Make-Whole Fundamental Change if the relevant Conversion Date occurs on or subsequent to the Make-Whole Fundamental Change Effective Date but on or before the Business
Day immediately preceding the related Fundamental Change Repurchase Date (or, if such Make-Whole Fundamental Change does not also constitute a Fundamental Change, or constitutes an Exempted Fundamental Change, on or before the 35th Trading Day
following the Make-Whole Fundamental Change Effective Date). 

  
 23 

 The Company will notify the Trustee in writing and the Holders of the occurrence of each
Make-Whole Fundamental Change no later than two Business Days after the relevant Make-Whole Fundamental Change Effective Date. 

(e)    Upon conversion of a Note, a Holder shall not receive any separate Cash payment for accrued and unpaid interest, if
any, except as set forth below, and the Company will not adjust the Conversion Rate to account for accrued and unpaid interest. By delivering shares of Common Stock to the Holder plus a Cash payment for a fractional share, if applicable, the Company
will be deemed to have satisfied its obligation to pay the principal amount of the Notes so converted and its obligation to pay accrued and unpaid interest attributable to the period from the most recent Interest Payment Date through the Conversion
Date (which amount will be deemed to be paid in full rather than cancelled, extinguished and forfeited); provided, however, that if a Holder converts a Note after a Regular Record Date and prior to the Open of Business on the corresponding
Interest Payment Date, the Company will still be obligated to pay the interest payment due on such Interest Payment Date to the Holder of such Note as of the Close of Business on such Regular Record Date pursuant to Section 4.02(c). 

(f)    If a Holder tenders a Fundamental Change Repurchase Notice with respect to a Note in accordance with Article 3, the
Holder may not surrender such Note for conversion until the Holder has withdrawn the Fundamental Change Repurchase Notice in accordance with Section 3.01. 

Section 4.02    Settlement Upon Conversion; Conversion Procedure.  

(a)    Subject to this Section 4.02, Section 4.01(d) and Section 4.10, upon conversion of any Note, the
Company will deliver to the converting Holder, in respect of each $1,000 principal amount of the Notes being converted, a number of shares of Common Stock equal to the Conversion Rate in effect on the Conversion Date for such conversion, together
with Cash, if applicable, in lieu of delivering any fractional share of Common Stock in accordance with Section 4.03 as set forth in this Section 4.02, based on the Last Reported Sale Price per share of the Common Stock on the Conversion
Date for such conversion (or, if such Conversion Date is not a Trading Day, the immediately preceding Trading Day). 

(b)    A Person with a beneficial interest in a Global Note that wishes to convert such beneficial interest must comply
with Applicable Procedures for converting a beneficial interest in a Global Note and, if required, pay funds equal to interest payable on the next Interest Payment Date and, if required, pay all taxes or duties, if any. The exercise of such
conversion rights shall be irrevocable. To convert a Certificated Note, a Holder must (1) complete and manually sign the conversion notice on the back of the Note (the “Conversion Notice”), or a facsimile of the Conversion
Notice, (2) deliver such Conversion Notice, which is irrevocable, and the Note to the Conversion Agent, (3) if required, furnish appropriate endorsements and transfer documents if required by the Registrar or the Conversion Agent,
(4) if required, pay funds equal to the interest payable on the next Interest Payment Date and (5) if required, pay all transfer or similar taxes. Holders may obtain copies of the required form of the Conversion Notice from the Conversion
Agent. The date on which the Holder satisfies all the applicable requirements for conversion is the “Conversion Date.” Notes surrendered for conversion will be deemed to be converted at the Close of Business on the Conversion Date.
Except as described under Section 4.06, upon the 

  
 24 

 conversion of a Note, the Company will deliver the consideration due in respect of such conversion, without
service charge, by the third (or, if the T+2 Effective Date has occurred on or before the relevant Conversion Date, the second) Business Day immediately following such Conversion Date; provided that with respect to any Conversion Date
occurring on or after March 1, 2024, settlement will occur on the Final Maturity Date. 
 (c)    The Person in
whose name shares of Common Stock are issuable upon conversion shall be deemed to be a holder of record of such Common Stock as of the Close of Business on the relevant Conversion Date. Upon conversion of a Note, such Person shall no longer be a
Holder of such Note. Except as set forth in this Indenture, no payment or adjustment will be made for dividends or distributions declared or made on shares of Common Stock issued upon conversion of a Note, if any, prior to the issuance of such
shares. 
 (d)    Holders of Notes at the Close of Business on a Regular Record Date will receive payment of interest
payable on the corresponding Interest Payment Date notwithstanding the conversion of such Notes at any time after the Close of Business on the applicable Regular Record Date. Notes surrendered for conversion (in whole or in part) by a Holder during
the period from the Close of Business on any Regular Record Date to the opening of business on the next succeeding Interest Payment Date must be accompanied by payment in funds to the Conversion Agent acceptable to the Company of an amount equal to
the interest payable on such corresponding Interest Payment Date that the Holder is to receive on the Notes; provided, however that no such payment need be made (i) if the Company has specified a Fundamental Change Repurchase Date that is after
such Regular Record Date and on or prior to the Business Day following the corresponding Interest Payment Date, (ii) only to the extent of overdue interest, if any overdue interest exists at the time of conversion with respect to the Note or
(iii) if conversion occurs after the last Regular Record Date prior to the Final Maturity Date. 
 Therefore, for the avoidance of
doubt, all Holders on the Regular Record Date immediately preceding the Final Maturity Date will receive the full interest payment due on the Final Maturity Date regardless of whether their Notes have been converted following the Regular Record
Date. 
 (e)    Subject to Section 4.02(d), nothing in this Section 4.02 shall affect the right of a Holder in
whose name any Note is registered at the Close of Business on a Regular Record Date to receive the interest payable on such Note on the related Interest Payment Date in accordance with the terms of this Indenture and the Notes. If a Holder converts
more than one Note at the same time, the consideration due upon the conversion (and the amount of any Cash in lieu of fractional shares pursuant to Section 4.03) shall be based on the aggregate principal amount of all Notes so converted. 

(f)    In the case of any Note which is converted in part only, upon such conversion the Company will execute and the
Trustee, upon receipt of a Company Order, shall authenticate and make available for delivery to the Holder thereof, without service charge, a new Note or Notes of authorized denominations in an aggregate principal amount equal to, and in exchange
for, the unconverted portion of the principal amount of such Note. A Note may be converted in part, but only if the principal amount of such part is in a minimum denomination of $1,000 in principal amount or an integral multiple of $1,000 in excess
thereof and the principal amount of such Note 

  
 25 

 
to remain outstanding after such conversion is equal to a minimum of $1,000 or any integral multiple of $1,000 in excess thereof. 

Section 4.03    Fractional Shares. No fractional share of Common Stock shall be issued upon conversion of any
Note or Notes. If more than one Note shall be surrendered for conversion at one time by the same Holder, the number of full shares which shall be issued upon conversion thereof shall be computed on the basis of the aggregate principal amount of the
Notes (or specified portions thereof) so surrendered. Instead of any fractional share of Common Stock which would otherwise be issued upon conversion of any Note or Notes (or specified portions thereof), the Company will pay Cash based on the Last
Reported Sale Price on the relevant Conversion Date. 
 Section 4.04    Taxes on Conversion. If a Holder
converts its Notes, the Company will pay any documentary, stamp or similar issue or transfer tax due on the issuance of shares of Common Stock upon the conversion, unless the tax is due because the Holder requests any such shares to be issued or
delivered to a person other than the Holder, in which case the Holder shall pay that tax. The Company or the Conversion Agent may refuse to have the certificates representing the shares of Common Stock being issued in a name other than the
Holder’s name delivered until the Trustee receives a sum sufficient to pay any tax that is due by such Holder in accordance with the immediately preceding sentence. 

Section 4.05    Company to Provide Common Stock. The Company will, prior to issuance of any Notes hereunder,
and from time to time as may be necessary, reserve, out of its authorized but unissued Common Stock, a sufficient number of shares of Common Stock to permit the conversion of all outstanding Notes into shares of Common Stock. 

(a)    All shares of Common Stock delivered upon conversion of the Notes shall be newly issued shares, shall be duly
authorized, validly issued, fully paid and nonassessable and shall be free from preemptive or similar rights and free of any lien or adverse claim as the result of any action by the Company. 

(b)    The Company will promptly comply with all federal and state securities laws regulating the offer and delivery of
shares of Common Stock upon conversion of Notes. 
 (c)    The Company will use its best efforts to ensure that the
shares of Common Stock to be issued upon conversion of the Notes will be listed on any securities exchange or quoted on any quotation system that the Common Stock is then so listed or quoted on. 

Section 4.06    Adjustment of Conversion Rate 

(a)    The Conversion Rate shall be subject to adjustment, without duplication, upon the occurrence of any of the following
events, except that the Company will not make any adjustments to the Conversion Rate if Holders participate (other than in the case of (x) a share split or share combination or (y) a tender offer or exchange offer), at the same time and
upon the same terms as holders of the Common Stock and solely as a result of holding the Notes, in any of the transactions described in this Section 4.06(a) without such Holders having to convert their Notes as if they held a number of shares
of Common Stock equal to the Conversion Rate, multiplied by the principal amount (expressed in thousands) of Notes held by such Holder: 

  
 26 

 (1)    If the Company issues solely shares of Common Stock as
a dividend or distribution on all shares of Common Stock, or if the Company effects a share split or share combination of the Common Stock (in each case excluding any issuance solely pursuant to a Common Stock Change Event, as to which
Section 4.10 will apply), then the Conversion Rate will be adjusted based on the following formula: 
  

											
		 	CR’	 	= 	 	CR0×  	 	OS’	  	
	 	 	 	 	OS0	  	

  

			
		 	where,
		
	CR0 =	 	the Conversion Rate in effect immediately prior to the Open of Business on the Ex-Dividend Date of such dividend or distribution, or immediately prior to the Open of Business on the
Effective Date of such share split or share combination, as the case may be;
		
	CR’ =	 	the Conversion Rate in effect immediately after the Open of Business on such Ex-Dividend Date or Effective Date, as the case may be;
		
	OS0 =	 	the number of shares of Common Stock outstanding immediately prior to the Open of Business on such Ex-Dividend Date or Effective Date, as the case may be; and
		
	OS’ =	 	the number of shares of Common Stock outstanding immediately after giving effect to such dividend or distribution, or such share split or share combination, as the case may be.

 An adjustment made under this clause (1) will become effective immediately after the Open
of Business on the Ex-Dividend Date for such dividend or distribution, or immediately after the Open of Business on the Effective Date for such share split or share combination, as the case may be. 

If any dividend, distribution, share split or share combination of the type described in this clause (1) is declared but
not so paid or made, then the Conversion Rate shall be immediately readjusted, effective as of the date the Board of Directors determines not to pay such dividend or distribution or to effect such share split or share combination, to the Conversion
Rate that would then be in effect if such dividend, distribution, share split or share combination had not been declared. 

(2)    If the Company issues to all or substantially all holders of Common Stock any rights, options or
warrants (other than Rights issued pursuant to a Rights Plan adopted by the Company, as to which Section 4.06(c) applies) entitling them, for a period expiring not more than 45 days immediately following the date of announcement of such
issuance, to purchase or subscribe for shares of Common Stock at a price per share less than the average of the Last Reported Sale Prices of Common Stock over the 10 consecutive Trading Day period ending on, and including, the Trading Day
immediately preceding the date of announcement for such issuance, the Conversion Rate will be increased based on the following formula: 
  

											
		 	CR’	 	= 	 	CR0×  	 	OSo + X	  	
	 	 	 	 	OS0 + Y	  	

  
 27 

							
		 				 	where,
			
	CR0	 	 	=	 	 	the Conversion Rate in effect immediately prior to the Open of Business on the Ex-Dividend Date for such issuance;
			
	CR’	 	 	=	 	 	the Conversion Rate in effect immediately after the Open of Business on such Ex-Dividend Date;
			
	OS0	 	 	=	 	 	the number of shares of Common Stock outstanding immediately prior to the Open of Business on such Ex-Dividend Date;
			
	X	 	 	=	 	 	the total number of shares of Common Stock issuable pursuant to such rights, options or warrants; and
			
	Y	 	 	=	 	 	the number of shares of Common Stock equal to the aggregate price payable to exercise such rights, options or warrants, divided by the average of the Last Reported Sale Prices of Common Stock over the 10 consecutive Trading Day
period ending on, and including, the Trading Day immediately preceding the date of announcement for such issuance.

 Any increase made under this clause (2) will be made successively whenever any such
rights, options or warrants are issued and will become effective immediately after the Open of Business on the Ex-Dividend Date for such issuance. To the extent that shares of Common Stock are not delivered
after expiration of such rights, options or warrants (including as a result of such rights, options or warrants not being exercised), the Conversion Rate shall be readjusted, effective as of the date of such expiration, to the Conversion Rate that
would then be in effect had the increase with respect to the issuance of such rights, options or warrants been made on the basis of delivery of only the number of shares of Common Stock actually delivered. If such rights, options or warrants are not
so issued, the Conversion Rate shall be decreased, effective as of the date the Board of Directors determines not to make such issuance, to the Conversion Rate that would then be in effect if such Ex-Dividend
Date for such issuance had not occurred. 
 For the purpose of this clause (2), in determining whether any rights, options or
warrants entitle the holders to subscribe for or purchase shares of Common Stock at less than such average of the Last Reported Sale Prices for the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the
date of announcement for such issuance, and in determining the aggregate offering price of such shares of Common Stock, there shall be taken into account any consideration received by the Company for such rights, options or warrants and any amount
payable on exercise or conversion thereof, the value of such consideration, if other than Cash, to be determined by the Company in good faith. 

(3) (x) If the Company distributes shares of the Company’s Capital Stock, evidences of the Company’s indebtedness or
other assets, securities or property of the Company or issues rights, options or warrants to acquire the Company’s Capital Stock or other securities, to all or substantially all holders of Common Stock, excluding: 

  
 28 

 i.    dividends or distributions as to which an adjustment was effected (or
would be effected without regard to the Deferral Exception) pursuant to clause (1) or clause (2) of this Section 4.06(a); 

ii.    dividends or distributions paid exclusively in Cash as to which an adjustment was effected (or would be effected
without regard to the Deferral Exception) pursuant to clause (4) of this Section 4.06(a); 
 iii.    except as
otherwise provided in Section 4.06(c), Rights issued pursuant to a Rights Plan adopted by the Company; 
 iv.    a
distribution solely pursuant to a Common Stock Change Event, as to which Section 4.10 will apply; and 

iii.    Spin-offs, as to which the provisions set forth in clause (y) of this clause (3) shall apply (or would
apply without regard to the Deferral Exception), 
 then the Conversion Rate will be increased based on the following formula: 

 

													
		 	CR’	 	=	 	CR0× 	 		 	SPo	 	
	 	 	 	 	 	SP0 – FMV	 	

  

							
		 				 	where,
			
	CR0	 	 	=	 	 	the Conversion Rate in effect immediately prior to the Open of Business on the Ex-Dividend Date for such distribution;
			
	CR’	 	 	=	 	 	the Conversion Rate in effect immediately after the Open of Business on such Ex-Dividend Date;
			
	SP0	 	 	=	 	 	the average of the Last Reported Sale Prices of Common Stock over the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the Ex-Dividend Date for
such distribution; and
			
	FMV	 	 	=	 	 	the fair market value (as determined by the Company in good faith) of the shares of capital stock, evidences of indebtedness, assets, securities or property or rights, options or warrants to acquire the Company’s Capital Stock
or other securities distributable with respect to each outstanding share of Common Stock on the Ex-Dividend Date for such distribution.

 If “FMV” (as defined above) is equal to or greater than “SP0” (as defined above), then, in lieu of the foregoing increase, provision shall be made for each Holder of a Note to receive, for each $1,000 principal amount of the Notes, at the same time and
upon the same terms as holders of Common Stock, the amount and kind of the Company’s Capital Stock, evidences of the Company’s indebtedness, other assets, securities or property of the Company or rights, options or warrants to acquire the
Company’s Capital Stock or other securities that such Holder would have received as if such Holder owned a number 

  
 29 

 
of shares of Common Stock equal to the Conversion Rate in effect on the Record Date for the distribution. 

An adjustment made under this clause (3)(x) will become effective immediately after the Open of Business on the Ex-Dividend Date for such distribution. If such distribution is not so paid or made, the Conversion Rate shall be decreased, effective as of the date the Board of Directors determines not to make such distribution,
to the Conversion Rate that would then be in effect if such dividend or distribution had not been declared. 

(y)    If the Company makes a payment of a dividend or other distribution on the Common Stock of Capital
Stock of any class or series, or similar equity interests, of or relating to a subsidiary or other business unit (other than a distribution solely pursuant to a Common Stock Change Event, as to which Section 4.10 will apply), where such Capital
Stock or similar equity interest is listed or quoted (or will be listed or quoted upon consummation of the Spin-off) on a U.S. national securities exchange
(“Spin-off”), the Conversion Rate will be increased based on the following formula: 
  

											
		 	CR’	 	=	 	CR0× 	 	FMV + MP0	 	
	 	 	 	 	MP0	 	

  

					
		 		 	where,
			
	CR0	 	=	 	the Conversion Rate in effect immediately prior to the Close of Business on the last Trading Day of the Valuation Period;
			
	CR’	 	=	 	the Conversion Rate in effect immediately after the Close of Business on the last Trading Day of the Valuation Period;
			
	FMV	 	=	 	the average of the Last Reported Sale Prices of the capital stock or similar equity interest distributed to holders of Common Stock applicable to one share of Common Stock (such average to be determined as if references to the
Common Stock in the definition of Last Reported Sale Price were instead references to such Capital Stock or equity interests) over the 10 consecutive Trading Days immediately following, and including, the
Ex-Dividend Date for the Spin-off (the “Valuation Period”); and
			
	MP0	 	=	 	the average of the Last Reported Sale Prices of Common Stock over the Valuation Period.

 The adjustment to the Conversion Rate under the preceding paragraph will occur at the Close of
Business on the last Trading Day of the Valuation Period; provided that in respect of any conversion of the Notes where the Conversion Date occurs within the Valuation Period, then, solely for purposes of such conversion, the Valuation Period
will be deemed to be the period from, and including, the Ex-Dividend Date for such Spin-off to, and including, such Conversion Date (or, if such Conversion Date is not a
Trading Day, to, and including, the immediately preceding Trading Day). If such Spin-off is subsequently cancelled and does not become effective, the Conversion Rate shall be

  
 30 

 
readjusted, as of the date of such cancellation, to be the Conversion Rate that would have been in effect if such Spin-off had not been declared. 

(4)    If any Cash dividend or distribution is made to all or substantially all holders of Common Stock,
the Conversion Rate will be increased based on the following formula: 
  

							
	CR’	 	=	 	CR0×	 	SPo
	 	 	 	SP0 – C 

  

					
		 		 	where,
			
	 CR0
	 	=	 	the Conversion Rate in effect immediately prior to the Open of Business on the Ex-Dividend Date for such dividend or distribution;
			
	 CR’
	 	=	 	the Conversion Rate in effect immediately after the Open of Business on the Ex-Dividend Date for such dividend or distribution;
			
	 SP0
	 	=	 	the average of the Last Reported Sale Prices of Common Stock over the 10 consecutive Trading Day period immediately preceding the Ex-Dividend Date for such dividend or distribution;
and
			
	 C
	 	=	 	the amount in Cash per share of Common Stock the Company distributes to holders of Common Stock.

 If “C” (as defined above) is equal to or greater than “SP0” (as defined
above), then, in lieu of the foregoing increase, provision shall be made for each Holder of a Note to receive, for each $1,000 principal amount of the relevant, at the same time and upon the same terms as holders of Common Stock, the amount of Cash
that such Holder would have received as if such Holder owned a number of shares of Common Stock equal to the Conversion Rate on the Record Date for such Cash dividend or distribution. 

An adjustment made under the provision of this clause (4) will become effective immediately after the Open of Business on
the Ex-Dividend Date for such dividend or distribution. If such dividend or distribution is not so paid, the Conversion Rate shall be decreased, effective as of the date the Board of Directors determines not
to pay such dividend or distribution, to the Conversion Rate that would then be in effect if such dividend or distribution had not been declared. 

(5)    If the Company or any of the Company’s subsidiaries makes a payment in respect of a tender
offer or exchange offer for Common Stock that is subject to the then-applicable tender offer rules under the Exchange Act (other than an odd-lot tender offer that satisfies the requirements of Rule 13e-4(h)(5), or any successor rule), if the cash and value (determined as of the Expiration Time by the Company in good faith) of any other consideration included in the payment per share of Common Stock exceeds the
Last Reported Sale Prices of Common Stock on the Trading Day next succeeding the last date on which tenders or exchanges may be made pursuant to such tender or exchange offer (the “Expiration Date”), the Conversion Rate will be
increased based on the following formula: 

  
 31 

													
		 	CR’	 	=	 	CR0×	 		 	
AC + (SP’ × OS’) 
	  	
	 	 	 	 	 	
OS0 × SP’
	  	

  

					
		 		 	where,
			
	CR0	 	=	 	the Conversion Rate in effect immediately prior to the Close of Business on the last Trading Day of the Averaging Period;
			
	CR’	 	=	 	the Conversion Rate in effect immediately after the Close of Business on the last Trading Day of the Averaging Period;
			
	AC	 	=	 	the aggregate value of all Cash and any other consideration (as determined by the Company in good faith) paid or payable for shares purchased in such tender or exchange offer;
			
	OS0	 	=	 	the number of shares of Common Stock outstanding immediately prior to the time (the “Expiration Time”) such tender or exchange offer expires (prior to giving effect to the purchase of all shares accepted for
purchase or exchange in such tender or exchange offer);
			
	OS’	 	=	 	the number of shares of Common Stock outstanding immediately after the Expiration Time (after giving effect to the purchase of all shares accepted for purchase or exchange in such tender or exchange offer); and
			
	SP’	 	=	 	the average of the Last Reported Sale Prices of Common Stock over the 10 consecutive Trading Day period commencing on, and including, the Expiration Date (the “Averaging Period”).

 The adjustment to the Conversion Rate under the preceding paragraph will occur immediately
after the Close of Business on the last Trading Day of the Averaging Period; provided that in respect of any conversion of Notes where the Conversion Date occurs within the Averaging Period, then, solely for purposes of such conversion, the
Averaging Period will be deemed to be the period from, and including, the Expiration Date to, and including, such Conversion Date (or, if such Conversion Date is not a Trading Day, to, and including, the immediately preceding Trading Day). If the
Company is, or one of the Company’s subsidiaries is, obligated to purchase Common Stock pursuant to any such tender or exchange offer but the Company is, or such subsidiary is, permanently prevented by applicable law from effecting any such
purchase or all such purchases are rescinded, the Conversion Rate shall be immediately decreased to the Conversion Rate that would be in effect if such tender or exchange offer had not been made. 

(b)    Notwithstanding anything to the contrary, if: 

(i)    a Note is to be converted; 

(ii)    the Record Date or Effective Date for any event that requires an adjustment to the Conversion Rate
pursuant to clauses (1) through (4) of Section 4.06(a), inclusive, has occurred on or before the Conversion Date for such conversion, but an 

  
 32 

 
adjustment to the Conversion Rate for such event has not yet become effective as of such Conversion Date; 

(iii)    the consideration due upon such conversion includes any whole shares of Common Stock; and 

(iv)    such shares of Common Stock are not entitled to participate in such event (because they were not
held on the related Record Date or otherwise), 
 then, solely for purposes of such conversion, the Company will, without duplication, give effect to such
adjustment on such Conversion Date, and, for the avoidance of doubt, such shares of Common Stock will not be entitled to participate in such event. In such case, if the date the Company is otherwise required to deliver the consideration due upon
such conversion is before the first date on which the amount of such adjustment can be determined, then the Company will delay the settlement of such conversion until the third (or, if the T+2 Effective Date has occurred by such first date, the
second) Business Day after such first date on which the amount of such adjustment can be determined. 
 (c)    To the
extent the Company has a Rights Plan in effect upon conversion of the Notes pursuant to this Article 4: (i) if such Rights have not separated from the Common Stock prior to the conversion of the Notes, in addition to the Common Stock issuable upon
conversion, the Rights Plan shall provide that upon conversion of the Notes, such Holders will receive the appropriate number of Rights, if any, under such Rights Plan and the certificates representing the Common Stock issued upon such conversion
shall bear such legends, if any, in each case as may be provided by the terms of any Rights Plan; or (ii) if such Rights have separated from the Common Stock prior to the conversion of the Notes, the Conversion Rate will be adjusted as though
the Company distributed to all holders of Common Stock, shares of the Company’s Capital Stock, evidences of indebtedness or assets as described in Section 4.06(a)(3) on the date of such separation. If such an adjustment is made and the
Rights expire or are later redeemed, invalidated or terminated, then a corresponding reversing adjustment will be made to the Conversion Rate on an equitable basis. For the avoidance of doubt, any issuance of Rights will not cause an adjustment of
the Conversion Rate unless and until such Rights have separated from the Common Stock before the time of conversion.

(d)    If one or more events occur requiring an adjustment be made to the Conversion Rate for a particular period,
adjustments to the Conversion Rate shall be determined by the Company in good faith to reflect the combined impact of such Conversion Rate adjustment events, as set out in this Section 4.06, during such period. 

(e)    If the Company makes a distribution of property to holders of Common Stock that would be taxable to them as a
dividend for U.S. federal income tax purposes and the applicable Conversion Rate is increased, this increase would generally be deemed to be the receipt of taxable income by U.S. holders of the Notes and would generally result in withholding taxes
for non-U.S. holders. Because this deemed income would not give rise to any Cash from which any applicable withholding tax could be satisfied, the Company may offset any such withholding tax applicable to non-U.S. holders against Cash payments of interest payable on the Notes. 

  
 33 

 Section 4.07    No Adjustment. 

(a)    No adjustment in the Conversion Rate shall be required if Holders may participate in the transactions set forth in
Section 4.06 above (to the same extent as if the Notes had been converted into Common Stock immediately prior to such transactions) without converting the Notes held by such Holders. 

(b)    No adjustment in the Conversion Rate shall be required unless such adjustment would require an increase or decrease
of at least 1% in the Conversion Rate then effective (the “Deferral Exception”); provided, however, that any adjustments which would be required to be made but for this Section 4.07(b) shall be carried forward and taken
into account in any subsequent adjustment which, together with the original adjustment shall aggregate at least 1% of the then effective Conversion Rate; provided, further, that any carry forward amount shall be given effect (i) on each
Conversion Date; (ii) if a Fundamental Change or Make-Whole Fundamental Change occurs; and (iii) on and after March 1, 2024. Adjustments to the Conversion Rate under this Article 4 will be calculated to the nearest cent or to the
nearest one-ten thousandth of a share, as the case may be, with one half cent and 0.00005 of a share, respectively, being rounded upward. 

(c)    Except as set forth in Sections 4.01(d), 4.06(a) and 4.12, the Conversion Rate will not be adjusted. Without
limiting the foregoing, the Company will not be required to adjust the Conversion Rate on account of: 

(i)    except as described in Section 4.06(a), the sale of shares of Common Stock for a purchase price
that is less than the market price per share of Common Stock or less than the Conversion Price; 

(ii)    the issuance of any shares of Common Stock pursuant to any present or future plan providing for the
reinvestment of dividends or interest payable on the Company’s securities and the investment of additional optional amounts in shares of Common Stock under any such plan; 

(iii)    the issuance of any shares of Common Stock or options or rights to purchase shares of Common Stock
pursuant to any present or future employee, director or consultant benefit plan or program of, or assumed by, the Company or any of its subsidiaries; 

(iv)    the issuance of any shares of Common Stock pursuant to any option, warrant, right or convertible or
exchangeable security of the Company’s outstanding as of the Issue Date; 
 (v)    a third-party
tender offer, other than a tender offer that is subject to clause (5) of Section 4.06(a); 

(vi)    the repurchase of any shares of Common Stock pursuant to an open market share purchase program or
other buyback transaction, including structured or derivative transactions such as accelerated share repurchase transactions or similar 

  
 34 

 
forward derivatives, or other buyback transaction, in each case that is not subject to clause (5) of Section 4.06(a); 

(vii)    a change in the par value of Common Stock; or 

(viii)    accrued and unpaid interest on the Notes. 

Section 4.08    Notice of Adjustment. Whenever the Conversion Rate or conversion privilege is required to be
adjusted pursuant to this Indenture, the Company will compute the adjusted Conversion Rate and promptly file with the Trustee, including in its capacity as the Conversion Agent, an Officer’s Certificate briefly stating the facts requiring the
adjustment, the adjusted Conversion Rate and the manner of computing it. Failure to send such notice or any defect therein shall not affect the validity of any such adjustment. Unless and until a Responsible Officer of the Trustee, including in its
capacity as the Conversion Agent, shall have received such an Officer’s Certificate, the Trustee, including in its capacity as the Conversion Agent, shall not be deemed to have knowledge of any adjustment of the Conversion Rate and may assume
without inquiry that the Conversion Rate has not been adjusted and that the initial Conversion Rate, or the last Conversion Rate with respect to which a Responsible Officer of the Trustee has received such Officer’s Certificate, remains in
effect. Promptly after delivery of such Officer’s Certificate, the Company shall prepare a notice of such adjustment of the Conversion Rate setting forth the adjusted Conversion Rate and the date on which such adjustment became effective and
shall deliver such notice of such adjustment of the Conversion Rate to each Holder. Failure to send such notice or any defect therein shall not affect the validity of any such adjustment. 

Section 4.09    [Reserved]. 

Section 4.10    Effect of Reclassification, Consolidation, Merger or Sale on Conversion Privilege. If any of
the following events occur: 
 (a)    any recapitalization, reclassification or change of the Common Stock other than
(x) changes resulting solely from a subdivision or combination of Common Stock, (y) a change only in par value or from par value to no par value or from no par value to par value or (z) stock splits and stock combinations that do not
involve the issuance of any other series or class of securities, 
 (b)    a consolidation, merger, combination or
statutory share exchange involving the Company, or 
 (c)    a sale, conveyance or lease to a third party of all or
substantially all of the Company’s and the Company’s subsidiaries’ property and assets, taken as a whole, to any Person, 
 in each case, as
a result of which holders of Common Stock are entitled to receive stock, other securities, other property or assets (including Cash or any combination thereof) with respect to or in exchange for such Common Stock, (such an event, a “Common
Stock Change Event,” and such other securities, Cash or property, the “Reference Property,” and the amount and kind of Reference Property that a holder of one share of Common Stock would be entitled to receive on

  
 35 

 
account of such Common Stock Change Event (without giving effect to any arrangement not to issue or deliver a fractional portion of any security or other property), a “Reference Property
Unit”), then, from and after the effective time of such Common Stock Change Event, (i) the consideration due upon conversion of any Note will be determined in the same manner as if each reference to any number of shares of Common Stock
in the provisions described under this Article 4 (or in any related definitions) were instead a reference to the same number of Reference Property Units and (ii) for purposes of the definition of Fundamental Change and Make-Whole Fundamental
Change, (x) the terms “Common Stock” and “Capital Stock” will be deemed to mean the common equity and Capital Stock, respectively (which terms will be deemed to include depositary receipts or shares representing common
equity), if any, forming part of such Reference Property and (y) references to the Company will be deemed to be references to the entity that is the issuer of such common equity or Capital Stock, as applicable. Prior to or at the effective time
of such Common Stock Change Event, the Company or the successor or purchasing Person (if other than the Company), as the case may be (the Company or such other Person, as applicable, the “Successor Person”), will execute with the
Trustee (subject to the Trustee’s rights as provided in this Indenture) a supplemental indenture permitted under Section 9.01(e) providing for the changes described in this Section 4.10 and such other provisions as the Company
reasonably determines are appropriate to preserve the economic interests of the Holders. If such Reference Property includes, in whole or in part, any stock or other securities, then such supplemental indenture will, to the extent applicable,
provide for subsequent adjustments to the Conversion Rate in a manner consistent with the provisions described above. In addition, if the Reference Property includes, in whole or part, shares of stock or other securities or assets (other than Cash
or cash equivalents) of a Person other than the Successor Person, then such other Person will also execute such supplemental indenture and such supplemental indenture will contain such additional provisions the Company reasonably determines are
appropriate to preserve the economic interests of Holders. The Trustee shall have no responsibility whatsoever with respect to such adjustments or other provisions, and may conclusively rely on the Company’s determination that they are
appropriate to preserve the economic interests of the Holders. 
 At and after the effective time of the Common Stock Change Event, the Last
Reported Sale Price will be calculated based on the value of a Reference Property Unit. If the Common Stock Change Event causes Common Stock to be converted into, or exchanged for, the right to receive more than a single type of consideration
(determined based in part upon any form of stockholder election), the composition of the Reference Property Unit will be deemed to be the weighted average of the types and amounts of consideration received by the holders of Common Stock that
affirmatively make such an election (or, if no holders of Common Stock affirmatively make such an election, the weighted average of the types and amounts of consideration actually received by the holders of Common Stock). If the holders of Common
Stock receive only Cash in such Common Stock Change Event, then for all conversions that occur after the effective date of such Common Stock Change Event, the consideration due upon conversion of each $1,000 principal amount of the Notes shall be
solely Cash in an amount equal to the Conversion Rate in effect on the Conversion Date (as may be increased by any additional shares as described under Section 4.01(d)), multiplied by the price paid per share of Common Stock in such Common
Stock Change Event. The Company will notify Holders and the Trustee, including in its capacity as the Conversion Agent, in writing of the weighted average as soon as practicable after such determination is made. 

  
 36 

 The Company may not become a party to any such transaction unless its terms are consistent with
the foregoing provisions. None of the foregoing provisions shall affect the rights of a Holder of Notes to convert its Notes into shares of Common Stock prior to the effective date of such transaction. 

In the event the Company shall execute a supplemental indenture pursuant to this Section 4.10, without prejudice to the other rights of
the Trustee under the Indenture, the Company will promptly file with the Trustee (i) an Officer’s Certificate briefly stating the reasons therefor, the kind or amount of shares of stock or other securities or property (including Cash) that
a holder of a number of shares of Common Stock equal to the Conversion Rate immediately prior to such transaction would have owned or been entitled to receive after any such transaction, and any adjustment to be made with respect thereto and that
all conditions precedent have been complied with and (ii) an Opinion of Counsel that all conditions precedent have been complied with. The Company will cause notice of the execution of such supplemental indenture to be sent to each Holder, at
the address of such Holder as it appears on the register of the Notes, within 20 days after execution thereof. Failure to send such notice shall not affect the legality or validity of such supplemental indenture. 

The above provisions of this Section 4.10 shall similarly apply to successive recapitalizations, reclassifications, mergers,
consolidations, statutory share exchanges, combinations, sales and conveyances. 
 If this Section 4.10 applies to any event or
occurrence, Section 4.06(a) hereof shall not apply. 

Section 4.11    Trustee’s Disclaimer. 

(a)    The Trustee, in its capacity as Trustee, Conversion Agent or otherwise, shall not at any time have any duty or
responsibility to determine or calculate the Conversion Rate (or any adjustment thereto), to determine when an adjustment under this Article 4 should be made to the Conversion Rate, or to determine how any adjustment should be made, what such
adjustment should be, or with respect to the nature or extent or calculation of any such adjustment when made, or with respect to the method employed, or herein or in any supplemental indenture provided to be employed, in making the same, but may
accept as conclusive evidence of that fact or the correctness of any such adjustment, and shall be protected in relying upon, an Officer’s Certificate and Opinion of Counsel, including the Officer’s Certificate with respect thereto which
the Company is obligated to file with the Trustee pursuant to Section 4.08. Unless and until a Responsible Officer of the Trustee receives such Officer’s Certificate delivered pursuant to Section 4.08, the Trustee not be deemed to
have knowledge of any adjustment and may assume without inquiry that no such adjustment has been made and the initial Conversion Rate as defined herein, or the last adjusted Conversion Rate with respect to which the Company has delivered such an
Officer’s Certificate to the Trustee and Conversion Agent, remains in effect. The Trustee, in its capacity as Trustee, Conversion Agent or otherwise, shall not be accountable for and makes no representation as to the validity or value (or the
kind or amount) of any securities or assets issued upon conversion of Notes, and the Trustee shall not be responsible for the Company’s failure to issue, transfer or deliver any shares of Common Stock or stock certificates or other securities
or assets or property or Cash upon the surrender of any Security 

  
 37 

 
for the purpose of conversion or to comply with any of the duties, responsibilities or covenants of the Company contained in this Article 4 or the Indenture. The rights, privileges, protections,
immunities and benefits given to the Trustee, including without limitation, its right to be compensated, reimbursed and indemnified, are extended to and shall be enforceable by the Trustee in each of its capacities hereunder, including its capacity
as Conversion Agent. 
 (b)    Without limiting the generality of the foregoing, the Trustee, in its capacity as
Trustee, Conversion Agent or otherwise, shall have no duty to determine when any of the events discussed in Section 4.10 has occurred, whether the Holders are entitled to an opportunity to determine the form of consideration into which the
Notes shall be convertible in connection with any such event, how the Holders should participate in such determination, how it should be made and whether it is conducted in accordance with the provisions of Section 4.10, shall not be under any
responsibility to determine the correctness of any provisions contained in any supplemental indenture executed pursuant to Section 4.10, or whether they comply with the requirements of Section 4.10, but may accept as conclusive evidence of
the correctness of all of the foregoing, and shall be fully protected in relying upon, the Officer’s Certificate and Opinion of Counsel, with respect thereto which the Company is obligated to file with the Trustee pursuant to Section 4.10
hereof and Section 13.08 of the Base Indenture. 
 Section 4.12    Voluntary Increase. The
Company may, from time to time, to the extent permitted by applicable law and subject to the applicable rules of the principal securities exchange on which the Common Stock is then listed, increase the Conversion Rate by any amount for a period of
at least 20 days. The Company may make such increase in addition to those set forth in Section 4.01(d) and Section 4.06, as the Board of Directors deems advisable to avoid or diminish income tax to holders of shares of Common Stock
resulting from any dividend or distribution of stock, or rights to acquire stock, or from any event treated as such for income tax purposes, and it will be conclusive. The Company will provide 15 days’ prior written notice of any such increase
in the Conversion Rate to the Trustee and the Holders. 
 Section 4.13    Other Adjustments. Whenever any
provision of this Supplemental Indenture requires the calculation of the Last Reported Sale Prices over a span of multiple days (including the Stock Price for purposes of a Make-Whole Fundamental Change), the Company will make appropriate
adjustments to the Last Reported Sale Price or such function thereof to account for any adjustment to the Conversion Rate that becomes effective, or any event requiring an adjustment to the Conversion Rate where the Record Date, Ex-Dividend Date, Effective Date or Expiration Date of the event occurs at any time during the period when the Last Reported Sale Prices or functions thereof are to be calculated. 

Section 4.14    Exchange in Lieu of Conversion. 

(a)    When a Holder surrenders any Note for conversion, the Company may, at its election (an “Exchange
Election”), direct the Conversion Agent to surrender, on or prior to the Business Day immediately following the Conversion Date, such Note to one or more financial institutions designated by the Company for exchange in lieu of conversion.
In order to accept any Notes surrendered for conversion, the designated financial institution(s) must agree to timely pay or deliver, as the case may be, in exchange for such Note, the consideration that would otherwise be due upon conversion as
described in Section 4.02. To make an Exchange Election 

  
 38 

 
with respect to any Note, the Company must, by the Close of Business on the Business Day following the relevant Conversion Date, notify in writing the Trustee, the Conversion Agent (if other than
the Trustee) and the Holder of such Note and the Company must notify the designated financial institution(s) of the relevant deadline for delivery of the consideration due upon conversion and the type of conversion consideration to be paid or
delivered, as the case may be. 
 (b)    Any Notes exchanged by the designated financial institution(s) will remain
outstanding, subject to the Applicable Procedures, if applicable. If any financial institution agrees to accept any Notes for exchange but does not timely pay or deliver, as the case may be, the related conversion consideration, or if such
designated financial institution does not accept the Notes for exchange, then the Company will pay or deliver, as the case may be, the relevant conversion consideration, as, and at the time, required pursuant to the indenture as if the Company had
not made the Exchange Election. 
 (c)    The Company’s designation of any financial institution(s) to which the
Notes may be submitted for exchange does not require such financial institution(s) to accept any Notes. 
 ARTICLE 5 

SUBORDINATION 

Section 5.01    Notes Subordinated to Senior Debt. The Company covenants and agrees, and each Holder of
Notes, by such Holder’s acceptance thereof, likewise covenants and agrees, that the Indebtedness represented by the Notes and the payment of the principal of and premium, if any, and interest on each and all of the Notes is hereby expressly
subordinated and junior, to the extent and in the manner set forth in this Section 5.01, in right of payment to the prior payment in full of all Senior Debt; provided, however, that the Notes, the Indebtedness represented thereby and the
payment of the principal of and premium, if any, and interest on the Notes in all respects shall rank equally with, or prior to, all existing and future Indebtedness of the Company that is expressly subordinated to any Senior Debt. 

(a)    In the event of any payment or distribution of assets of the Company upon any dissolution, winding up, liquidation
or reorganization of the Company, whether in bankruptcy, insolvency, reorganization or receivership proceedings or upon an assignment for the benefit of creditors or any other marshaling of the assets and liabilities of the Company or otherwise, the
holders of all Senior Debt shall first be entitled to receive payment of the full amount due thereon in respect of all such Senior Debt and all other amounts due or provision shall be made for such amount in Cash, or other payments satisfactory to
the holders of Senior Debt, before the Holders of any of the Notes are entitled to receive any payment or distribution of any character, whether in Cash, Notes or other property, on account of the principal of or premium, if any, or interest on the
Notes. 
 (b)    In the event of any acceleration of the Final Maturity Date of the Notes because of an Event of
Default, unless the full amount due in respect of all Senior Debt is paid in Cash or other form of payment satisfactory to the holders of Senior Debt, no payment shall be made by the Company with respect to the principal of, premium, if any, or
interest on the Notes or to acquire any of the Notes (including any conversion or Cash repurchase pursuant to the exercise 

  
 39 

 
of the Fundamental Change Repurchase Right or otherwise), and the Company will give prompt written notice of such acceleration to such holders of Senior Debt. 

(c)    In the event of and during the continuance of any default in payment of the principal of or premium, if any, or
interest on, rent or other payment obligations in respect of, any Senior Debt, unless all such payments due in respect of such Senior Debt have been paid in full in Cash or other payments satisfactory to the holders of Senior Debt, no payment shall
be made by the Company with respect to the principal of, premium, if any, or interest on the Notes or to acquire any of the Notes (including any conversion or Cash repurchase pursuant to the exercise of the Fundamental Change Repurchase Right);
provided, however, that the issuance and delivery of shares of Common Stock and Cash in lieu of any fractional share of Common Stock upon conversion of any Notes in accordance with this Indenture and the Notes will be deemed not to
constitute a payment on or with respect to any Note. The Company will give prompt written notice to the Trustee of any default under any Senior Debt or under any agreement pursuant to which Senior Debt may have been issued. 

(d)    In the event that, notwithstanding the foregoing provisions of Sections 5.01(a), 5.01(b) and 5.01(c), any payment
on account of principal of, premium, if any, or interest on the Notes shall be made by or on behalf of the Company and received by the Trustee, by any Holder or by any Paying Agent (or, if the Company is acting as its own Paying Agent, money for any
such payment shall be segregated and held in trust): 
 (i)    after the occurrence of an event specified
in Section 5.01(a) or 5.01(b), then, unless all Senior Debt is paid in full in Cash, or other payments or other provisions satisfactory to the holders of Senior Debt shall be made therefor, or 

(ii)    after the happening of an event of default of the type specified in Section 5.01(c) above,
then, unless the amount of such Senior Debt then due shall have been paid in full in cash, or other payments or other provisions satisfactory to the holders of Senior Debt shall be made therefor or such event of default shall have been cured or
waived, 
 such payment (subject, in each case, to the provisions of Section 5.07 hereof) shall be held in trust for the benefit of, and shall be
immediately paid over to, the holders of Senior Debt or their representative or representatives, the agent or agents or the trustee or trustees under any indenture under which any instruments evidencing any of the Senior Debt may have been issued,
as their interests may appear. 
 Section 5.02    Subrogation. Subject to the payment in full of all
Senior Debt to which the Indebtedness evidenced by the Notes is in the circumstances subordinated as provided in Section 5.01 hereof, the Holders of the Notes shall be subrogated to the rights of the holders of such Senior Debt to receive
payments or distributions of cash, property or Notes of the Company applicable to such Senior Debt until all amounts owing on the Notes shall be paid in full, and, as between the Company, its creditors other than holders of such Senior Debt, and the
Holders of the Notes, no such payment or distribution made to the holders of Senior Debt by virtue of this Article which otherwise would have been made to the Holders of the Notes shall be deemed to be a payment by the Company on account of such
Senior Debt; provided, however, that the provisions of this Article 5 are and are intended solely for the purpose of defining the relative 

  
 40 

 
rights of the Holders of the Notes, on the one hand, and the holders of Senior Debt, on the other hand. 

Section 5.03    Obligation of the Company is Absolute and Unconditional. Nothing contained in this Article 5
or elsewhere in the Indenture or in the Notes is intended to or shall impair, as between the Company, its creditors other than the holders of Senior Debt, and the Holders of the Notes, the obligation of the Company, which is absolute and
unconditional, to pay to the Holders of the Notes the principal of and premium, if any, and interest on the Notes as and when the same shall become due and payable in accordance with their terms, or is intended to or shall affect the relative rights
of the Holders of the Notes and creditors of the Company other than the holders of Senior Debt, nor shall anything contained herein or therein prevent the Trustee or the Holder of any Note from exercising all remedies otherwise permitted by
applicable law upon default under the Indenture, subject to the rights, if any, under this Article of the holders of Senior Debt in respect of Cash, property or Notes of the Company received upon the exercise of any such remedy. 

Section 5.04    Maturity of or Default on Senior Debt. Upon the maturity of any Senior Debt by lapse of time,
acceleration or otherwise, all principal of or premium, if any, or interest on, rent or other payment obligations in respect of all such matured Senior Debt shall first be paid in full in cash, or other payment or other provision satisfactory to the
holders of Senior Debt shall have been duly provided for, before any payment on account of principal, or premium, if any, or interest is made upon the Notes. 

Section 5.05    Payments on Notes Permitted. Except as expressly provided in this Article, nothing contained
in this Article shall affect the obligation of the Company to make, or prevent the Company from making, payments of the principal of, premium, if any, or interest on the Notes in accordance with the provisions hereof and thereof, or shall prevent
the Trustee or any Paying Agent from applying any money deposited with it hereunder to the payment of the principal of, or premium, if any, or interest on the Notes. 

Section 5.06    Effectuation of Subordination by Trustee. Each Holder of Notes, by such Holder’s
acceptance thereof, authorizes and directs the Trustee on such Holder’s behalf to take such action as may be necessary or appropriate to effectuate the subordination provided in this Article 5 and appoints the Trustee such Holder’s attorney-in-fact for any and all such purposes. Upon any payment or distribution of assets of the Company referred to in this Article 5, the Trustee and the Holders of the
Notes shall be entitled to rely upon any order or decree made by any court of competent jurisdiction in which any such dissolution, winding up, liquidation or reorganization proceeding affecting the affairs of the Company is pending or upon a
certificate of the trustee in bankruptcy, receiver, assignee for the benefit of creditors, liquidating trustee or agent or other Person making any payment or distribution, delivered to the Trustee or to the Holders of the Notes, for the purpose of
ascertaining the Persons entitled to participate in such payment or distribution, and as to other facts pertinent to the right of such Persons under this Article 5, and if such evidence is not furnished, the Trustee may defer any payment to such
Persons pending judicial determination as to the right of such Persons to receive such payment. 

  
 41 

 Section 5.07    Knowledge of Trustee. Notwithstanding the
provision of this Article 5 or any other provisions of this Indenture, the Trustee, in its capacity a Trustee, Paying Agent or otherwise, shall not be charged with knowledge of the existence of any Senior Debt, of any default in payment of principal
of, premium, if any, or interest on, rent or other payment obligation in respect of any Senior Debt, or of any facts which would prohibit the making of any payment of money to or by the Trustee, or the taking of any other action by the Trustee,
unless a Responsible Officer of the Trustee having responsibility for the administration of the trust established by the Indenture shall have received written notice thereof from the Company and, prior to the receipt of any such written notice, the
Trustee shall be entitled in all respects to assume that no such default or facts exist; provided, however, that unless on the third Business Day prior to the date upon which by the terms hereof any such money may become payable for any
purpose the Trustee shall have received the notice provided for in this Section 5.07, then, anything herein contained to the contrary notwithstanding, the Trustee shall have full power and authority to receive such money and apply the same to
the purpose for which it was received, and shall not be affected by any notice to the contrary which may be received by it on or after such date. 

Section 5.08    Trustee’s Relation to Senior Debt. The Trustee in its individual capacity
shall be entitled to all the rights set forth in this Article 5 with respect to any Senior Debt at the time held by it, to the same extent as any other holder of Senior Debt and nothing in the Indenture shall deprive the Trustee of any of its rights
as such holder. Nothing contained in this Article shall apply to claims of or payments to the Trustee under or pursuant to Section 7.06 of the Base Indenture. With respect to the holders of Senior Debt, the Trustee undertakes to perform or to
observe only such of its covenants and obligations as are specifically set forth in this Article, and no implied covenants or obligations with respect to the holders of Senior Debt shall be read into the Indenture against the Trustee. The Trustee
shall not be deemed to owe any duties (including without limitation, any fiduciary duty) to the holders of Senior Debt and the Trustee shall not be liable to any holder of Senior Debt if it shall pay over or deliver to Holders, the Company or any
other Person money or assets to which any holder of Senior Debt shall be entitled by virtue of this Article or otherwise. 
 Nothing in this
Article shall apply to claims of, or payments to, the Trustee, in any of its capacities hereunder, or pursuant to Section 7.06 of the Base Indenture. 

Section 5.09    Rights of Holders of Senior Debt Not Impaired. No right of any present or future holder of any
Senior Debt to enforce the subordination herein shall at any time or in any way be prejudiced or impaired by any act or failure to act on the part of the Company or by any noncompliance by the Company with the terms, provisions and covenants of the
Indenture, regardless of any knowledge thereof any such holder may have or be otherwise charged with. 

Section 5.10    Modification of Terms of Senior Debt. Any renewal or extension of the time of payment of any
Senior Debt or the exercise by the holders of Senior Debt of any of their rights under any instrument creating or evidencing Senior Debt, including without limitation the waiver of default thereunder, may be made or done all without notice to or
assent from the Holders of the Notes or the Trustee. No compromise, alteration, amendment, modification, extension, renewal or other change of, or waiver, consent or other action in respect 

  
 42 

 
of, any liability or obligation under or in respect of, or of any of the terms, covenants or conditions of any indenture or other instrument under which any Senior Debt is outstanding or of such
Senior Debt, whether or not such compromise, alteration, amendment, modification, extension, renewal or other change of, or waiver, consent or other action is in accordance with the provisions of any applicable document, shall in any way alter or
affect any of the provisions of this Article or of the Notes relating to the subordination thereof. 

Section 5.11    Certain Conversions Not Deemed Payment. For the purposes of this Article 5 only, and without
limiting the generality of the proviso to Section 5.01(c): 
 (a)    the issuance and delivery of Junior Securities
upon conversion of Notes in accordance with Article 4 hereof shall not be deemed to constitute a payment or distribution on account of the principal of, premium, if any, or interest on Notes or on account of the purchase or other acquisition of
Notes, and 
 (b)    the payment, issuance or delivery of Cash (except in satisfaction of fractional shares pursuant to
Section 4.03 hereof), property or Notes (other than Junior Securities) upon conversion of a Note shall be deemed to constitute payment on account of the principal, premium, if any, or interest of such Note. For the purposes of this
Section 5.11, the term “Junior Securities” means: 
 (i)    shares of any Common
Stock, or 
 (ii)    other securities of the Company that are subordinated in right of payment to all
Senior Debt that may be outstanding at the time of issuance or delivery of such Notes to substantially the same extent as, or to a greater extent than, the Notes are so subordinated as provided in this Article. Nothing contained in this Article 5 or
elsewhere in the Indenture or in the Notes is intended to or shall impair, as among the Company, its creditors (other than holders of Senior Debt) and the Holders of Notes, the right, which is absolute and unconditional, of the Holder of any Note to
convert such Note in accordance with Article 4 hereof. 
 Section 5.12    Relation to other Indebtedness.
The Notes shall not be “Senior Debt” for purposes of the First Supplemental Indenture, dated October 15, 2013, by and between the Company and the Trustee, relating to the 2018 Notes or the Second Supplemental Indenture, dated
October 15, 2013, by and between the Company and the Trustee, relating to the 2020 Notes, but shall rank equally in right of payment with the 2018 Notes and the 2020 Notes. 

ARTICLE 6 

COVENANTS 

Article 4 of the Base Indenture is hereby supplemented, with respect to the Notes, to add or replace the following covenants, as indicated:

 The following covenants shall apply with respect to the Notes authorized and designated under this Indenture. 

  
 43 

 Section 6.01    Payment of Notes. The following covenant replaces
Section 4.01 of the Base Indenture with respect to the Notes: 
 (a)    The Company will promptly make all payments
in respect of the Notes on the dates and in the manner provided in the Notes and this Indenture. A payment of principal or interest shall be considered paid on the date it is due if the Paying Agent (other than the Company) holds by 10:00 a.m., New
York City time, on that date money deposited by or on behalf of the Company in immediately available funds and designated for and sufficient to make the payment. Subject to Section 4.02 and Section 3.04, accrued and unpaid interest on any
Note that is payable, and is punctually paid or duly provided for, on any Interest Payment Date shall be paid to the Person in whose name that Note is registered on the Security Registrar at the Close of Business on any Regular Record Date for such
interest at the office or agency of the Company maintained for such purpose. Principal, Fundamental Change Repurchase Price and interest, in each case if payable, shall be considered paid on the applicable date due if, as of 10:00 a.m., New York
City time, on such date the Trustee or the Paying Agent holds, in accordance with this Indenture, money in immediately available funds and designated for and sufficient to pay all such amounts then due. The Company will, to the fullest extent
permitted by law, pay interest in immediately available funds on overdue principal amount and overdue installment of interest at the annual rate borne by the Notes compounded semiannually, which interest shall accrue from the date such overdue
amount was originally due to the date payment of such amount, including interest thereon, has been made or duly provided for. All such interest shall be payable by the Company, at its election in each case, as provided in clause (i) or (ii)
below: 
 (i)    The Company may elect to make payment to the Persons in whose names the Notes are
registered at the Close of Business on a special record date for the payment of such overdue amounts, which shall be fixed in the following manner. The Company shall notify the Trustee in writing of the amount of the overdue amounts proposed to be
paid on each Note and the date of the proposed payment (which shall be not less than 25 days after the receipt by the Trustee of such notice, unless the Trustee shall consent to an earlier date), and at the same time the Company shall deposit with
the Trustee an amount of money equal to the aggregate amount to be paid in respect of such overdue amounts or shall make arrangements satisfactory to the Trustee for such deposit on or prior to the date of the proposed payment, such money when
deposited to be held in trust for the benefit of the Persons entitled to such overdue amounts as in this clause provided. Thereupon the Company shall fix a special record date for the payment of such overdue amounts which shall be not more than 15
days and not less than 10 days prior to the date of the proposed payment, and not less than 10 days after the receipt by the Trustee of the notice of the proposed payment (unless the Trustee shall consent to an earlier date). The Company shall
promptly notify the Trustee of such special record date, and the Trustee, at the Company’s written request and in the name and at the expense of the Company, shall cause notice of the proposed payment of such overdue amounts and the special
record date therefor to be delivered to each Holder not less than 10 days prior to such special record date. Notice of the proposed payment of such overdue amounts and the special record date therefor having been so delivered, such overdue amounts
shall be paid to the Persons in whose names the Notes are registered at the Close of Business on such special record date and shall no longer be payable pursuant to the following clause (ii) of 

  
 44 

 
this Section 6.01(a)(i). The Trustee shall have no responsibility whatsoever for the calculation or verification of any overdue amounts. 

(ii)    The Company may make payment of any overdue amounts in any other lawful manner not inconsistent
with the requirements of any securities exchange or automated quotation system on which the Notes may be listed or designated for issuance, and upon such notice as may be required by such exchange or automated quotation system, if, after notice
given by the Company to the Trustee of the proposed payment pursuant to this clause, such manner of payment shall be deemed practicable by the Trustee. 

(b)    Payment of the principal of and interest on the Notes shall be made at the office or agency of the Company
maintained for that purpose, which shall initially be at the Corporate Trust Administration Office, in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debts;
provided, however, that the Company may pay principal interest in respect of any Certificated Note by check or wire transfer payable in such money; provided further, that at the option of the Company payment of interest may be made by
check sent to the address of the Person entitled thereto as such address appears in the register of the Notes; provided further, that a Holder with an aggregate principal amount in excess of $5,000,000 will be paid by wire transfer in
immediately available funds at the election of such Holder if such Holder has provided wire transfer instructions to the Trustee at least 10 Business Days prior to the payment date. Any wire transfer instructions received by the Trustee will remain
in effect until revoked by the Holder. Notwithstanding the foregoing, so long as the Notes are registered in the name of a Depositary or its nominee, all payments thereon shall be made by wire transfer of immediately available funds to the account
of the Depositary or its nominee. 
 Section 6.02    SEC Reports. The following covenant replaces
Section 5.03 of the Base Indenture with respect to the Notes: 
 The Company shall timely file all quarterly and annual reports (on
Form 10-K or 10-Q or any respective successor form) that it is required to file with the SEC pursuant to Section 13 or 15(d) of the Exchange Act (excluding any
information, documents or reports, or portions thereof, subject to confidential treatment and any correspondence with the SEC), and within 15 days after it is required to file them with the SEC, the Company shall deliver copies of all such reports,
information and other documents to the Trustee (giving effect to any grace period provided by Rule 12b-25 or any successor rule under the Exchange Act). Reports filed by the Company with the SEC via EDGAR (or
any successor thereto) will be deemed to be filed with the Trustee as of the time such documents are filed via EDGAR (or any successor thereto), provided that the Trustee shall have no obligation whatsoever to determine whether or not any
such documents have been filed via EDGAR (or any successor thereto). Delivery or deemed delivery of such reports, information and documents required in this Section 6.02 to the Trustee is for informational purposes only and the Trustee’s
receipt and deemed receipt of such shall not constitute actual or constructive notice of any information contained therein or determinable from information contained therein, including the Company’s compliance with any of its covenants
hereunder (as to which the Trustee is entitled to rely conclusively on Officer’s Certificates). The Trustee is under no duty to examine any such documents delivered to the 

  
 45 

 
Trustee or filed via EDGAR (or any successor thereto) to ensure compliance with the provisions of the Indenture or to ascertain the correctness or otherwise of the information or the statements
contained therein. The Company will also comply with the other provisions of TIA § 314(a). 

Section 6.03    Stay, Extension and Usury Laws. To the extent that it may lawfully do so, the Company
(a) agrees that it will not at any time insist upon, plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay, extension or usury law (wherever or whenever enacted or in force) that may affect the covenants or the
performance of this Indenture; and (b) expressly waives all benefits or advantages of any such law and agrees that it will not, by resort to any such law, hinder, delay or impede the execution of any power granted to the Trustee by this
Indenture, but will suffer and permit the execution of every such power as though no such law has been enacted. 
 ARTICLE 7 

CONSOLIDATION; MERGER; CONVEYANCE; TRANSFER OR
LEASE 
 Article 10 of the Base Indenture is hereby amended and restated in full, solely with respect to the Notes, to
read as follows: 
 Section 7.01    Company May Consolidate, Etc., Only on Certain Terms.  

(a)    Subject to Section 7.02, the Company may not, without the consent of the Holders, consolidate with, merge into
or transfer all or substantially all of the consolidated assets of the Company (“Reorganization Event”) to another Person (the “Reorganization Successor Corporation”) unless: 

(i)    either (A) the Company will be the resulting or surviving corporation or (B) the
Reorganization Successor Corporation (if other than the Company), shall (i) be a corporation organized under the laws of the United States of America or any of its political subdivisions and (ii) expressly assume, by an indenture
supplemental hereto, executed and delivered to the Trustee, in form satisfactory to the Trustee, all of the obligations of the Company under the Notes and this Indenture; 

(ii)    at the time of and immediately after giving effect to such Reorganization Event, no Event of
Default, and no event which, after notice or lapse of time or both, would become an Event of Default, shall have occurred and be continuing; 

(iii)    if the Company will not be the resulting or surviving corporation of the Reorganization Event, the
Company will have, at or prior to the effective date of such Reorganization Event, delivered to the Trustee an Officer’s Certificate and an Opinion of Counsel, each stating that such Reorganization Event complies with this Indenture. 

Section 7.02    Successor Substituted. Upon any consolidation of the Company with, or merger of the Company
into, any other Reorganization Successor Corporation or any conveyance, transfer or lease of all or substantially all of the properties and assets of the Company and its Subsidiaries, taken as a whole, in accordance with Section 7.01, the
successor Reorganization Successor Corporation formed by such consolidation or into which the Company is merged or to which such conveyance, transfer or lease is made shall succeed to, and be 

  
 46 

 
substituted for, and may exercise every right and power of, the Company under this Indenture with the same effect as if such successor Reorganization Successor Corporation had been named as the
Company herein, and thereafter, except in the case of a lease, and except for obligations the predecessor Person may have under a supplemental indenture, the predecessor Person shall be relieved of all obligations and covenants under the Indenture
and the Notes. 
 ARTICLE 8 

DEFAULTS AND REMEDIES 

Article 6 of the Base Indenture is hereby amended and restated in full, solely with respect to the Notes, to read as follows: 

Section 8.01    Events of Default. An “Event of Default” shall occur when any of the
following occurs (whatever the reason for such Event of Default and whether it shall be occasioned by the provisions of Article 5 hereof or be voluntary or involuntary or be effected by operation of law or pursuant to any judgment, decree or order
of any court or any order, rule or regulation of any administrative or governmental body): 
 (a)    the Company shall
fail to pay when due the principal of or premium, if any, on the Notes, including the Fundamental Change Repurchase Price of any Note and any Make-Whole Premium, when the same becomes due and payable whether at the Final Maturity Date, upon exercise
of a repurchase right or otherwise, whether or not such payment is prohibited by Article 5 hereof; or 
 (b)    the
Company shall fail to pay an installment of interest on any of the Notes, which failure continues for 30 days after the date when due whether or not such payment is prohibited by Article 5 hereof; or 

(c)    the Company shall fail to deliver, when due, the consideration due upon conversion of any Note, and that failure
continues for 10 days; or 
 (d)    the Company shall fail to perform or observe any other term, covenant or agreement
contained in the Notes or this Indenture and the failure continues for a period of 60 days after written notice of such failure, requiring the Company to remedy the same, shall have been given to (i) the Company by the Trustee or (ii) to
the Company and the Trustee by the Holders of at least 25% in aggregate principal amount of the then-outstanding Notes; or 

(e)    (i) the Company shall fail to make any payment by the end of the applicable grace period, if any, after the
maturity of any indebtedness for borrowed money in an amount in excess of $75,000,000 or (ii) there is an acceleration of any indebtedness for borrowed money in an amount in excess of $75,000,000 because of a default with respect to such
indebtedness without such indebtedness having been discharged or such acceleration having been cured, waived, rescinded or annulled, in the case of either (i) or (ii) above, for a period of 60 days after written notice (i) to the Company
by the Trustee or (ii) to the Company and the Trustee by Holders of at least 25% in aggregate principal amount of the then-outstanding Notes; or 

  
 47 

 (f)    the Company shall fail to provide a Fundamental Change Company Notice
to the Holders and the Trustee in accordance with Section 3.01 or a notice of a Make-Whole Fundamental Change in accordance with Section 4.01(e); or 

(g)    a court having jurisdiction enters (i) a decree or order for relief in respect of the Company or any of its
Significant Subsidiaries in an involuntary case or proceeding under any Bankruptcy Law or (ii) a decree or order adjudging the Company or any of its Significant Subsidiaries bankrupt or insolvent, or approves as properly filed a petition
seeking reorganization, arrangement, adjustment or composition of or in respect of the Company or any of its Significant Subsidiaries under any applicable U.S. federal or state law, or appoints a Receiver of the Company or any of its Significant
Subsidiaries or of any substantial part of its property, or orders the winding up or liquidation of its affairs, and the continuance of any such decree or order for relief or any such other decree or order unstayed and in effect for a period of 60
consecutive days; or 
 (h)    the Company or any of its Significant Subsidiaries pursuant to or within the meaning of
any Bankruptcy Law: 
 (i)    commences as a debtor a voluntary case or proceeding; 

(ii)    consents to the entry of an order for relief against it in an involuntary case or proceeding or the
commencement of any case against it; 
 (iii)    consents to the appointment of a Receiver of it or for
all or substantially all of its property; 
 (iv)    makes a general assignment for the benefit of its
creditors; 
 (v)    files a petition in bankruptcy or answer or consent seeking reorganization or
relief; or 
 (vi)    consents to the filing of such a petition or the appointment of or taking
possession by a Receiver. 
 The term “Bankruptcy Law” means title 11, U.S. Code or any similar Federal or State law for
the relief of debtors. The term “Custodian” means any receiver, trustee, assignee, liquidator or similar official under any Bankruptcy Law. 

Section 8.02    Acceleration of Maturity; Rescission and Annulment. If an Event of Default with respect to
outstanding Notes (other than an Event of Default specified in Section 8.01(g) or 8.01(h) with respect to the Company) occurs and is continuing, the Trustee or the Holders of at least 25% in aggregate principal amount of the then-outstanding
Notes, by written notice to the Company and the Trustee, may declare due and payable 100% of the principal amount of all outstanding Notes plus any accrued and unpaid interest to the date of payment. Upon a declaration of acceleration, such
principal and accrued and unpaid interest to the date of payment shall be immediately due and payable. 

  
 48 

 If an Event of Default specified in Section 8.01(g) or 8.01(h) occurs with respect to the
Company, all unpaid principal of and accrued and unpaid interest on the outstanding Notes shall become and be immediately due and payable, without any declaration or other act on the part of the Trustee or any Holder. 

Notwithstanding the foregoing or anything to the contrary set forth in this Indenture, to the extent elected by the Company, the sole remedy
for an Event of Default relating to the failure to comply with the reporting obligations set forth in Section 6.02 herein and for any failure to comply with the requirements of Section 314(a)(1) of the TIA (at any time such section is
applicable to the Indenture), will for the first 365 days after the occurrence of such an Event of Default consist exclusively of the right to receive Special Interest on the Notes. Any Special Interest that accrues on a Note will accrue at an
annual rate equal to 0.25% of the outstanding principal amount of the Notes for the first 180 days on which Special Interest accrues and, thereafter, at an annual rate equal to 0.50% of the outstanding principal amount of the Notes from the 181st
day to, and including, the 365th day on which Special Interest accrues. In order to exercise this right and elect to pay Special Interest as the sole remedy during the first 365 days after the occurrence of any Event of Default relating to the
failure to comply with the reporting obligations, the Company must notify all Holders of the Notes and the Trustee (in writing) and Paying Agent (if other than the Trustee) of such election on or before the Close of Business on the date on which
such Event of Default first occurs and comply with the other conditions of the Indenture. The Special Interest will be paid semi-annually in arrears, with the first semi-annual payment (prorated for the number of days during which the Company is in
Default) due on the first Interest Payment Date following the date on which the Special Interest began to accrue on any Notes. The Special Interest will accrue on all outstanding Notes from and including the date on which an Event of Default
relating to a failure to comply with the reporting obligations set forth in Section 6.02 herein first occurs to and including the 365th day thereafter (or such earlier date on which the Event of Default shall have been cured or waived). On the
366th day (or earlier, if the Event of Default relating to the reporting obligations is cured or waived prior to such 366th day), such Special Interest will cease to accrue and, if the Event of Default relating to reporting obligations has not been
cured or waived prior to such 366th day, the Notes will be subject to acceleration as provided above in this Section 8.02. In the event the Company does not elect to pay Special Interest upon an Event of Default in accordance with this
paragraph, the Notes will be subject to acceleration as provided above. If the Company elects to pay Special Interest as the sole remedy for an Event of Default relating to the failure to comply with reporting obligations in Section 6.02 or for
any failure to comply with the requirements of Section 314(a)(1) of the TIA (at any time such section is applicable to the Indenture), then the Company will notify all Holders, the Trustee and Paying Agent of such election on or before the
Close of Business on the date on which such Event of Default first occurs and shall deliver to the Trustee an Officer’s Certificate stating (i) a brief description of the report or reports that the Company failed to file that resulted in
the Event of Default under Section 8.01(e), (ii) that the Company is electing to pay Special Interest and the date on which such Event of Default occurred, (iii) the amount of such Special Interest that is payable and (iv) the date on
which such Special Interest is payable. If the Company has paid Special Interest directly to the Persons entitled to such Special Interest, the Company shall deliver to the Trustee an Officer’s Certificate setting forth the particulars of such
payment. Nothing in this Section 8.02 shall affect the rights of Holders in the event of the occurrence of any other Event of Default. 

  
 49 

 The Holders of a majority in aggregate principal amount of the then-outstanding Notes by written
notice to the Company and the Trustee may rescind and annul an acceleration and its consequences if: 

(1)    all existing Events of Default, other than the nonpayment of principal of or interest on the Notes
which has become due solely because of the acceleration, have been remedied, cured or waived, and 

(2)    the rescission would not conflict with any judgment or decree of a court of competent jurisdiction;

 provided, however, that in the event such declaration of acceleration has been made based on the existence of an Event of Default under
Section 8.01(e) hereof and such Event of Default has been remedied, cured or waived in accordance with Section 8.01(e) hereof, then, without any further action by the Holders, such declaration of acceleration shall be rescinded
automatically and the consequences of such declaration shall be annulled. No such rescission or annulment shall affect any subsequent Default or impair any right consequent thereon. 

Section 8.03    Other Remedies. If an Event of Default with respect to outstanding Notes occurs and is
continuing, the Trustee may pursue any available remedy by proceeding at law or in equity to collect the payment of principal of or interest on the Notes or to enforce the performance of any provision of the Notes. 

Section 8.04    Waiver of Past Defaults. The Holders, either (a) through the written consent of at least
a majority in aggregate principal amount of the then-outstanding Notes or (b) by the adoption of a written resolution, at a meeting of Holders of the then-outstanding Notes at which a quorum is present, by the Holders of at least a majority in
aggregate principal amount of the then outstanding Notes, may, on behalf of the Holders of all of the Notes, waive any past or existing Default or Event of Default and its consequences, except a Default or Event of Default: 

(a)    in the payment of the principal of, or premium, if any, or interest on any Note (provided, however, that
subject to Section 8.07 hereof, the Holders of a majority in aggregate principal amount of the then-outstanding Notes may rescind an acceleration and its consequences, including any related payment default that resulted from such acceleration);

 (b)    in respect of the right to convert any Note in accordance with Article 4; or 

(c)    in respect of a covenant or provision hereof which, under Section 9.02 hereof, cannot be modified or amended
without the consent of the Holder of each outstanding Note affected. 
 Upon any such waiver, such Default shall cease to exist, and any
Event of Default arising therefrom shall be deemed to have been cured, for every purpose of this Indenture; provided, however, that no such waiver shall extend to any subsequent or other Default or Event of Default or impair any right
consequent thereon. 

  
 50 

 Section 8.05    Control by Majority. The Holders, either
(a) through the written consent of at least a majority in aggregate principal amount of the Notes then outstanding, or (b) by the adoption of a written resolution, at a meeting of Holders of the Notes then outstanding at which a quorum is
present, by the Holders of at least a majority in aggregate principal amount of the Notes then outstanding, will have the right to direct the time, method and place of conducting any proceeding for any remedy available to the Trustee or exercising
any trust or power conferred to the Trustee, subject to the provisions of this Indenture. Prior to taking any such action hereunder, the Trustee will be entitled to indemnification satisfactory to it against all losses and expenses caused by taking
or not taking such action. However, the Trustee may refuse to follow any direction that: 
 (a)    conflicts with
applicable law or the Indenture, 
 (b)    the Trustee determines may be unduly prejudicial to the rights of the Trustee
or any Holders not joining therein, or 
 (c)    would involve the Trustee in personal liability. 

The Trustee may take any other action deemed proper by the Trustee which in the opinion of the Trustee is not inconsistent with such
direction. 
 Section 8.06    Limitation on Suit. No Holder of any Note shall have any right to pursue any
remedy with respect to this Indenture or the Notes (including instituting any proceeding, judicial or otherwise, with respect to this Indenture or for the appointment of a receiver or trustee) unless: 

(a)    such Holder has previously given written notice to the Trustee of an Event of Default that is continuing; 

(b)    the Holders of at least 25% in aggregate principal amount of the Notes then outstanding shall have made written
request to the Trustee to pursue the remedy; 
 (c)    such Holder or Holders have offered and, if requested, provided,
to the Trustee indemnity or security satisfactory to the Trustee against any losses, costs, expenses and liabilities incurred in complying with such request; 

(d)    the Trustee has failed to comply with the request for 60 days after its receipt of such notice, request and offer
of security or indemnity; and 
 (e)    during such 60-day period, no direction
which in the opinion of the Trustee is inconsistent with such written request has been given to the Trustee by the Holders of a majority in aggregate principal amount of the Notes then outstanding. 

Section 8.07    Unconditional Rights of Holders to Receive Payment and to Convert. In addition to the other
rights and remedies set forth in this Article 8, the following shall apply with respect to the Notes authorized and designated under this Indenture. 

  
 51 

 Notwithstanding any other provision in this Indenture, the Holder of any Note will have the
right, which is absolute and unconditional, to receive payment of the principal amount, premium, including Make-Whole Premium, if any, Fundamental Change Repurchase Price, interest in respect of the Notes held by such Holder, on or after the
respective due dates expressed in the Notes and this Indenture, and to convert such Note in accordance with Article 4, and to bring suit for the enforcement of any such payment on or after such respective due dates expressed in the Notes and this
Indenture and to convert in accordance with Article 4, and shall not be impaired or affected without the consent of such Holder. 

Section 8.08    Collection of Indebtedness and Suits for Enforcement by the Trustee. The Company
covenants that if: 
 (a)    a Default or Event of Default occurs in the payment of any interest on any Note when such
interest becomes due and payable and such Default or Event of Default continues for a period of 30 days, or 
 (b)    a
Default or Event of Default occurs in the payment of the principal of or premium, if any, on any Note at the Final Maturity Date thereof, the Company shall, upon demand of the Trustee, pay to it, for the benefit of the Holders of such Notes, the
whole amount then due and payable (as expressed therein or as a result of any acceleration effected pursuant to Section 8.02 hereof) on such Notes for principal and premium, if any, and interest and, to the extent that payment of such interest
shall be legally enforceable, interest, accruing at the Interest Rate, on any overdue principal and premium, if any, and on any overdue interest and, in addition thereto, such further amount as shall be sufficient to cover the costs and expenses of
collection, including the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel. 
 If the
Company fails to pay such amounts forthwith upon such demand, the Trustee, in its own name and as trustee of an express trust, may institute a judicial proceeding for the collection of the sums so due and unpaid, may prosecute such proceeding to
judgment or final decree and may enforce the same against the Company and collect the money adjudged or decreed to be payable in the manner provided by law out of the property of the Company, wherever situated. 

If an Event of Default (other than an Event of Default specified in Section 8.01(g) or 8.01(h) hereof) occurs and is continuing, upon
acceleration of the Notes, the Trustee may in its discretion proceed to protect and enforce its rights and the rights of the Holders of Notes by such appropriate judicial proceedings (or by any other available remedy) as the Trustee shall deem most
effectual to protect and enforce any such rights, whether for the specific enforcement of any covenant or agreement in this Indenture or in aid of the exercise of any power granted herein, or to enforce any other proper remedy. 

Section 8.09    Trustee May File Proofs of Claim. In case of the pendency of any receivership, insolvency,
liquidation, bankruptcy, reorganization, arrangement, adjustment, composition or other judicial proceeding relative to the Company or the property of the Company or its creditors, the Trustee (irrespective of whether the principal of the Notes shall
then be due and payable as therein expressed or by declaration or otherwise and irrespective of whether the Trustee shall have made any demand on the Company for the payment of overdue 

  
 52 

 
principal or interest) shall be entitled and empowered, by intervention in such proceeding or otherwise, (1) to file and prove a claim for the whole amount of principal and premium, if any,
and interest owing and unpaid in respect of the Notes and to file such other papers or documents as may be necessary or advisable in order to have the claims of the Trustee (including any claim for the reasonable compensation, expenses,
disbursements and advances of the Trustee, its agents and counsel, and any other amounts due to the Trustee hereunder) and of the Holders of Notes allowed in such judicial proceeding, and (2) to collect and receive any money or other property
payable or deliverable on any such claim and to distribute the same; and any custodian, receiver, assignee, trustee, liquidator or other similar official in any such judicial proceedings is hereby authorized by each Holder of Notes to make such
payments to the Trustee and, in the event that the Trustee shall consent to the making of such payments directly to the Holders of Notes, to pay to the Trustee any amount due to it for the reasonable compensation, expenses, disbursements and
advances of the Trustee, its agents and counsel and any other amounts due the Trustee under Section 7.06 of the Base Indenture. To the extent that the payment of any such compensation, expenses, disbursements and advances of the Trustee, its
agents and counsel, and any other amounts due the Trustee under Section 7.06 of the Base Indenture out of the estate in any such proceeding shall be denied for any reason, payment of the same shall be secured by a Lien on, and shall be paid out
of, any and all distributions, dividends, money, Notes and other properties that the Holders may be entitled to receive in such proceeding whether in liquidation or under any plan of reorganization or arrangement or otherwise. 

Nothing contained herein shall be deemed to authorize the Trustee to authorize or consent to or accept, or adopt on behalf of any Holder of a
Note, any plan of reorganization, arrangement, adjustment or composition affecting the Notes or the rights of any Holder thereof or to authorize the Trustee to vote in respect of the claim of any Holder of a Note in any such proceeding. 

Section 8.10    Trustee May Enforce Claims Without Possession of Notes. All rights of action and claims under
this Indenture or the Notes may be prosecuted and enforced by the Trustee without the possession of any of the Notes or the production thereof in any proceeding relating thereto, and any such proceeding instituted by the Trustee shall be brought in
its own name as trustee of an express trust, and any recovery of judgment shall, after provision for the payment of the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, be for the ratable benefit
of the Holders of the Notes in respect of which such judgment has been recovered. 
 Section 8.11    Restoration
of Rights and Remedies. If the Trustee or any Holder of a Note has instituted any proceeding to enforce any right or remedy under this Indenture and such proceeding has been discontinued or abandoned for any reason, or has been determined
adversely to the Trustee or to such Holder, then and in every such case, subject to any determination in such proceeding, the Company, the Trustee and the Holders of Notes shall be restored severally and respectively to their former positions
hereunder and thereafter all rights and remedies of the Trustee and the Holders shall continue as though no such proceeding had been instituted. 

Section 8.12    Rights and Remedies Cumulative. No right or remedy conferred in this Indenture upon or
reserved to the Trustee or to the Holders of Notes is intended to be exclusive of any other right or remedy, and every right and remedy shall, to the extent permitted 

  
 53 

 
by law, be cumulative and in addition to every other right and remedy given hereunder or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy
hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other appropriate right or remedy. 

Section 8.13    Delay or Omission Not Waiver. No delay or omission of the Trustee or of any Holder of any Note
to exercise any right or remedy accruing upon any Event of Default shall impair any such right or remedy or constitute a waiver of any such Event of Default or any acquiescence therein. Every right and remedy given by this Article or by law to the
Trustee or to the Holders of Notes may be exercised from time to time, and as often as may be deemed expedient, by the Trustee or by the Holders of Notes, as the case may be. 

Section 8.14    Application of Money Collected. Subject to Article 5 hereof, any money and property collected
by the Trustee pursuant to this Article shall be applied in the following order, at the date or dates fixed by the Trustee and, in case of the distribution of such money and property on account of principal or premium, if any, or interest upon
presentation of the Notes and the notation thereon of the payment if only partially paid and upon surrender thereof if fully paid: 
 FIRST:
To the payment of all amounts due the Trustee, including its agents and attorneys; 
 SECOND: To the payment of the amounts then due and
unpaid for principal of and premium, if any, and interest on the Notes in respect of which or for the benefit of which such money has been collected, ratably, without preference or priority of any kind, according to the amounts due and payable on
such Notes for principal and premium, if any, and interest, respectively; and 
 THIRD: Any remaining amounts shall be repaid to the
Company. 
 Section 8.15    Undertaking for Costs. All parties to this Indenture agree, and each Holder of
any Note by such Holder’s acceptance thereof shall be deemed to have agreed, that any court may in its discretion require, in any suit for the enforcement of any right or remedy under this Indenture, or in any suit against the Trustee for any
action taken, suffered or omitted by it as Trustee, the filing by any party litigant in such suit of an undertaking to pay the costs of such suit, and that such court may in its discretion assess reasonable costs, including reasonable
attorneys’ fees, against any party litigant in such suit, having due regard to the merits and good faith of the claims or defenses made by such party litigant; but the provisions of this Section shall not apply to any suit instituted by the
Company, to any suit instituted by the Trustee, to any suit instituted by any Holder, or group of Holders, holding in the aggregate more than 10% in aggregate principal amount of the Notes then outstanding, or to any suit instituted by any Holder of
any Note for the enforcement of the payment of the principal of or premium, if any, or interest on any Note on or after the Final Maturity Date expressed in such Note (or, in the case of exercise of a repurchase right in connection with a
Fundamental Change, on or after the related Fundamental Change Repurchase Date) or for the enforcement of the right to convert any Note in accordance with Article 4. 

  
 54 

 Section 8.16    Waiver of Stay or Extension Laws. The Company
covenants (to the extent that it may lawfully do so) that it will not at any time insist upon, or plead, or in any manner whatsoever claim to take the benefit or advantage of, any stay or extension law wherever enacted, now or at any time hereafter
in force, which may affect the covenants or the performance of this Indenture; and the Company (to the extent that it may lawfully do so) hereby expressly waives all benefit or advantage of any such law and covenants that it will not hinder, delay
or impede the execution of any power herein granted to the Trustee, but will suffer and permit the execution of every such power as though no such law had been enacted. 

Section 8.17    Notice of Defaults. Section 7.13 of the Base Indenture is hereby amended and restated in
full solely with respect to the Notes as follows: The Trustee shall, within 90 days of the occurrence of an Event of Default, of which a Responsible Officer of the Trustee has received written notice or has actual knowledge, give to the registered
Holders notice of all uncured Events of Default known to such Responsible Officer, but the Trustee shall be protected in withholding such notice if the Trustee, in good faith, determines that the withholding of such notice is in the interests of
such registered Holders, except in the case of an Event of Default in the payment of the principal of, or premium, if any, or interest on, any of the Notes when due or, if applicable, in the payment of any repurchase obligation pursuant to Article
3. The Company is also required to deliver to the Trustee, within 30 days after obtaining knowledge of the occurrence of any Event of Default, written notice of such Event of Default, its status and what action the Company is taking or proposing to
take in respect thereof; provided, however, that the Company is not required to deliver such notice if such Event of Default has been cured. 

ARTICLE 9 

AMENDMENTS AND WAIVERS 

Article 9 of the Base Indenture is hereby amended and restated in full, with respect to the Notes, to read as follows: 

Section 9.01    Without Consent of Holders. The Company and the Trustee may also amend or supplement this
Indenture or the Notes without notice to or consent of any Holder of a Note for any of the following purposes: 

(a)    to add to the covenants of the Company for the benefit of the Holders of Notes; 

(b)    to add guarantees with respect to the Company’s obligations under this Indenture or the Notes; 

(c)    to secure the Notes; 

(d)    to surrender any right or power herein conferred upon the Company; 

(e)    to enter into supplemental indentures as described in Section 4.10; 

(f)    to provide for the assumption of the Company’s obligations to the Holders of Notes in the case of a merger,
consolidation, conveyance, transfer or lease pursuant to Article 7; 

  
 55 

 (g)    to increase the Conversion Rate; provided, however, that such
increase in the Conversion Rate shall not adversely, in the good faith opinion of the Board of Directors, affect the interest of the Holders of Notes in any material respect and such increase is made only in compliance with the applicable rules of
the principal securities exchange on which the Common Stock is then listed; 
 (h)    to comply with the requirements of
the SEC in order to effect or maintain the qualification of this Indenture and any supplemental indenture under the TIA; 

(i)    to evidence or provide for the acceptance of the appointment of a successor Trustee; 

(j)    to provide for or confirm the issuance of Additional Notes pursuant to this Indenture; 

(k)    to cure any ambiguity, omission or inconsistency, correct or supplement any provision herein which may be
inconsistent with any other provision herein or which is otherwise defective; provided, however, that such action pursuant to this clause (k) does not, in the good faith opinion of the Board of Directors, adversely affect the interests
of the Holders of Notes in any material respect; and provided further, that no modification or amendment made to conform this Indenture or the Notes to the section of the Prospectus Supplement entitled “Description of the Notes” shall be
deemed to adversely affect the interests of the Holders of the Notes; 
 (l)    to add or modify any other provisions
with respect to matters or questions arising under this Indenture which the Company may deem necessary or desirable and which shall not be inconsistent with the provisions of this Indenture, provided, however, that such action pursuant to
this clause (l) does not adversely affect the interests of the Holders of Notes in any material respect in the good faith opinion of the Board of Directors; or 

(m)    to comply with the Applicable Procedures. 

Section 9.02    With Consent of Holders. Except as provided below in this Section 9.02, this Indenture or
the Notes may be amended or supplemented, and noncompliance by the Company in any particular instance with any provision of this Indenture or the Notes may be waived, in each case (i) with the written consent of the Holders of at least a
majority in aggregate principal amount of the then-outstanding Notes or (ii) by the adoption of a written resolution, at a meeting of Holders of the Notes then outstanding at which a quorum is present, by the Holders of at least a majority in
aggregate principal amount of the then outstanding Notes. 
 Without the written consent or the affirmative vote of each Holder of Notes
affected, an amendment or waiver under this Section 9.02 may not: 
 (a)    change the Final Maturity Date of the
principal of, or any installment of interest on, any Note; 
 (b)    reduce the principal amount of or premium, if any,
on any Note; 

  
 56 

 (c)    reduce the Interest Rate or interest on any Note; 

(d)    change the currency of payment of principal of, premium, if any, or interest on any Note; 

(e)    impair the right of any Holder to institute suit for the enforcement of any payment on or with respect to, or the
conversion of, any Note; 
 (f)    except as permitted by Section 4.10 hereof, adversely affect the right to
convert any Note as provided in Article 4 hereof; 
 (g)    adversely affect the right of Holders to require the Company
to repurchase the Notes in the event of a Fundamental Change or change the times at which, or the circumstances under which, the Notes may or will be repurchased by the Company; 

(h)    modify the subordination provisions of the Notes in a manner adverse to the Holders of Notes; 

(i)    reduce the percentage in aggregate principal amount of the Notes outstanding necessary to modify or amend the
Indenture or to waive any past default; or 
 (j)    reduce the percentage in aggregate principal amount of the Notes
outstanding required for the adoption of a resolution or the quorum required at any meeting of Holders of the Notes at which a resolution is adopted. 

It shall not be necessary for any act of Holders of Notes under this Section to approve the particular form of any proposed supplemental
indenture, but it shall be sufficient if such act shall approve the substance thereof. 
 After an amendment, supplement or waiver under
this Section 9.02 becomes effective, the Company will promptly send to the Holders affected thereby a notice briefly describing the amendment, supplement or waiver. Any failure of the Company to send such notice, or any defect therein, shall
not, however, in any way impair or affect the validity of any such amendment, supplement or waiver. 

Section 9.03    Revocation and Effect of Consents. Until an amendment, supplement or waiver becomes effective,
a consent to it by a Holder of a Note is a continuing consent by the Holder and every subsequent Holder of a Note or portion of a Note that evidences the same debt as the consenting Holder’s Note, even if notation of the consent is not made on
any Note. However, any such Holder or subsequent Holder may revoke the consent as to his Note or portion of a Note if the Trustee receives the notice of revocation before the date the amendment or waiver becomes effective. 

Any amendment or waiver once effective shall bind every Holder affected by such amendment or waiver unless it is of the type described in any
of clauses (a) through (j) of Section 9.02. In that case, the amendment or waiver shall bind each Holder of a Note who has consented to it and every subsequent Holder of a Note or portion of a Note that evidences the same debt as the
consenting Holder’s Note. 

  
 57 

 The Company may, but shall not be obligated to, fix a record date for the purpose of determining
the Holders entitled to give their consent or take any other action described above or required or permitted to be taken pursuant to this Indenture. If a record date is fixed, then notwithstanding the immediately preceding paragraph, those Persons
who were Holders at such record date (or their duly designated proxies), and only those Persons, shall be entitled to give such consent or to revoke any consent previously given or to take any such action, whether or not such Persons continue to be
Holders after such record date. Any amendment to this Indenture or the Notes shall be set forth in a supplemental indenture to the Indenture that complies with the TIA as then in effect. 

Section 9.04    Notation on or Exchange of Notes. The Trustee may place an appropriate notation about an
amendment or waiver on any Note thereafter authenticated. The Company in exchange for Notes may issue and the Trustee shall authenticate upon written request in a Company Order new Notes that reflect the amendment or waiver. 

Section 9.05    Trustee Protected. In executing, or accepting the additional trusts created by, any
supplemental indenture permitted by this Article 9 or the modifications thereby of the trusts created by this Indenture, the Trustee shall not be under any responsibility to determine the correctness of any provisions contained therein, and shall be
entitled to receive, and (subject to Section 7.01 of the Base Indenture) shall be fully protected in relying upon, an Officer’s Certificate and Opinion of Counsel stating that the execution of such amended or supplemental indenture is
authorized or permitted by this Indenture and that the amended or supplemental indenture has been duly authorized, executed and delivered by the Company and is enforceable against the Company in accordance with its terms. Upon the written request of
the Company accompanied by a resolution of its Board of Directors authorizing the execution of any such amended or supplemental indenture, and only upon the receipt of the documents described in this Section and in Section 7.02 of the Base
Indenture, and, if applicable, evidence that the consent of the Holders of the required principal amount of the outstanding Notes has been obtained, the Trustee shall sign all supplemental indentures that are authorized by and conform to the terms
of this Article 9, except that the Trustee may in its discretion but shall not be obligated to, sign any supplemental indenture that in the opinion of the Trustee adversely affects its rights, protections, obligations, duties, liabilities immunities
or indemnities under this Indenture or otherwise. 
 ARTICLE 10 

SATISFACTION AND DISCHARGE 

Article 11 of the Base Indenture is hereby amended and restated in full, with respect to the Notes, to read as follows: 

Section 10.01    Satisfaction and Discharge of Indenture. 

(a)    This Indenture shall, subject to Section 10.01(b), cease to be of further effect with respect to the Notes if:

 (i)    the Company (A) delivers all outstanding Notes (other than Notes which have been
destroyed, lost or stolen and which have been replaced, paid or converted as 

  
 58 

 
provided in Section 2.07 of the Base Indenture) to the Trustee for cancellation or (B)(x) irrevocably deposits or causes to be deposited with the Trustee or the Paying Agent after such Notes
have become due and payable, whether at the Final Maturity Date, upon conversion, or on any Fundamental Change Repurchase Date, Cash (including any Cash in lieu of fractional shares in connection with any conversion) and (y) in the case of a
conversion, delivers to the converting Holders shares of Common Stock (and, if applicable, Cash in lieu of any fractional share) due upon conversion, calculated in accordance with this Indenture sufficient to satisfy all obligations due on all
outstanding Notes and pays all other sums payable under this Indenture; and 
 (ii)    the Company has
delivered to the Trustee (i) irrevocable instructions under this Indenture to apply the deposited money toward payment of the Notes at the Final Maturity Date or at such time as they otherwise are due and payable, as the case may be, and
(ii) an Officer’s Certificate and an Opinion of Counsel, each stating that all conditions precedent provided herein relating to the satisfaction and discharge of this Indenture with respect to the Notes have been complied with. 

(b)    Notwithstanding Section 10.01(a), the obligations of the Company in Sections 2.04 and 2.05 of this
Supplemental Indenture, Sections 2.05, 2.07, 2.08, 5.01, 7.05 and 7.06 of the Base Indenture and in this Article 10 and the other rights, powers, trusts and immunities of the Trustee under the Indenture and the Company’s obligations in
connection therewith, shall survive until the Notes have been paid in full. Thereafter, the obligations of the Company in Sections 705, 7.06, 10.02 and 10.03 and the other rights, powers, trusts and immunities of the Trustee under the Indenture and
the Company’s obligations in connection therewith shall survive such satisfaction and discharge. 
 (c)    The
Trustee, upon request and at the expense of the Company contained in an Officer’s Certificate and at the expense of the Company, shall execute instruments acknowledging such satisfaction and discharge of this Indenture and the Notes prepared by
the Company and satisfactory to the Trustee. 
 Section 10.02    Return of Unclaimed Money. The Trustee and
the Paying Agent shall, subject to any applicable unclaimed property laws, pay to the Company upon written request any money held by them for the payment of principal or premium, if any, or interest that remains unclaimed for two years after the
date upon which such payment shall have become due. Notwithstanding the foregoing, the Trustee and Paying Agent shall have the right to withhold payment of such money to the Company until the Trustee or Paying Agent at the expense of the Company
publishes in a newspaper of general circulation in New York City, or mails to each Holder, a notice stating that such money shall be repaid to the Company if unclaimed after a date no less than 30 days from the publication of such press release or
mailing of such notice. After payment to the Company, all liability of the Trustee and the Paying Agent with respect to such money shall cease, and Holders entitled to the money must look to the Company for payment as general creditors unless an
applicable abandoned property law designates another Person. 
 Section 10.03    Application of Trust Funds;
Indemnification. Subject to the provisions of Section 10.03, all money deposited with the Trustee pursuant to Section 10.01 will be held in trust and applied by it, in accordance with the provisions of the Notes and this

  
 59 

 
Indenture, to the payment, either directly or through any Paying Agent (including the Company acting as its own Paying Agent) as instructed by the Company or as the Trustee may determine, to the
Holder of such Notes, of the principal, premium, if any, and interest for whose payment such money has been deposited with or received by the Trustee, but such money need not be segregated from other funds except to the extent required by law. 

If the Trustee or Paying Agent is unable to apply any of the money in accordance with Section 10.01 by reason of any legal proceeding or
by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, the Company’s obligations under this Indenture and the Securities shall be revived and reinstated as
though no deposit had occurred pursuant to Section 10.01 until such time as the Trustee or Paying Agent is permitted to apply all money in accordance with Section 10.01; provided that if the Company has made any payment of principal
of or interest on Notes because of the reinstatement of its obligations, the Company shall be subrogated to the rights of the Holders of such Notes to receive such payment from the money. 

ARTICLE 11 

MEETING OF HOLDERS OF NOTES 

Section 11.01    Purposes for Which Meetings May Be Called. A meeting of Holders of Notes may be called at any
time and from time to time pursuant to this Article 11 to make, give or take any request, demand, authorization, direction, notice, consent, waiver or other action provided by this Indenture to be made, given or taken by Holders of Notes. 

Notwithstanding anything contained in this Article 11, the Trustee may, during the pendency of a Default or an Event of Default, call a
meeting of Holders of Notes in accordance with its standard practices. 
 Section 11.02    Call Notice and Place
of Meetings. 
 (a)    The Trustee may at any time call a meeting of Holders of Notes for any purpose specified in
Section 11.01 hereof, to be held at such time and at such place in the City of New York as the Trustee shall determine. Notice of every meeting of Holders of Notes, setting forth the time and the place of such meeting, in general terms the
action proposed to be taken at such meeting and the percentage of the principal amount of the then-outstanding Notes which shall constitute a quorum at such meeting, shall be given, in the manner provided in the Indenture hereof, not less than 10
nor more than 60 days prior to the date fixed for the meeting. 
 (b)    In case at any time the Company, pursuant to a
resolution of the Board of Directors and a Company Order, or the Holders of at least 10% in principal amount of the Notes then outstanding shall have requested the Trustee to call a meeting of the Holders of Notes for any purpose specified in
Section 11.01 hereof, by written request setting forth in reasonable detail the action proposed to be taken at the meeting, and the Trustee shall not have made the first publication of the notice of such meeting within 10 days after receipt of
such request or shall not thereafter proceed to cause the meeting to be held as provided herein, then the Company or the Holders of Notes in the amount specified, as the case may be, may determine the time and the

  
 60 

 
place in the City of New York for such meeting and may call such meeting for such purposes by giving notice thereof as provided in paragraph (a) of this Section. 

Section 11.03    Persons Entitled to Vote at Meetings. To be entitled to vote at any meeting of Holders
of Notes, a Person shall be (a) a Holder of one or more outstanding Notes or (b) a Person appointed by an instrument in writing as proxy for a Holder or Holders of one or more outstanding Notes by such Holder or Holders. The only Persons
who shall be entitled to be present or to speak at any meeting of Holders shall be the Persons entitled to vote at such meeting and their counsel, any representatives of the Trustee and its counsel and any representatives of the Company and its
counsel. 
 Section 11.04    Quorum; Action. The Persons entitled to vote a majority in principal amount of
the then-outstanding Notes shall constitute a quorum. In the absence of a quorum within 30 minutes of the time appointed for any such meeting, the meeting shall, if convened at the request of Holders of Notes, be dissolved. In any other case, the
meeting may be adjourned for a period of not less than 10 days as determined by the chairman of the meeting prior to the adjournment of such meeting. In the absence of a quorum at any such adjourned meeting, such adjourned meeting may be further
adjourned for a period of not less than 10 days as determined by the chairman of the meeting prior to the adjournment of such adjourned meeting. Notice of the reconvening of any adjourned meeting shall be given as provided in Section 11.02(a)
hereof, except that such notice need be given only once and not less than five days prior to the date on which the meeting is scheduled to be reconvened. 

At a meeting or an adjourned meeting duly reconvened and at which a quorum is present as aforesaid, any resolution and all matters (except as
limited by the third paragraph of Section 9.02 hereof) shall be effectively passed and decided if passed or decided by the Persons entitled to vote at least a majority in principal amount of the Notes then outstanding. 

Any resolution passed or decisions taken at any meeting of Holders of Notes duly held in accordance with this Section shall be binding on all
the Holders of Notes, whether or not present or represented at the meeting. 
 Section 11.05    Determination of
Voting Rights; Conduct and Adjournment of Meetings. 
 (a)    Notwithstanding any other provisions of this Indenture,
the Trustee may make such reasonable regulations as it may deem advisable for any meeting of Holders of Notes in regard to proof of the holding of Notes and of the appointment of proxies and in regard to the appointment and duties of inspectors of
votes, the submission and examination of proxies, certificates and other evidence of the right to vote, and such other matters concerning the conduct of the meeting as it shall deem appropriate. 

(b)    The Trustee shall, by an instrument in writing, appoint a temporary chairman (which may be the Trustee) of the
meeting, unless the meeting shall have been called by the Company or by Holders of Notes as provided in Section 11.02(b) hereof, in which case the Company or the Holders of Notes calling the meeting, as the case may be, shall in like manner
appoint a temporary chairman. A permanent chairman and a permanent secretary of the meeting 

  
 61 

 
shall be elected by vote of the Persons entitled to vote a majority in principal amount of the outstanding Notes represented at the meeting (even if a quorum is not established). 

(c)    At any meeting, each Holder of a Note or proxy shall be entitled to one vote for each $1,000 principal amount of
the Notes held or represented by him; provided, however, that no vote shall be cast or counted at any meeting in respect of any Security challenged as not outstanding and ruled by the chairman of the meeting to be not outstanding. The
chairman of the meeting shall have no right to vote, except as a Holder of a Note or proxy. 
 (d)    Any meeting of
Holders of Notes duly called pursuant to Section 11.02 hereof at which a quorum is present may be adjourned from time to time by Persons entitled to vote a majority in principal amount of the then-outstanding Notes represented at the meeting,
and the meeting may be held as so adjourned without further notice. 
 Section 11.06    Counting Votes and
Recording Action of Meetings. The vote upon any resolution submitted to any meeting of Holders of Notes shall be by written ballots on which shall be subscribed the signatures of the Holders of Notes or of their representatives by proxy and the
principal amounts and serial numbers of the outstanding Notes held or represented by them. The permanent chairman of the meeting shall appoint two inspectors of votes who shall count all votes cast at the meeting for or against any resolution and
who shall make and file with the secretary of the meeting their verified written reports in duplicate of all votes cast at the meeting. A record, at least in duplicate, of the proceedings of each meeting of Holders of Notes shall be prepared by the
secretary of the meeting and there shall be attached to said record the original reports of the inspectors of votes on any vote by ballot taken thereat and affidavits by one or more Persons having knowledge of the facts setting forth a copy of the
notice of the meeting and showing that said notice was given as provided in Section 11.02 hereof and, if applicable, Section 11.04 hereof. Each copy shall be signed and verified by the affidavits of the permanent chairman and secretary of
the meeting and one such copy shall be delivered to the Company and another to the Trustee to be preserved by the Trustee, the Trustee’s copy to have attached thereto the ballots voted at the meeting. Any record so signed and verified shall be
conclusive evidence of the matters therein stated; provided, however, that the Trustee shall not be required to take or refrain from taking any action based on any vote by the Holders at any such meeting, unless the Trustee shall have
received an Officer’s Certificate and an Opinion of Counsel as required by Section 13.08 of the Base Indenture and the Holders shall have offered the Trustee security or indemnity satisfactory to the Trustee against the costs, expenses and
liabilities that may be incurred by taking or refraining from taking such action, or if in the opinion of the Trustee such action or inaction adversely affects its rights, protections, obligations duties, liabilities, immunities or indemnities under
this Indenture or otherwise. 
 ARTICLE 12 

MISCELLANEOUS 

Section 12.01    Calculations in Respect of Notes. Article 13 of the Base Indenture is hereby supplemented,
with respect to the Notes, to add the following: The Company will be responsible for making all calculations required pursuant to this Supplemental Indenture, including, without limitation, calculations with respect to determinations of the Last
Reported Sale Prices, accrued interest payable on the Notes, the Conversion Price, the Conversion Rate 

  
 62 

 
and Make-Whole Premium. The Company shall make all such calculations in good faith and, absent manifest error, the Company’s calculations shall be binding on the Holders. The Company will
provide a written schedule of such calculations to the Trustee, including in its capacity as the Conversion Agent, and the Trustee shall be entitled to conclusively rely upon the accuracy of the Company’s calculations without responsibility for
independent verification thereof and shall not be responsible for such calculations. The Trustee shall forward a copy of such calculations to any Holder upon such Holder’s written request and at the sole cost and expense of the Company. 

Section 12.02    Notices. Section 13.04 of the Base Indenture is hereby amended and restated in full
solely with respect to the Notes as follows: 
 Any notice or communication by the Company or the Trustee to the other or by a Holder to the
Company or the Trustee is duly given if it is in writing and is delivered in person or sent by first-class mail (registered or certified, return receipt requested), facsimile transmission, or overnight air courier guaranteeing next day delivery, to
the following address and, in the case of notice to the Trustee, has been actually received by a Responsible Officer of the Trustee: 
 if
to the Company: 
 BioMarin Pharmaceutical Inc. 

770 Lindaro Street 
 San Rafael,
California 94901 
 Attention: General Counsel 

if to the Trustee: 
 Wilmington
Trust, National Association 
 1100 North Market Street 

Wilmington, Delaware 19890-0001 

Attention: BioMarin Pharmaceutical Inc. Administrator 

with a copy to: 
 Curtis,
Mallet-Prevost, Colt & Mosle LLP 
 101 Park Avenue 

Suite 3500 
 New York, New York
10178 
 Facsimile No.: (212) 697-1559 

Attention:         Steven J. Reisman, Esq. 

                          
        Raymond T. Hum, Esq. 
 The Company or the Trustee by notice to the other may designate
additional or different addresses for subsequent notices or communications. 
 Any notice or communication to a Holder shall be sent
electronically (in accordance with the Applicable Procedures) or by first-class mail, certified mail, return receipt requested or by 

  
 63 

 
overnight air courier guaranteeing next day delivery to its address shown on the register kept by the Registrar, in accordance with the Applicable Procedures. Failure to mail a notice or
communication to a Holder or any defect in it shall not affect its sufficiency with respect to other Holder of that or any other Series. 

If a notice or communication is sent to any Holder in the manner provided above, within the time prescribed, it is duly given, whether or not
the Holder receives it. Any notice given in accordance with the Applicable Procedures will be deemed to have been provided in writing. 

[SIGNATURE PAGE FOLLOWS] 

  
 64 

 IN WITNESS WHEREOF, the parties hereto have hereunto set their hands as of the date and year
first above written. 
  

			
	BIOMARIN PHARMACEUTICAL INC.
		
	By	 	 /s/ Daniel Spiegelman

	Name:	 	Daniel Spiegelman
	Title:	 	Executive Vice President and Chief Financial Officer

			
	WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee
		
	By	 	 /s/ John T. Needham Jr.

	Name:	 	John T. Needham Jr.
	Title:	 	Vice President

 EXHIBIT A 

[FORM OF FACE OF NOTE] 

[Include the following legend for Global Notes only (the “Global Notes Legend”):]

 [UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY TO THE COMPANY OR ITS
AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (AND ANY
PAYMENT HEREON IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL
SINCE THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. THIS NOTE IS A GLOBAL NOTE WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A DEPOSITARY OR A NOMINEE THEREOF, WHICH MAY BE
TREATED BY THE COMPANY, THE TRUSTEE AND ANY AGENT THEREOF AS OWNER AND HOLDER OF THIS NOTE FOR ALL PURPOSES. THIS NOTE IS EXCHANGEABLE FOR NOTES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITARY OR ITS NOMINEE ONLY IN THE LIMITED
CIRCUMSTANCES DESCRIBED IN THE INDENTURE AND, UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR NOTES IN DEFINITIVE FORM, THIS NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF
THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY.] 

 BIOMARIN PHARMACEUTICAL INC. 

0.599% SENIOR SUBORDINATED CONVERTIBLE NOTES DUE 2024 

NO. [            ] CUSIP: [●] 

BioMarin Pharmaceutical Inc., a Delaware corporation, promises to pay to Cede & Co. or registered assigns the principal amount of
[        ] Dollars ($        ) on August 1, 2024. 

Interest Payment Dates:    February 1 and August 1 of each year, commencing
[                    ]. 
 Regular Record
Dates:    January 15 and July 15 of each year (whether or not a Business Day). 
 This Note shall bear
interest as specified on the other side of this Note. This Note is convertible as specified on the other side of this Note. 
 Additional
provisions of this Note are set forth on the other side of this Note. 
 Dated:
                     
 [SIGNATURE
PAGE FOLLOWS] 

 IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed as of
            ,         . 
  

	
	 BioMarin Pharmaceutical Inc.

	
	 By:

	
	
                      
                                         
         

 Trustee’s Certificate of Authentication: 

This is one of the Notes referred to in the within-mentioned Indenture. 

Wilmington Trust, National Association, as Trustee 
  

			
	 By:
	 	  

		 	Authorized Signatory:

 [FORM OF REVERSE SIDE OF NOTE] 

BIOMARIN PHARMACEUTICAL INC. 

0.599% SENIOR SUBORDINATED CONVERTIBLE NOTES DUE 2024 
  

	1.	INTEREST 

 The Company promises to pay interest on the principal amount of this Note at the rate
of 0.599% per annum. The Company shall pay interest semiannually in arrears on February 1 and August 1 of each year (each, an “Interest Payment Date”), commencing on [date]. Interest on the Notes shall accrue from
the most recent date to which interest has been paid or, if no interest has been paid, from [date]; provided, however, that if there is not an existing default in the payment of interest and if this Note is authenticated between a
record date referred to on the face hereof and the next succeeding Interest Payment Date, such Interest Payment Date. Interest will be computed on the basis of a 360-day year composed of twelve 30-day months. 
 If the Holder elects to require the Company to repurchase this Note pursuant to
Section 5 of this Note, on a date that is after the Regular Record Date and prior to the corresponding Interest Payment Date, interest accrued and unpaid hereon to, but not including, the applicable Fundamental Change Repurchase Date, will be
paid to the Holder in whose name the Notes are registered as of the Close of Business on the Regular Record Date immediately preceding the applicable Fundamental Change Repurchase Date. 

A Holder of any Note at the Close of Business on a Regular Record Date shall be entitled to receive interest on such Note on the corresponding
Interest Payment Date. A Holder of any Note which is converted after the Close of Business on a Regular Record Date and prior to the corresponding Interest Payment Date (other than any Note whose Final Maturity Date is prior to such Interest Payment
Date) shall be entitled to receive interest on the principal amount of such Note, notwithstanding the conversion of such Note prior to such Interest Payment Date. However, any such Holder which surrenders any such Note for conversion during the
period between the Close of Business on such Regular Record Date and ending with the opening of business on the corresponding Interest Payment Date shall be required to pay the Company an amount equal to the interest on the principal amount of such
Note so converted (but excluding any overdue interest on the principal amount of such Note so converted that exists at the time such Holder surrenders such Note for conversion), which is payable by the Company to such Holder on such Interest Payment
Date, at the time such Holder surrenders such Note for conversion. Notwithstanding the foregoing, any such Holder which surrenders for conversion any Note (a) with respect to which the Company has specified a Fundamental Change Repurchase Date
that is after such Regular Record Date and on or prior to the next succeeding Interest Payment Date, (b) to the extent of overdue interest, if any overdue interest exists at the time of conversion with respect to the Note or (c) after the
last Regular Record Date prior to the Final Maturity Date, in either case, shall be entitled to receive (and retain) such interest and need not pay the Company an amount equal to the interest on the principal amount of such Note so converted at the
time such Holder surrenders such Note for conversion. 

 Therefore, for the avoidance of doubt, all record holders on the Regular Record Date immediately
preceding the Final Maturity Date will receive the full interest payment due on the Final Maturity Date regardless of whether their Notes have been converted following such Regular Record Date. 

 

	2.	METHOD OF PAYMENT 

 The Company shall pay interest on this Note (except defaulted interest) to
the Person who is the Holder of this Note at the Close of Business on January 15 and July 15 (whether or not a Business Day), as the case may be (each, a “Regular Record Date”), immediately preceding the related Interest
Payment Date. The Holder must surrender this Note to a Paying Agent to collect payment of principal. The Company will pay principal and interest and Special Interest, if any, in money of the United States that at the time of payment is legal tender
for payment of public and private debts. The Company may pay principal and interest in respect of any Certificated Note to the Holder thereof by check or wire transfer payable in such money; provided, however, that a Holder with an aggregate
principal amount in excess of $5,000,000 will be paid by wire transfer in immediately available funds at the election of such Holder if such Holder has provided wire transfer instructions to the Trustee at least 10 Business Days prior to the Payment
Date. The Company may send an interest check to the Holder’s registered address. Notwithstanding the foregoing, so long as this Note is registered in the name of a Depositary or its nominee, all payments hereon shall be made by wire transfer of
immediately available funds to the account of the Depositary or its nominee. 
 Any wire transfer instructions received by the Trustee will
remain in effect until revoked by the Holder. 
  

	3.	PAYING AGENT, REGISTRAR, CONVERSION AGENT AND NOTICE AGENT 

 Initially, Wilmington Trust,
National Association (the “Trustee,” which term shall include any successor trustee under the Indenture hereinafter referred to) will act as Paying Agent, Registrar, Conversion Agent and Notice Agent. The Company may change any
Paying Agent, Registrar, Conversion Agent and Notice Agent without notice to the Holder. The Company or any of its Subsidiaries may, subject to certain limitations set forth in the Indenture, act as Paying Agent or Registrar. 

 

	4.	INDENTURE, LIMITATIONS 

 This Note is one of a duly authorized issue of Notes of the Company
designated as its 0.599% Senior Subordinated Convertible Notes Due 2024 (the “Notes”), issued under a Base Indenture, dated as of August 11, 2017 (the “Base Indenture”), between the Company and the
Trustee, as supplemented by the First Supplemental Indenture with respect to the Notes, dated as of August 11, 2017 (the Base Indenture, as so supplemented, the “Indenture”). The terms of this Note include those stated in the
Indenture and those required by or made part of the Indenture by reference to the Trust Indenture Act of 1939, as amended, as in effect on the date of the Indenture. This Note is subject to all such terms, and the Holder of this Note is referred to
the Indenture and said Act for a statement of them. 

 The Notes are senior subordinated unsecured obligations of the Company. The Indenture does not
limit the incurrence of additional Notes (subject to certain conditions) or other debt of the Company or its existing or future Subsidiaries, secured or unsecured. 
  

	5.	PURCHASE OF NOTES AT OPTION OF HOLDER UPON A FUNDAMENTAL CHANGE 

 If a Fundamental Change
occurs, at the option of the Holder and subject to the terms and conditions of the Indenture, the Company shall become obligated to purchase for Cash, subject to certain exceptions described in the Indenture all or any part specified by the Holder
(so long as the principal amount of such part is $1,000 or an integral multiple of $1,000 in excess thereof) of the Notes held by such Holder on a Fundamental Change Repurchase Date, which will be a Business Day, specified by the Company that is no
more than 35, nor less than 20, Business Days after the date of the Fundamental Change Company Notice, at a purchase price equal to 100% of the principal amount thereof together with unpaid interest accrued to, but excluding, the Fundamental Change
Repurchase Date. A Fundamental Change Company Notice shall be given by the Company to the Trustee and the Holders as provided in the Indenture. To exercise such repurchase right, a Holder must deliver to the Trustee a Fundamental Change Repurchase
Notice as provided in the Indenture. 
  

	6.	NO REDEMPTION AT THE OPTION OF THE COMPANY 

 The Company may not redeem the Notes prior to the
Final Maturity Date. The Notes are not subject to redemption through the operation of any sinking fund or otherwise. 
  

	7.	CONVERSION 

 Subject to and upon compliance with the provisions of the Indenture, a Holder may
surrender for conversion any Note that is $1,000 in principal amount or an integral multiple of $1,000 in excess thereof. 
 Subject to
certain conditions provided for in the Indenture, in certain circumstances, a Holder may receive an amount in Common Stock equal to the Make-Whole Premium, in addition to the consideration due upon conversion of such Note. 

The Conversion Rate shall be initially equal to 8.0212 shares of Common Stock per $1,000 principal amount of the Notes. The Conversion Rate
shall be adjusted under certain circumstances as provided in the Indenture. 
 No fractional share of Common Stock shall be issued upon
conversion of a Note. Instead, the Company shall pay a Cash adjustment as provided in the Indenture. Subject to the terms of the Indenture, upon conversion of any Note, the Company deliver to the converting Holder in respect of each $1,000 principal
amount of the Notes being converted, a number of shares of Common Stock equal to the Conversion Rate in effect on the Conversion Date for such conversion, together with Cash, if applicable, in lieu of delivering any fractional share of Common Stock.

	8.	SUBORDINATION 

 The Indebtedness evidenced by this Note is, to the extent and in the manner
provided in the Indenture, subordinated and subject in right of payment to the prior payment in full of all amounts then due on all Senior Debt of the Company; provided, however, that the Notes, the Indebtedness represented thereby and the
payment of the principal of and premium, if any, and interest on the Notes in all respects shall rank equally with, or prior to, all existing and future Indebtedness of the Company that is expressly subordinated to any Senior Debt, and this Note is
issued subject to such provisions of the Indenture with respect thereto. Each Holder of this Note, by accepting the same, (a) agrees to and shall be bound by such provisions, (b) authorizes and directs the Trustee on such Holder’s
behalf to take such action as may be necessary or appropriate to effectuate the subordination so provided and (c) appoints the Trustee such Holder’s
attorney-in-fact for any and all such purposes. 
  

	9.	DENOMINATIONS, TRANSFER, EXCHANGE 

 The Notes are in registered form, without coupons, in
minimum denominations of $1,000 in principal amount and integral multiples of $1,000 in excess thereof. A Holder may register the transfer of or exchange Notes in accordance with the Indenture. The Registrar may require a Holder, among other things,
to furnish appropriate endorsements and transfer documents and to pay any taxes or other governmental charges that may be imposed in relation thereto by law or permitted by the Indenture. 

 

	10.	PERSONS DEEMED OWNERS 

 The Holder of a Note may be treated as the owner of it for all purposes.

  

	11.	UNCLAIMED MONEY 

 If money for the payment of principal or interest remains unclaimed for two
years, the Trustee and any Paying Agent will, subject to any applicable unclaimed property laws, pay the money back to the Company at its written request, subject to applicable unclaimed property law and the provisions of the Indenture. After that,
Holders entitled to money must look to the Company for payment as general creditors unless an applicable abandoned property law designates another Person. 
  

	12.	DISCHARGE PRIOR TO MATURITY. 

 Subject to certain conditions contained in the Indenture, the
Company may discharge its obligations under the Notes and the Indenture if the Company (A) delivers all outstanding Notes to the Trustee for cancellation or (B)(x) deposits with the Trustee or the Paying Agent after such Notes have become due
and payable, whether at stated maturity, upon conversion, or on any Fundamental Change Repurchase Date, Cash (including any Cash in lieu of fractional shares in connection with any conversion) and (y) in the case of a conversion, delivers to
the converting Holders shares of Common Stock (and, if applicable, Cash in lieu of any fractional share) due upon conversion, calculated in accordance with this Indenture sufficient to satisfy all obligations due on all outstanding Notes and pays
all other sums payable under this Indenture. 

	13.	AMENDMENT, SUPPLEMENT AND WAIVER 

 The Indenture permits, with certain exceptions as therein
provided, the amendment thereof and the modification of the rights and obligations of the Company and the rights of the Holders of the Notes under the Indenture at any time by the Company and the Trustee with the consent of the Holders of at least a
majority in aggregate principal amount of the Notes then outstanding. Certain waivers or consents require the consent of the Holder of a Note to be binding on such Holder. Any such consent or waiver by the Holders of this Note shall be conclusive
and binding upon such Holders and upon all future Holders of this Note and of any Note issued upon registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or waiver is made upon this Note or
such other Note. The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Notes at the time outstanding, on behalf of the Holders of all the Notes, to waive compliance by the Company with
certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. 
 No reference herein to the
Indenture and no provision of this Note or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of and premium, if any, and interest on this Note at the times, places and
rate, and in the coin or currency, herein prescribed or to convert this Note as provided in the Indenture. 
  

	14.	SUCCESSOR ENTITY 

 When a successor corporation assumes all the obligations of its predecessor
under the Notes and the Indenture in accordance with the terms and conditions of the Indenture, the predecessor corporation (except in certain circumstances specified in the Indenture) shall be released from those obligations. 

 

	15.	DEFAULTS AND REMEDIES 

 If an Event of Default shall occur and be continuing, the principal of
all the Notes may be declared due and payable in the manner and with the effect provided in the Indenture. 
  

	16.	TRUSTEE DEALINGS WITH THE COMPANY 

 Wilmington Trust, National Association, the initial Trustee
under the Indenture, in its individual or any other capacity, may make loans to, accept deposits from and perform services for the Company or an Affiliate of the Company, and may otherwise deal with the Company or an Affiliate of the Company, as if
it were not the Trustee. 
  

	17.	NO RECOURSE AGAINST OTHERS 

 A director, officer, employee or shareholder, as such, of the
Company shall not have any liability for any obligations of the Company under the Notes or the Indenture nor for any claim based on, in respect of or by reason of such obligations or their creation. The Holder of this Note by accepting this Note
waives and releases all such liability. The waiver and release are part of the consideration for the issuance of this Note. 

	18.	AUTHENTICATION 

 This Note shall not be valid until the Trustee or an authenticating agent
manually signs the certificate of authentication on the other side of this Note. 
  

	19.	ABBREVIATIONS AND DEFINITIONS 

 Customary abbreviations may be used in the name of the Holder or
an assignee, such as: TEN COM (= tenants in common), TEN ENT (= tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian) and UGMA (= Uniform Gifts to Minors Act). 

All terms defined in the Indenture and used in this Note but not specifically defined herein are defined in the Indenture and are used herein
as so defined. 
  

	20.	CUSIP NUMBERS 

 Pursuant to a recommendation promulgated by the Committee on Uniform Note
Identification Procedures, the Company has caused CUSIP numbers to be printed on this Note. No representation is made as to the accuracy of such numbers either as printed on this Note or otherwise and reliance may be placed only on the other
identification numbers placed thereon. 
  

	21.	INDENTURE TO CONTROL; GOVERNING LAW 

 In the case of any conflict between the provisions of this
Note and the Indenture, the provisions of the Indenture shall control. This Note and the Indenture shall be governed by, and construed in accordance with, the laws of the State of New York applicable to agreements made and to be performed in such
state. 
 The Company will furnish to any Holder, upon written request and without charge, a copy of the Indenture. Requests may be made to:
BioMarin Pharmaceutical Inc., 770 Lindaro Street, San Rafael, California, 94901, Attention: Corporate Counsel, Facsimile No.: (415) 382-7889, Telephone No.: (415)
506-6700. 

 ASSIGNMENT FORM 

To assign this Note, fill in the form below: 
 I or we assign
and transfer this Note to 
  
  

(Insert assignee’s soc. sec. or tax I.D. no.) 
  

 
  

 
  

 
 (Print or type assignee’s name, address and zip
code) and irrevocably appoint 
  
  

Agent to transfer this Note on the books of the Company. The agent may substitute another to act for him or her. 

 

									
	Date:	 	                                     
                       	 		 	Your Signature:	 	  

		 		 		 		 	(Sign exactly as your name appears on the other side of this Note)

  

			
	 *  Signature guaranteed by:

		
	By:	 	
                     

  

	*	The signature must be guaranteed by an institution which is a member of one of the following recognized signature guaranty programs: (i) the Notes Transfer Agent Medallion Program (STAMP); (ii) the New York Stock
Exchange Medallion Program (MSP); (iii) the Stock Exchange Medallion Program (SEMP); or (iv) such other guaranty program acceptable to the Trustee. 

 CONVERSION NOTICE 

To convert this Note, check the box: 
  

☐ 
 To convert only part of this Note,
state the principal amount to be converted (must be $1,000 or an integral multiple of $1,000 in excess thereof): $        . 

If you want the Cash paid to another Person or the stock certificate made out in another Person’s name, fill in the form below: 

 
  

(Insert assignee’s soc. sec. or tax I.D. no.) 
  

 
  

 
  

 
 (Print or type assignee’s name, address and zip
code) and irrevocably appoint 
  
  

Agent to transfer this Note on the books of the Company. The agent may substitute another to act for him or her. 

 

									
	Date:	 	                                     
                           	 		 	Your Signature:	 	  

		 		 		 		 	(Sign exactly as your name appears on the other side of this Note)
				
	 *  Signature guaranteed by:
	 		 		 	

									
					
	By:	 	
                     

	 		 		 	

  

	*	The signature must be guaranteed by an institution which is a member of one of the following recognized signature guaranty programs: (i) the Notes Transfer Agent Medallion Program (STAMP); (ii) the New York Stock
Exchange Medallion Program (MSP); (iii) the Stock Exchange Medallion Program (SEMP); or (iv) such other guaranty program acceptable to the Trustee. 

 FUNDAMENTAL CHANGE REPURCHASE NOTICE 

 

	To:	BioMarin Pharmaceutical Inc. 

 The undersigned registered owner of this Note hereby irrevocably
acknowledges receipt of a notice from BioMarin Pharmaceutical Inc. (the “Company”) as to the occurrence of a Fundamental Change with respect to the Company and requests and instructs the Company to purchase the entire principal
amount of this Note, or the portion thereof (which is $1,000 in principal amount or an integral multiple of $1,000 in excess thereof) below designated, in accordance with the terms of the Indenture referred to in this Note at the Fundamental Change
Repurchase Price to the registered Holder hereof. 
  

									
	Date:	 	
                     

	 		 	Your Signature:	 	
                     

 Signature(s) must be guaranteed by a qualified guarantor institution with membership in an approved signature guarantee
program pursuant to Rule 17Ad-15 under the Securities Exchange Act of 1934. 
  

 
 Signature Guaranty 

Principal amount to be repurchased (in an integral multiple of $1,000, if less than all): 

NOTICE: The signature to the foregoing Election must correspond to the Name as written upon the face of this Note in every particular, without any alteration
or change whatsoever. 

 SCHEDULE OF EXCHANGES OF NOTES 

The following exchanges, purchase, repurchases, purchases or conversions of a part of this Global Note have been made: 

 

									
	 Date of Exchange
	 	 Amount of

Decrease in

Principal Amount

of this Note
	 	 Amount of Increase

in Principal

Amount of this

Note
	  	 Principal Amount

of this Global Note

following Each

Increase or

Decrease
	  	
Signature of
Authorized Officer
of Trusteenano-ex101_6.htm

 

Exhibit 10.1

 

NANOMETRICS INCORPORATED

August 9, 2017

Timothy J. Stultz, Ph.D.

1550 Buckeye Drive

Milpitas, CA 95035

 

RE: Transition and Consulting Agreement

Dear Tim:

As you know, you have notified the Board of Directors (the “Board”) of your plans to retire from your positions as President and Chief Executive Officer of Nanometrics Incorporated (the “Company”) and thereby terminate your employment with the Company, but have agreed to stay on until a successor CEO has been named.  This letter sets forth the terms of the transition and consulting agreement (the “Agreement”) that the Company is offering to you in connection with your retirement and employment transition.

1.Retirement and Resignation.  Your employment with the Company will continue through the date on which the Company appoints a successor CEO, or such earlier date as the Company may determine in its sole discretion, which will become your retirement and employment termination date (the “Retirement Date”).  The Retirement Date will be determined by the Company based on the recruiting process for the successor CEO, and you will be notified of the actual Retirement Date prior to such date. 

2.Transition Period.  From the date you sign this Agreement until the Retirement Date (the “Transition Period”), you will remain the Company’s President and CEO, on the following terms:

(a)Transition Period Duties.  You will report to the Board and will make yourself available to perform your assigned duties and responsibilities, and to transition these duties and responsibilities, as reasonably requested by the Board and in a manner consistent with the Company’s policies and procedures. 

(b)Transition Period Salary and Bonus.  During the Transition Period, you will continue to be paid a base salary at the rate of $41,666.66 per month (which is equivalent to $500,000 per year), which base salary shall be paid according to the Company’s regular payroll practices (the “Base Salary”).  You also will continue to remain eligible to earn (i) an annual bonus for Fiscal Year 2017 in accordance with the performance goals previously established and communicated to you under the terms of the Company’s Executive Performance Bonus Program, as approved by the Board (the “Bonus Plan”), with a target bonus of $500,000 for such Fiscal Year, and (ii) an annual bonus for Fiscal Year 2018 under the Bonus Plan fixed at $500,000, which, in each case, will be subject to standard deductions and withholdings and (except as set forth below) prorated for any partial employment during the year in which the Retirement Date 

 

August 9, 2017
Timothy J, Stultz, Ph.D.

Page 2

 

 

occurs.  As an additional benefit under this Agreement, in the event that the Retirement Date occurs prior to December 31, 2017, and provided that your employment has not terminated for Cause (as defined below): (i) the Company will continue to pay your Base Salary in the form of severance payments, subject to standard deductions and withholdings, from the Retirement Date through December 31, 2017; and (ii) notwithstanding your employment termination prior to the end of Fiscal Year 2017, which would otherwise reduce your eligibility for a bonus to a prorated bonus amount, you will remain eligible to receive, without proration, your full year annual bonus for 2017, as determined in accordance with the performance goals previously established and communicated to you pursuant to the terms and conditions of the Bonus Plan, and such bonus amount, if awarded, will be paid to you on or before March 15, 2018, as an additional severance payment and subject to standard deductions and withholdings.   In addition, in the event the Retirement Date has not occurred by January 31, 2018, the Company shall discuss with you and consider in good faith what if any additional compensation should become payable to you with respect to Fiscal Year 2018 in light of the anticipated duration and responsibilities of your continued service as CEO in that Fiscal Year.  

(c)Transition Period Benefits.  During the Transition Period, you will: (a) remain eligible to participate in Company benefit plans, including basic health coverage and the Executive Health Care Plan, pursuant to the terms and conditions of those plans as they may be amended from time to time, as applicable to all plan participants; (b) receive a car allowance in the amount of $1,200 per month (prorated for any partial months of employment service), subject to any applicable taxes; and (c) be eligible for a 401(k) match pursuant to the Company’s 401(k) policy as applicable to executive employees.  For the avoidance of doubt, during the Transition Period you will not be eligible for any other benefits other than as set forth in this paragraph, including without limitation, any enhanced benefits with respect to a change in control as may be set forth in any Company policy, plan or agreement, including but not limited to the Severance Agreement (as defined in Paragraph 8 below).

(d)Equity Awards.  The unvested restricted stock units (“RSUs”) and performance stock units (“PSUs”) held by you as of the date hereof are set forth on Exhibit A hereto.  Vesting of your outstanding RSUs and PSUs (collectively, the “Equity Awards”) will continue during the Transition Period and so long as you continue to serve as a director or as a consultant to the Company pursuant to Paragraphs 6 and 7 below, and during such period you will continue to be treated as a Service Provider under the Equity Award documents.  Your Equity Awards will continue to be governed by the terms of the applicable Equity Award documents; provided that upon a Change in Control as defined in the Severance Agreement (a “Change in Control”), your Equity Awards will vest in full.

(e)Employment Termination.  Nothing in this Agreement alters your employment at will status.  Either you or the Company may terminate your employment at any time during the Transition Period, with or without Cause (as defined below), upon notice to the other.  If the Company terminates your employment without Cause, then you will remain eligible to be retained by the Company as a consultant (as defined and described in Paragraph 7 below), provided that you satisfy all conditions set forth in Paragraph 7 below for such engagement.  If prior to the Retirement Date you resign your employment or the Company terminates your employment for Cause, then you will not be entitled to be retained as a consultant as set forth below.  For purposes of this Agreement, “Cause” for termination will mean any one or more of 

 

 

 

August 9, 2017
Timothy J, Stultz, Ph.D.

Page 3

 

 

the following:  (i) your willful gross misconduct; (ii) your unjustifiable neglect of your duties (as determined in the good faith judgment of the Board); (iii) your acting in any manner that has a direct, substantial and adverse effect on the Company or its reputation; (iv) your repeated material failure or repeated refusal to comply with reasonable written policies, standards and regulations established by the Company from time to time which failure, if curable, is not cured to the reasonable satisfaction of the Board during the thirty (30) day period following written notice of such failure from the Company; (v) any tortious act, unlawful act or malfeasance which causes or reasonably could cause (for example, if it became publicly known) material harm to the Company’s standing, condition or reputation; (vi) any material breach by you of the provisions of any confidential information agreement with the Company or other material improper disclosure of the Company’s confidential or proprietary information; (vii) your theft, dishonesty, or falsification of any Company records; (viii) your being found liable in any Securities and Exchange Commission or other civil or criminal securities law action or entering any cease and desist order with respect to such action (regardless of whether or not you admit or deny liability); or (ix) you (A) obstructing or impeding; (B) endeavoring to influence, obstruct or impede, or (C) failing to materially cooperate with, any investigation authorized by the Board or any governmental or self-regulatory entity (an “Investigation”). However, your failure to waive attorney-client privilege relating to communications with your own attorney in connection with an Investigation will not constitute “Cause.”  

3.Accrued Salary.  On the Retirement Date, the Company will pay you all accrued salary earned by you through the Retirement Date, less standard payroll deductions and withholdings.  You will receive this payment when your employment ends regardless of whether you enter into this Agreement.  You acknowledge and agree that, consistent with our policy and practice of non-accrual of vacation time for executives, as of the Retirement Date you will not have any accrued but unused vacation or paid time off for which you are entitled to payment.

4.Expense Reimbursement.  You agree that, within thirty (30) days of the Retirement Date, you will submit your documented expense reimbursement statement reflecting all business expenses you incurred through the Retirement Date, if any, for which you seek reimbursement.  The Company will reimburse you promptly for such expenses pursuant to its regular business practice.

5.Health Insurance Benefits After the Retirement Date.  Your participation in the Company’s employee benefit plans will continue in the same manner as in effect on the date hereof through the Retirement Date and then terminate on the Retirement Date, except to the extent such benefits continue to be available to you as a member of the Company’s Board pursuant to Paragraph 6 below.  To the extent provided by the federal COBRA law or, if applicable, state insurance laws (collectively, “COBRA”), and by the Company’s current group health insurance policies, you will be eligible to continue your group health insurance benefits at your own expense after the Retirement Date.  You will be provided with a separate notice describing your rights and obligations under COBRA laws on or after the Retirement Date.  

6.Board Position.  You may continue to serve as a member of the Board, so long as you have been nominated and elected to the Board, in accordance with the Company’s by-laws and applicable law, and on the following terms:

 

 

 

August 9, 2017
Timothy J, Stultz, Ph.D.

Page 4

 

 

(a)Board Status.  For the duration of your Board membership, you will serve as a non-executive member of the Board who is not an independent member.  Accordingly, you will not serve on any committees of the Board.  

(b)Compensation.  During any period of your Board membership when you are not an employee, you will be eligible to receive cash and equity compensation for serving as a member of the Board on the same basis as other non-employee directors of the Company at such time (the “Director Compensation”).  For avoidance of doubt, you shall not be provided with any Director Compensation during any period that you are an employee, and the Director Compensation will be prorated from the period of time between the Retirement Date and the date of the Company’s next annual meeting following the Retirement Date, provided you remain a member of the Board during such time.  The Company will not withhold any amount for taxes, social security or other payroll deductions from the Director Compensation.  The Company will report the Director Compensation on an IRS Form 1099.  You acknowledge that you will be entirely responsible for payment of any taxes that may be due on the Director Compensation.  You will not be eligible for any other cash compensation, including without limitation any bonus or incentive payments, for your service as a member of the Board.

(c)Benefits.  You will be eligible to participate in the Company’s basic health coverage and Executive Health Care Plan on the same terms and conditions as other non-executive members of the Board, pursuant to the terms and conditions of those plans and subject to possible changes from time to time.  You will not be eligible to participate in any other Company benefit plans or receive any fringe or other benefits.

(d)Equity Awards.  Vesting of your outstanding Equity Awards will continue during your service as a member of the Board; provided, however, that except with respect to any tranches of PSUs scheduled to vest in February 2018, which shall vest (if at all) in accordance with their terms, the vesting schedule of the PSUs shall be converted to a time-based schedule, such that each tranche shall vest on its Vesting Date (as defined in the documentation evidencing such PSUs) at the target level so long as you continue to be a member of the Board or a consultant on that date, without regard to any achievement of performance criteria above or below such level.  Your Equity Awards will otherwise continue to be governed by the terms of the applicable Equity Award documents; provided that upon a Change in Control, your Equity Awards will vest in full.  Your service as a member of the Board or consultant pursuant to this Agreement will constitute Continuous Status as a Service Provider under the Company’s 2005 Equity Incentive Plan, as amended (the “2005 Plan”).

7.Consulting Agreement After Retirement.  If you timely return this fully-executed Agreement to the Company, allow it to become effective, and on or within twenty-one (21) days after the Retirement Date execute and return to the Company the Retirement Date Release attached hereto as Exhibit B, and allow the releases contained in the Retirement Date Release to become effective, the Company will retain you as a consultant under the terms specified below.

(a)Consulting Period.  The consulting relationship will be deemed to have commenced on the Retirement Date and will continue until March 31, 2020, unless terminated earlier pursuant to Paragraph 7(i) below or extended by agreement of you and the Company (the 

 

 

 

August 9, 2017
Timothy J, Stultz, Ph.D.

Page 5

 

 

“Consulting Period”).  Any agreement to extend the Consulting Period after the initial period must be set forth in writing signed by you and a duly authorized officer or director of the Company.

(b)Consulting Services.  You agree to provide consulting services to the Company in any area of your expertise, including but not limited to, assisting in the transition of your job duties, supporting the new president or CEO of the Company and being available to provide advice as needed, and completing other assignments as requested (the “Consulting Services”) by the CEO.  During the Consulting Period, you will report directly to the CEO.  You agree to exercise the highest degree of professionalism and utilize your expertise and creative talents in performing these services.  You agree to make yourself available to perform such Consulting Services throughout the Consulting Period, up to a maximum of 50 hours per quarter, at times mutually agreed between you and the CEO.  You will not be required to report to the Company’s offices during the Consulting Period, except as specifically requested by the Company for a matter that could not reasonably be accomplished otherwise.  When providing such services, you shall abide by the Company’s policies and procedures.

(c)Independent Contractor Relationship.  Your relationship with the Company during the Consulting Period will be that of an independent contractor, and nothing in this Agreement is intended to, or should be construed to, create a partnership, agency, joint venture or employment relationship after the Retirement Date.  You will not be entitled to any of the benefits that the Company may make available to its employees, including but not limited to, group health or life insurance, profit-sharing or retirement benefits, and you acknowledge and agree that your relationship with the Company during the Consulting Period will not be subject to the Fair Labor Standards Act or other laws or regulations governing employment relationships. 

(d)Consulting Fees.  During any period of time during the Consulting Period when you are not a member of the Board, and provided that you remain in compliance with this Agreement, you will receive consulting fees (“Consulting Fees”) in the amount of $4,166.66 per month (equivalent to $50,000 annually).  For the avoidance of doubt, for any time during the Consulting Period that you also are serving as a member of the Board, you will not receive additional compensation beyond the Director Compensation for the Consulting Services.  Because you will be providing the Consulting Services as an independent contractor, the Company will not withhold any amount for taxes, social security or other payroll deductions from the Consulting Fees.  The Company will report the Consulting Fees on an IRS Form 1099.  You acknowledge that you will be entirely responsible for payment of any taxes that may be due on the Consulting Fees.  The Consulting Fees will be paid on the last business day of each respective calendar month of service during the Consulting Period (pro-rated for any partial months of service).  During the Consulting Period you will not be eligible for any other cash compensation as a consultant (other than reimbursement of reasonable business expenses pursuant to the Company’s regular business practice), including without limitation any bonus or incentive payments, for the Consulting Services.

(e)Equity Awards.  Vesting of your outstanding Equity Awards will continue during the Consulting Period; provided, however, that except with respect to any tranches of PSUs scheduled to vest in 2018, which shall vest (if at all) in accordance with their 

 

 

 

August 9, 2017
Timothy J, Stultz, Ph.D.

Page 6

 

 

terms, the vesting schedule of the PSUs shall be converted to a time-based schedule, such that each tranche shall vest on its Vesting Date (as defined in the documentation evidencing such PSUs) at the target level so long as you remain a consultant under this Agreement without regard to any achievement of performance criteria above or below such level.  Your Equity Awards will otherwise continue to be governed by the terms of the applicable Equity Award documents; provided that upon a Change in Control, your Equity Awards will vest in full.  Your service as a consultant during the Consulting Period under this Agreement shall constitute Continuous Status as a Service Provider for purposes of the 2005 Plan.

(f)Limitations on Authority.  You will have no responsibilities or authority as a consultant to the Company other than as provided above.  You will have no authority to bind the Company to any contractual obligations, whether written, oral or implied, except with the written authorization of the CEO.  You agree not to represent or purport to represent the Company in any manner whatsoever to any third party unless authorized by the Company, in writing, to do so.

(g)Proprietary Information and Inventions.  You agree that, during the Consulting Period and thereafter, you will not use or disclose any confidential or proprietary information or materials of the Company, including any confidential or proprietary information that you obtained or developed at any time during your employment with the Company or as a member of the Board, and any confidential or proprietary information that you obtain or develop in the course of performing the Consulting Services.  Notwithstanding the foregoing, pursuant to 18 U.S.C. Section 1833(b), you shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that:  (1) is made in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law; or (2) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  Any and all work product you create in the course of performing the Consulting Services will be the sole and exclusive property of the Company.  You hereby assign to the Company all right, title, and interest in all inventions, techniques, processes, materials, and other intellectual property developed in the course of performing the Consulting Services.  You further acknowledge and reaffirm your continuing obligations under your At-Will Employment, Confidential Information, Invention Assignment and Arbitration Agreement signed and dated 8/27/07.

(h)Other Work Activities.  Throughout the Consulting Period, you retain the right to engage in employment, consulting, or other work relationships in addition to your work for the Company.  The Company will make reasonable arrangements to enable you to perform your work for the Company at such times and in such a manner so that it will not interfere with other activities in which you may engage.  In order to protect the trade secrets and confidential and proprietary information of the Company, you agree that, during the Consulting Period, you will not obtain employment with or perform competitive work for any business entity, or engage in any other work activity that is competitive with the Company.  If you engage in such competitive activity without the Company’s express written consent, or otherwise materially breach this Agreement, then (in addition to any other rights and remedies available to the Company at law, in equity or by contract), the Company’s obligation to pay you Consulting Fees will cease immediately.

 

 

 

August 9, 2017
Timothy J, Stultz, Ph.D.

Page 7

 

 

(i)Termination of Consulting Period.  The Consulting Period will terminate upon a Change in Control, at which time any unvested Equity Awards will vest in full. Without waiving any other rights or remedies, the Company may terminate immediately the Consulting Period and its corresponding obligation to pay you Consulting Fees for Cause.  In addition, you may terminate the Consulting Period at any time, for any reason, upon written notice to the Company.  Upon termination of the Consulting Period upon a Change in Control, by the Company for Cause or by you for any reason, the Company will pay only those Consulting Fees earned and expenses incurred through and including the date on which the termination of the Consulting Period becomes effective, and your obligations under this Agreement will remain in full force and effect.

(j)Section 4999.  Notwithstanding anything to the contrary in this Agreement, if you reasonably determine (which determination shall not be binding on the Company for its tax reporting or accounting purposes or any other purpose) that  the acceleration of the vesting of Equity Awards upon a Change in Control would result in you being subject to the excise tax imposed by Section 4999 of the Internal Revenue Code, then the vesting of the Equity Awards shall be accelerated only to the maximum extent that would not cause imposition of an excise tax imposed by Section 4999 of the Code and such Equity Awards that have not had their vesting accelerated because of this sentence shall continue to vest in accordance with their normal vesting schedule and the Consulting Period shall continue through the period of such vesting schedule; provided, however, that such Equity Awards shall instead vest into the consideration received by the stockholders of the Company in the Change in Control, as determined by the Board.  To the extent required to be specified for purposes of Section 409A or other tax purposes, the ordering of the Equity Award tranches to have accelerated vesting upon a Change in Control shall be those tranches of Equity Awards with the latest vesting dates first and continuing based on timing of vesting dates until the tranches of Equity Awards with the earliest vesting dates are accelerated.  To the extent that the vesting of all Equity Awards is not accelerated upon a Change in Control pursuant to this paragraph, the determination of the number of and the specific tranches of Equity Awards that shall accelerate and those that shall maintain their normal vesting schedule in order to not cause imposition on you of an excise tax imposed by Section 4999 of the Code shall be determined pursuant to this paragraph by the Company’s then-current accounting firm or another nationally-recognized accounting firm designated by the Company, subject to your reasonable review of such determination.

8.No Other Compensation or Benefits.  You agree and acknowledge that you are not entitled to any severance benefits in connection with your employment resignation, whether pursuant to that certain General Severance Benefits and Change in Control Severance Benefits Agreement between you and the Company, dated May 19, 2015 (the “Severance Agreement”), or otherwise.  By executing this Agreement, you hereby further agree and acknowledge that any such compensation or benefits are extinguished, including without limitation that you are no longer eligible for and you waive all rights you may have to benefits under the Severance Agreement.  You further agree and acknowledge that the consideration provided in this Agreement is in lieu of (or in satisfaction of) and supersedes any other compensation or benefits that you may be entitled to receive from the Company or its predecessors or affiliates under any other agreement or promise (including but not limited to any wages, severance benefits, bonuses, incentive pay, equity, or other compensation or benefits) other than benefits that had vested as of the date of this Agreement.  You further acknowledge that, except as expressly provided in this 

 

 

 

August 9, 2017
Timothy J, Stultz, Ph.D.

Page 8

 

 

Agreement, you have not earned and will not receive from the Company any additional fees, compensation, severance, or benefits on or after the Retirement Date.  

9.Return of Company Property.  You agree to return to the Company, on the Retirement Date or earlier if requested by the Company, all Company documents (and all copies thereof) and other property of the Company in your possession or control, including, but not limited to, Company files, notes, correspondence, memoranda, notebooks, drawings, records, reports, lists, compilations of data, proposals, agreements, drafts, minutes, studies, plans, forecasts, purchase orders, financial and operational information, product and training information, research and development information, sales and marketing information, personnel and compensation information, vendor information, promotional literature and instructions, product specifications and manufacturing information, computer-recorded information, electronic information (including e-mail and correspondence), other tangible property and equipment (including, but not limited to, computer equipment, devices, PDAs, facsimile machines, and cellular telephones), credit cards, entry cards, identification badges and keys; and any materials of any kind that contain or embody any proprietary or confidential information of the Company (and all reproductions thereof in whole or in part).  You agree that you will make a diligent search to locate any such documents, property and information prior to the Retirement Date.  In addition, if you have used any personally owned computer, server, or e-mail system to receive, store, review, prepare or transmit any Company confidential or proprietary data, materials or information, then you agree to provide the Company, on your Retirement Date (or earlier if requested by the Company), with a computer-useable copy of all such information and then permanently delete and expunge such Company confidential or proprietary information from those systems without retaining any reproductions (in whole or in part); and you agree to provide the Company access to your system as requested to verify that the necessary copying and/or deletion is done.  Your timely compliance with this Paragraph 9 is a precondition to your receipt of the benefits under this Agreement.  Notwithstanding the foregoing, you may retain Company property as reasonably required in connection with your Board membership and all contact information for persons you knew prior to joining the Company, and with whom you developed a relationship during your employment with the Company.  In addition, following the Retirement Date the Company may permit you to receive and/or use certain documents and/or information reasonably necessary to perform the Consulting Services, all of which you shall return to the Company by the last day of the Consulting Period, or earlier upon the Company’s request, without retaining any copies or embodiments (in whole or in part).

10.Cooperation and Assistance.  You agree to voluntarily cooperate fully with the Company at the Company’s expense in connection with its actual or contemplated defense, prosecution, or investigation of any claims or demands by or against third parties, or other matters arising from events, acts, or failures to act that occurred during the period of your employment by the Company.  Such cooperation includes, without limitation, making yourself available to the Company upon reasonable notice, without subpoena, to provide complete, truthful and accurate information in witness interviews, depositions, and trial testimony.

11.No Admissions.  Nothing contained in this Agreement shall be construed as an admission by you or the Company of any liability, obligation, wrongdoing or violation of law.

12.Release of Claims.

 

 

 

August 9, 2017
Timothy J, Stultz, Ph.D.

Page 9

 

 

(a)General Release.  In exchange for the consideration provided to you under this Agreement to which you would not otherwise be entitled, you hereby generally and completely release the Company, and its parents, subsidiaries, successors, predecessors, and affiliated entities, and each of such entities’ respective current and former directors, officers, employees, shareholders, partners, agents, attorneys, predecessors, successors, insurers, affiliates, and assigns (collectively, the “Released Parties”) of and from any and all claims, liabilities and obligations, both known and unknown, that arise out of or are in any way related to events, acts, conduct, or omissions occurring prior to or on the date you sign this Agreement (collectively, the “Released Claims”).

(b)Scope of Release.  The Released Claims include, but are not limited to:  (i) all claims arising out of or in any way related to your employment with the Company, or the decision to terminate such employment; (ii) all claims related to your compensation or benefits from the Company, including salary, bonuses, commissions, vacation pay, paid time off, expense reimbursements, severance pay, fringe benefits, stock, stock options, or any other ownership interests in the Company; (iii) all claims for breach of contract, wrongful termination, and breach of the implied covenant of good faith and fair dealing; (iv) all tort claims, including claims for fraud, defamation, emotional distress, and discharge in violation of public policy; and (v) all federal, state, and local statutory claims, including claims for discrimination, harassment, retaliation, attorneys’ fees, or other claims arising under the federal Civil Rights Act of 1964 (as amended), the federal Americans with Disabilities Act of 1990, the federal Age Discrimination in Employment Act of 1967 (as amended) (the “ADEA”), the Fair Labor Standards Act, the Employee Retirement Income Security Act of 1974, the Worker Adjustment and Retraining Notification Act, the California Labor Code (as amended), and the California Fair Employment and Housing Act (as amended).

(c)Excluded Claims and Protected Rights.  Notwithstanding the foregoing, the following are not included in the Released Claims (the “Excluded Claims”):  (i) any rights or claims for indemnification you may have pursuant to any written indemnification agreement with the Company to which you are a party, the charter, bylaws, or operating agreements of the Company, or under applicable law; (ii) any rights which are not waivable as a matter of law; and (iii) any claims for breach of this Agreement.  In addition, you understand that nothing in this Agreement limits your ability to file a charge or complaint with the Equal Employment Opportunity Commission, the National Labor Relations Board, the Occupational Safety and Health Administration, the Securities and Exchange Commission or any other federal, state or local governmental agency or commission (“Government Agencies”).  You further understand this Agreement does not limit your ability to communicate with any Government Agencies or otherwise participate in any investigation or proceeding that may be conducted by any Government Agency, including providing documents or other information, without notice to the Company.  While this Agreement does not limit your right to receive an award for information provided to the Securities and Exchange Commission, you understand and agree that, to maximum extent permitted by law, you are otherwise waiving any and all rights you may have to individual relief based on any claims that you have released and any rights you have waived by signing this Agreement.  You hereby represent and warrant that, other than the Excluded Claims, you are not aware of any claims you have or might have against any of the Released Parties that are not included in the Released Claims.

 

 

 

August 9, 2017
Timothy J, Stultz, Ph.D.

Page 10

 

 

(d)ADEA Waiver.  You acknowledge that you are knowingly and voluntarily waiving and releasing any rights you may have under the ADEA, and that the consideration given for the waiver and release in this Paragraph 12(d) is in addition to anything of value to which you are already entitled.  You further acknowledge that you have been advised, as required by the ADEA, that:  (i) your waiver and release do not apply to any rights or claims that may arise after the date that you sign this Agreement; (ii) you should consult with an attorney prior to signing this Agreement (although you may choose voluntarily not to do so); (iii) you have twenty-one (21) days in which to consider this Agreement (although you may choose voluntarily to sign it earlier); (iv) you have seven (7) days following the date you sign this Agreement to revoke the Agreement (by providing written notice of your revocation to the Board); and (v) this Agreement will not be effective until the date upon which the revocation period has expired, which will be the eighth day after the date that this Agreement is signed by you provided that you do not revoke it.

(e)Waiver of Unknown Claims.  In giving the releases set forth in this Agreement, which include claims which may be unknown to you at present, you acknowledge that you have read and understand Section 1542 of the California Civil Code which reads as follows: “A general release does not extend to claims which the creditor does not know or suspect to exist in his or her favor at the time of executing the release, which if known by him or her must have materially affected his or her settlement with the debtor.”  You hereby expressly waive and relinquish all rights and benefits under that section and any law or legal principle of similar effect in any jurisdiction with respect to your release of claims herein, including but not limited to the release of unknown and unsuspected claims.

13.Representations.  You hereby represent that you have been paid all compensation owed and for all hours worked, have received all the leave and leave benefits and protections for which you are eligible pursuant to the federal Family and Medical Leave Act, the California Family Rights Act, or any other applicable law or Company policy, and you have not suffered any on-the-job injury or illness for which you have not already filed a workers’ compensation claim.

14.Section 409A.

(a)The payments and benefits provided under this Agreement are intended to be exempt from, or comply with, the provisions of Section 409A of the Internal Revenue Code of 1986, as amended and the regulations and other guidance thereunder and any state law of similar effect (collectively “Section 409A”) and this Agreement shall be interpreted accordingly.  Any payments and benefits provided pursuant to this Agreement which constitute “deferred compensation” within the meaning of the Treasury Regulations issued pursuant to Section 409A that are paid or provided on termination of service shall not commence until you have incurred a “separation from service,” as such term is defined in Section 409A (“Separation From Service”), unless the Company reasonably determines that such amounts may be provided to you without causing you to incur the additional 20% tax under Section 409A.

(b)For purposes of Section 409A, your right to receive any installment payments under this Agreement (whether severance payments, reimbursements or otherwise) shall be treated as a right to receive a series of separate payments and, accordingly, each 

 

 

 

August 9, 2017
Timothy J, Stultz, Ph.D.

Page 11

 

 

installment payment hereunder shall at all times be considered a separate and distinct payment.  Notwithstanding any provision to the contrary in this Agreement, if the Company (or, if applicable, the successor entity thereto) determines that any payments upon your Separation From Service set forth herein and/or under any other agreement with the Company constitute “deferred compensation” under Section 409A and you are, on your Separation From Service, a “specified employee” of the Company or any successor entity thereto, as such term is defined in Section 409A(a)(2)(B)(i) of the Code, then, solely to the extent necessary to avoid the incurrence of the adverse personal tax consequences under Section 409A, the timing of the payments upon your Separation From Service shall be delayed until the earlier to occur of: (a) the date that is six months and one day after your Separation From Service or (b) the date of your death (such applicable date, the “Specified Employee Initial Payment Date”).  On the Specified Employee Initial Payment Date, the Company (or the successor entity thereto, as applicable) shall (A) pay you a lump sum amount equal to the sum of the payments upon your Separation From Service that you would otherwise have received through the Specified Employee Initial Payment Date if the commencement of the payment of the severance benefits had not been so delayed pursuant to this section and (B) commence paying the balance of the severance benefits in accordance with the applicable payment schedules set forth in this Agreement.

(c)With respect to reimbursements or in-kind benefits provided to you hereunder (or otherwise) that are not exempt from Section 409A, the following rules shall apply: (i) the amount of expenses eligible for reimbursement, or in-kind benefits provided, during any one of your taxable years shall not affect the expenses eligible for reimbursement, or in-kind benefit to be provided in any other taxable year, (ii) in the case of any reimbursements of eligible expenses, reimbursement shall be made on or before the last day of your taxable year following the taxable year in which the expense was incurred, (iii) the right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit.  If payments or benefits hereunder are subject to the execution of a valid release and the release revocation period could cross two years, amounts will be paid or provided in the second of the two years, to the extent necessary to avoid adverse tax treatment under Section 409A.

15.Indemnification and Insurance.   Your service during the Transition Period and Board service shall each constitute service for which indemnification and advancement of expenses is provided under the Indemnity Agreement dated as of February 20, 2013, which shall remain in full force and effect, and you shall be indemnified for your service during the Consulting Period to the maximum extent permitted by law, the Company’s Certificate of Incorporation or Bylaws.  With respect to your service during the Transition Period and your Board service, you shall have coverage under a director’s and officer’s liability insurance policy in amounts no less than and on terms no less favorable than those as provided to other members of the Board and senior executive officers of the Company.   

16.Miscellaneous.  This Agreement, including its exhibits and together with your signed At-Will Employment, Confidential Information, Invention Assignment and Arbitration Agreement, constitutes the complete, final and exclusive embodiment of the entire agreement between you and the Company with regard to its subject matter.  It is entered into without reliance on any promise or representation, written or oral, other than those expressly contained herein, and it supersedes any other such promises, warranties or representations.  This Agreement may not be modified or amended except in a written agreement signed by both you 

 

 

 

August 9, 2017
Timothy J, Stultz, Ph.D.

Page 12

 

 

and a duly authorized officer of the Company.  This Agreement will bind the heirs, personal representatives, successors and assigns of both you and the Company, and inure to the benefit of both you and the Company, and their heirs, successors and assigns.  This Agreement shall not be terminated by the voluntary or involuntary dissolution of the Company or by any merger or consolidation where the Company is not the surviving corporation, or upon any transfer of all or substantially all of the Company’s stock or assets.  In the event of such merger, consolidation or transfer, the provisions of this Agreement shall be binding upon and shall inure to the benefit of the surviving corporation or corporation to which such stock or assets of the Company shall be transferred.  As used in this Agreement, “Company” shall mean the Company as herein before defined and any successor to its business and/or assets as aforesaid.  If any provision of this Agreement is determined to be invalid or unenforceable, in whole or in part, this determination will not affect any other provision of this Agreement and the provision in question shall be deemed modified so as to be rendered enforceable in a manner consistent with the intent of the parties, insofar as possible under applicable law.  Any ambiguity in this Agreement shall not be construed against either party as the drafter.  Any waiver of a breach of this Agreement, or rights hereunder, shall be in writing and shall not be deemed to be a waiver of any successive breach or rights hereunder.  This Agreement shall be deemed to have been entered into, and shall be construed and enforced, in accordance with the laws of the State of California without regard to conflicts of law principles.  This Agreement may be executed in counterparts, each of which shall be deemed to be part of one original, and facsimile and electronic signatures shall be equivalent to original signatures. 

If this Agreement is acceptable to you, please sign below on or within 21 days after the date of this Agreement, and send me the fully signed Agreement.  If you do not sign and return it to the Company within the aforementioned timeframe, the Company’s offer to enter into this Agreement will expire.

Sincerely,

Nanometrics Incorporated

By:/s/ Janet Taylor

Janet Taylor

General Counsel

 

Understood and Agreed:

/s/ Timothy J. Stultz
Timothy J. Stultz

 

Date: 8-9-17___________________

 

 

 

 

 

 

 

 

Exhibit A

Unvested RSUs and PSUs Held by You

As of August 9, 2017 

			
	
 
	
Grant Date
	
Number of Shares

	
RSUs
	
2/8/2017
	
26,500

	
2/22/2016
	
30,000

	
2/24/2015
	
13,333

	
PSUs
	
2/8/2017
	
26,500

	
2/22/2016
	
30,000

	
3/18/2015
	
13,333

 

 

 

Exhibit B

 

Retirement Date Release

 

(To be signed and returned on or within twenty-one (21) days after the Retirement Date.)

 

In consideration for the benefits provided to me by Nanometrics Incorporated (the “Company”) pursuant to the terms of the transition and consulting agreement between me and the Company dated August 9, 2017 (the “Agreement”) which I would otherwise not be entitled to receive, I hereby release Company, and its parents, subsidiaries, successors, predecessors, and affiliated entities, and each of such entities’ current or former officers, directors, agents, servants, employees, partners, representatives, shareholders, attorneys, employee benefit plans, successors, and assigns (collectively, the “Released Parties”), of and from any and all claims, liabilities, demands, causes of action, costs, expenses, attorneys fees, damages, indemnities and obligations of every kind and nature, in law, equity, or otherwise, known and unknown, suspected and unsuspected, arising out of or in any way related to any agreements, events, acts or conduct at any time prior to and including the date I sign this Retirement Date Release (the “Release”) (collectively, the “Released Claims”).  The Released Claims include, but are not limited to:  (i) all claims arising out of or in any way related to my employment with the Company, or the termination of that employment; (ii) all claims related to compensation or benefits from the Company, including salary, bonuses, commissions, vacation, paid time off, expense reimbursements, severance pay, fringe benefits, stock, stock options, or any other ownership, equity, or profits interests in the Company; (iii) all claims for breach of contract, wrongful termination, and breach of the implied covenant of good faith and fair dealing; (iv) all tort claims, including claims for fraud, defamation, emotional distress, and discharge in violation of public policy; and (v) all federal, state, and local statutory claims, including claims for discrimination, harassment, retaliation, attorneys’ fees, or other claims arising under the federal Civil Rights Act of 1964 (as amended), the federal Americans with Disabilities Act of 1990, the federal Age Discrimination in Employment Act of 1967 (as amended) (the “ADEA”), the Fair Labor Standards Act, the Employee Retirement Income Security Act of 1974, the Worker Adjustment and Retraining Notification Act, the California Labor Code (as amended), and the California Fair Employment and Housing Act (as amended).

 

The following are not included in the Released Claims (the “Excluded Claims”):  (i) any rights or claims for indemnification I may have pursuant to any written indemnification agreement with the Company to which I am a party or under applicable law; (ii) any rights which cannot be waived as a matter of law; (iii) any rights I have to file or pursue a claim for workers’ compensation or unemployment insurance; and (iv) any claims for breach of this Agreement.  In addition, I understand that nothing in this Agreement limits my ability to file a charge or complaint with the Equal Employment Opportunity Commission, the National Labor Relations Board, the Occupational Safety and Health Administration, the Securities and Exchange Commission or any other federal, state or local governmental agency or commission (“Government Agencies”).  I further understand this Agreement does not limit my ability to communicate with any Government Agencies or otherwise participate in any investigation or proceeding that may be conducted by any Government Agency, including providing documents or other information, without notice to the Company.  While this Agreement does not limit my 

 

August 9, 2017
Timothy J, Stultz, Ph.D.

Page 2

 

 

right to receive an award for information provided to the Securities and Exchange Commission, I understand and agree that, to maximum extent permitted by law, I am otherwise waiving any and all rights I may have to individual relief based on any claims that I have released and any rights I have waived by signing this Agreement.  I represent and warrant that, other than the Excluded Claims, I am not aware of any claims I have or might have against any of the Released Parties that are not included in the Released Claims.

 

I acknowledge that I am knowingly and voluntarily waiving and releasing any rights I may have under the ADEA (“the “Release ADEA Waiver”), and that the consideration given for the Release ADEA Waiver is in addition to anything of value to which I am already entitled.  I further acknowledge that I have been advised by this writing, as required by the ADEA, that:  (a) my waiver and release does not apply to any rights or claims that may arise after the date I sign this Release; (b) I should consult with an attorney prior to signing this Release (although I may voluntarily decide not to do so); (c) I have twenty-one (21) days to consider this Release (although I may choose voluntarily to sign this Release sooner); (d) I have seven (7) days following the date I sign this Release to revoke it (in a written revocation sent to and received by the Company’s Board of Directors); and (e) this Release will not be effective until the date upon which the revocation period has expired, unexercised, which will be the eighth day after I sign it.

 

In giving the general release herein, which includes claims which may be unknown to me at present, I acknowledge that I have read and understand Section 1542 of the California Civil Code, which reads as follows:  “A general release does not extend to claims which the creditor does not know or suspect to exist in his or her favor at the time of executing the release, which if known by him or her must have materially affected his or her settlement with the debtor.”  I hereby expressly waive and relinquish all rights and benefits under that section and any law or legal principle of similar effect in any other jurisdiction of with respect to my release of claims contained herein, including but not limited to the release of unknown and unsuspected claims.

I hereby confirm that I have been paid all salary and other compensation owed to me for my services to the Company through the Retirement Date; I have received all leave and leave-related benefits to which I was entitled during my employment with the Company, pursuant to the federal Family and Medical Leave Act, the California Family Rights Act, or any other applicable law or Company policy; and I have not suffered any workplace injury or illness for which I have not already filed a claim.

 

 

By:

Timothy J. Stultz

 

Date:

B-2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00273-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00273-of-00352.parquet"}]]